DEVELOPMENT AND APPLICATIONS OF THE HINT FORCEFIELD IN PREDICTION OF ANTIBIOTIC EFFLUX AND VIRTUAL SCREENING FOR ANTIVIRALS by Sarkar, Aurijit
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
2010
DEVELOPMENT AND APPLICATIONS OF
THE HINT FORCEFIELD IN PREDICTION
OF ANTIBIOTIC EFFLUX AND VIRTUAL
SCREENING FOR ANTIVIRALS
Aurijit Sarkar
Virginia Commonwealth University
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Pharmacy and Pharmaceutical Sciences Commons
© The Author
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in
Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/2266
 DEVELOPMENT AND APPLICATIONS OF THE HINT FORCEFIELD IN PREDICTION 
OF ANTIBIOTIC EFFLUX AND VIRTUAL SCREENING FOR ANTIVIRALS 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of  
Doctor of Philosophy at Virginia Commonwealth University. 
 
 
 
by 
 
 
AURIJIT SARKAR 
M.Sc. Shri GS Institute of Technology & Science, Indore MP, India 2003 
B.Sc. Devi Ahilya University, Indore MP, India 2000 
 
Advisor: GLEN EUGENE KELLOGG, Ph.D. 
ASSOCIATE PROFESSOR, DEPARTMENT OF MEDICINAL CHEMISTRY & 
INSTITUTE FOR STRUCTURAL BIOLOGY AND DRUG DISCOVERY  
 
Virginia Commonwealth University 
Richmond VA 
 
August 2010 
 
 
ii 
 
 
 
 
 
 
 
“The woods are lovely dark and deep, 
But I have promises to keep, 
And miles to go before I sleep, 
And miles to go before I sleep” 
 
 
 
 
- Robert Frost 
(1874-1963) 
From Stopping by Woods on a Snowy Evening 
 
 
iii 
 
 
 
Acknowledgements 
 
This work is dedicated to all those people in my life who have shown unwavering 
faith in my capabilities and edged me on toward success. 
My parents, Cdr. Biswajit Sarkar (Indian Navy, retd.) and Mrs. Sumita Sarkar 
have always been there to support me in times of need. More importantly, they have 
never failed to steer me in the right direction whenever I strayed. Without their guidance 
and support, I would never have reached this far. Their love and care are gratefully 
acknowledged. I hope I have proven myself worthy of being called their son. 
Dr. Glen Kellogg, my doctoral advisor, has taught me much across the past five 
years. His contribution to my development as a scientist can never be matched. Without 
his constant support, I would be lost in this great and scary world of research. I will 
never forget his lessons, which will be a guiding light till my dying day. 
I will always be indebted to Dr. Richard Westkaemper, Dr. Umesh Desai, Dr. H. 
Tonie Wright and Dr. W. Mike Holmes, who have served as members of my graduate 
student committee, for their patient efforts in transforming my many ineptitudes into 
(perhaps) some potential. 
A lone man may find success in life, but never happiness. Friends play an 
important role in the development of an individual, often providing support and lending a 
sympathetic ear. However, Pinky Vinaykya‘s role in my life stands out. I may not have 
liked the truths she made me face, but they transformed my life forever! Her role in my 
transformation into a mature adult remains unparalleled. 
iv 
 
 
 
My life in Richmond and my successful completion of my doctoral degree would 
have been much harder, if not for my friends Nida, Maria and Tamara. Their acceptance 
of my eccentric ways and constant need for attention has been a boon. I gratefully 
acknowledge the role of their friendship in my life. 
I would also like to thank School of Pharmacy and the Department of Medicinal 
Chemistry, Virginia Commonwealth University for the financial assistance I received 
during the initial phase of my PhD, without which I perhaps would not dare to venture so 
far away from home. 
  
v 
 
 
 
Table of Contents 
Acknowledgements ….……………………………………………………………… 
Table of contents…………………………………………………………………….. 
List of tables………………………………………………………………………...... 
List of figures ………………………………………………………………………… 
List of schemes ……………………………………………………………………… 
Abstract ……………………………………………………………………………….. 
 
Chapter 
iii 
v 
viii 
ix 
xi 
xii 
 
Page 
1. Hydrophobicity: theories, estimation and applications ………………… 
1.1 Hydrophobicity and biological phenomena ……………………… 
1.2 A brief historical overview of hydrophobicity ……………………. 
1.3 Calculations of hydrophobicity and the hydrophobic effect…… 
1.3.1 Estimation of LogPo/w …………………………………………. 
1.4 Hydrophobicity scales and protein folding ………………………. 
1.5 LogP in drug design …………………………………………………. 
1.6 The Lipinski ―Rule of 5‖ ……………………………………………… 
1.6.1 Hydrophobicity in QSAR ……………………………………. 
1.6.2 Quantification of hydrophobic interactions ……………… 
1.7 The HINT paradigm ………………………………………………….. 
1.7.1     Intermolecular interaction analysis …………………………. 
1.7.2     Computational titration ……………………………………….. 
1.7.3     Analysis of briding waters ……………………………………. 
1.7.4     3D-QSAR with HINT …………………………………………… 
1.8 Aims and overview of this work ……………………………………. 
1.9 References …………………………………………………………….. 
2. Predicting efflux of antibiotics by AcrA-AcrB-TolC efflux pumps: a 
‗systems hydropathy‘ approach ……………………………………………. 
2.1 Introduction ……………………………………………………………. 
2.2 Experimental section …………………………………………………. 
2.2.1 Crystal structures of AcrB and TolC ……………………….. 
2.2.2 Efflux data and substrate molecules ……………………….. 
2.2.3 Docking and scoring ………………………………………… 
2.2.4 LogP calculations …………………………………………….. 
2.2.5 Prediction of molecular width by molecular dynamics 
calculations ……………………………………………………. 
2.2.6 3D-QSAR methods ……………………………………………. 
2.2.7 The systems hydropathy method …………………………… 
2.3 Results and discussion ………………………………………………. 
2.3.1 3D-QSAR ………………………………………………………. 
2.3.2 What factors might affect efflux? ……………………………. 
2.3.3 Systems hydropathy ………………………………………….. 
2.3.4 Model and descriptor interpretation ……………………….. 
1 
1 
2 
7 
7 
18 
21 
22 
26 
31 
32 
35 
37 
37 
38 
39 
42 
 
51 
51 
55 
55 
56 
59 
63 
 
63 
64 
65 
66 
68 
72 
73 
81 
vi 
 
 
 
2.4 Conclusions …………………………………………………………… 
2.5 References …………………………………………………………….. 
3. Targeting parainfluenza virus type 3 by virtual screening: the need for 
new tools ……………………………………………………………………….. 
3.1 An introduction to human parainfluenza viruses …………………. 
3.2 Hemagglutinin-neuraminidase in HPIV3 replication …………….. 
3.3 Inhibition of hemagglutinin-neuraminidase stops viral activity … 
3.3.1 Neuraminidase assays ……………………………………….. 
3.3.2 Fusion assay …………………………………………………… 
3.3.3 Plaque reduction assay ………………………………………. 
3.3.4 Hemadsorption assay ………………………………………… 
3.3.5 Neuraminic acid interaction with HN mediates membrane 
fusion …………………………………………………………… 
3.3.6 DANA and GANA inhibit hemagglutinin function of HN….. 
3.4 Virtual screening for HN inhibitors ………………………………….. 
3.4.1 Pharmacophore identification ………………………………. 
3.4.2 Design of queries ……………………………………………… 
3.4.3 Seggregation of drug-like and non drug-like compounds...  
3.4.4 Docking ………………………………………………………… 
3.4.5 Scoring of docked positions ……………………………….. 
3.5 Probing antiviral mechanism ……………………………………….. 
3.6 Probems with docking ………………………………………………. 
3.7 Summary ……………………………………………………………….. 
3.8 References …………………………………………………………….. 
4. Sidechain optimization using backbone-dependent rotamer libraries and 
HINT …………………………………………………………………………….. 
4.1 The induced-fit theory ………………………………………………… 
4.2 Emulating induced-fit in computational algorithms …………….... 
4.3 Designing our own algorithm – the cogs and wheels…………… 
4.3.1 Rotamer libraries ………………………………………………. 
4.3.1.1 Backbone-independent rotamer libraries….. 
4.3.1.2 Backbone-dependent rotamer libraries ……. 
4.3.2 Choice of scoring function …………………………………… 
4.4 The SCWRL algorithm ………………………………………………... 
4.4.1 SCWRL ―successfully‖ identifies ―correct‖ sidechain 
positions …………………………………… 
4.4.1.1 Initial sidechain rotamer placement ………… 
4.4.1.2 ―cluster‖ parsing method …………………….. 
4.4.1.3 Criteria for ―success‖ ………………………….. 
4.4.2 Can the HINT scoring function complement the SCWRL 
rotamer library? ……………………………………… 
4.5 The HINTaSCWRL algorithm ………………………………………… 
4.5.1 The backbone-dependent rotamer library …………. 
4.5.2 The HINTaSCWRL scoring function ………………... 
93 
95 
 
100 
100 
101 
102 
102 
103 
104 
105 
 
105 
106 
107 
107 
111 
112 
113 
115 
115 
116 
120 
122 
 
125 
125 
126 
127 
128 
128 
129 
133 
133 
 
134 
134 
135 
135 
 
136 
137 
139 
139 
vii 
 
 
 
4.5.3 Sorting through clashes and bad interactions ….. 
4.6 The test set …………………………………………………………….. 
4.7 HINTaSCWRL output analysis ………………………………………. 
4.7.1 Analysis of sidechain RMSD ………………………………… 
4.7.2 RMSD as a function of solvent accessible surface area…. 
4.7.3 Analysis of average RMSD per residue type ……………… 
4.8 Selected HINTaSCWRL output structures …………………………. 
4.8.1 Specific case studies …………………………………………. 
4.9 Conclusions …………………………………………………………… 
4.10 Future directions ………………………………………………………. 
4.11 References …………………………………………………………….. 
5. Conclusions …………………………………………………………………… 
5.1 References …………………………………………………………….. 
Appendices …………………………………………………………………………… 
Appendix A. List of hits from virtual screening for hemagglutinin-
neuraminidase inhibitors……………………………… ……………………….. 
Appendix   B. Descriptor values for all antibiotics………………………….. 
Vita ……………………………………………………………………………………… 
140 
140 
141 
142 
147 
151 
154 
154 
160 
162 
165 
167 
170 
172 
 
172 
178 
180 
 
 
  
viii 
 
 
 
List of Tables 
Table 1.1  Various types of methods for LogP calculations ……………………… 
Table 2.1  Efflux and molecular parameters for data set molecules …………….. 
Table 2.2  Efflux predictions for data set molecules ……………………………….. 
Table 2.3  Classification accuracy of efflux predictive model ……………………. 
Table 2.4  Fractional contribution of descriptors to models ……………………… 
Table 3.1  HINT analysis of inhibitors at site I and II of HN ………………………. 
Table 4.1  χ1 and χ2 bin limits ………………………………………………………….. 
 
8 
60 
77 
78 
82 
116 
131 
 
 
 
 
 
 
  
ix 
 
 
 
List of Figures 
Figure 1.1 The hydrophobic effect ……………………………………………….. 
Figure 1.2 3D QSAR ……………………………………………………………….... 
Figure 1.3 HINT map for the molecule of tyrosine ……………………………… 
Figure 2.1 Docking efflux substrates into different regions of AcrB and TolC..  
Figure 2.2 Calculation of molecular width ……………………………………….. 
Figure 2.3 Training set and test set validations for 3D-QSAR models ………. 
Figure 2.4 Correlation btween ALogPs predicted LogP values and efflux … 
Figure 2.5 Correlation plots for predicted vs. experimental efflux as obtained 
with the systems hydropathy approach …………………………… 
Figure 2.6 Systems hydropathy validation ……………………………………… 
Figure 2.7 Surface maps for TolC …………………………………………………. 
Figure 2.8 Relationship between efflux and individual descriptors ............... 
Figure 2.9 Proposed efflux mechanism ………………………………………….. 
Figure 3.1 Principle of the fusion assay ………………………………………… 
Figure 3.2 Interactions of HPIV3 HN ………………………………………………. 
Figure 3.3 Queries on the ZINC database ………………………………………... 
Figure 3.4 Sample structures rejected by visual inspection …………………… 
Figure 3.5 Structure of ZINC02857325…………………………………………… 
Figure 3.6 Interactions of GANA and ZINC02857325 with site II of HPIV3 HN. 
Figure 3.7 Rotation of residue sidechains improves docking scores ……… 
Figure 4.1 RMSD values for individual amino acid residue sidechains ……. 
4 
30 
33 
62 
64 
71 
74 
 
79 
80 
87 
88 
92 
102 
109 
112 
113 
118 
119 
121 
143 
x 
 
 
 
Figure 4.2 RMSD as a function of Log(SASA) in HINTaSCWRL output files… 
Figure 4.3 Overall RMSD across all residues as a function of Log(SASA) … 
Figure 4.4 Average RMSD for each type of amino acid residue …………….. 
Figure 4.5 Graphical representation of RMSD …………………………………. 
Figure 4.6 RMSD values plotted for each residue of 2CYG, 2VC8 and 4EUG.. 
Figure 4.7 Positions of sidechain showing highest deviation ……………… 
148 
150 
152 
156 
159 
161 
 
 
  
xi 
 
 
 
List of Schemes 
Scheme 1.1 Fragmental methods for determination of LogP values ……………… 
Scheme 1.2 Atom contribution methods ……………………………………………… 
Scheme 1.3 A parabolic relationship exists between drug potency and 
hydrophobicity ……………………………………………………………. 
Scheme 1.4 Hansch Analysis …………………………………………………………. 
Scheme 1.5 The HINT Paradigm ……………………………………………………… 
Scheme 2.1 Chemical structures for the -lactam antibiotic compounds ……….. 
Scheme 2.2 The chemical structures for the non--lactam antibiotic compounds  
12 
13 
 
23 
28 
34 
57 
58 
 
  
xii 
 
 
 
 
 
ABSTRACT 
 
DEVELOPMENT AND APPLICATIONS OF THE HINT FORCEFIELD IN PREDICTION 
OF ANTIBIOTIC EFFLUX AND VIRTUAL SCREENING FOR ANTIVIRALS 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of  
Doctor of Philosophy at Virginia Commonwealth University 
by 
AURIJIT SARKAR 
M.Sc. Shri GS Institute of Technology & Science, Indore MP, India 2003 
B.Sc. Devi Ahilya University, Indore MP, India 2000 
 
VIRGINIA COMMONWEALTH UNIVERSITY, 2010 
 
Advisor: GLEN EUGENE KELLOGG, Ph.D. 
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This work was aimed at developing novel tools that utilize HINT, an empirical 
forcefield capable of quantitating both hydrophobic and hydrophilic (hydropathic) 
interactions, for implementation in theoretical biology and drug discovery/design.  
xiii 
 
 
 
The role of hydrophobicity in determination of macromolecular structure and 
formation of complexes in biological molecules is undeniable and has been the subject 
of research across several decades. Hydrophobicity is introduced, with a review of its 
history and contemporary theories. This is followed by a description of various methods 
that quantify this all-pervading phenomenon and their use in protein folding and 
contemporary drug design projects – including a detailed overview of the HINT 
forcefield. 
The specific aim of this dissertation is to introduce our attempts at developing 
new methods for use in the study of antibacterial drug resistance and antiviral drug 
discovery. Multidrug efflux is commonly regarded as a fast growing problem in the field 
of medicine. Several species of microbes are known to have developed resistance 
against almost all classes of antibiotics by various modes-of-action, which include 
multidrug transporters (a.k.a. efflux pumps). These proteins are present in both gram-
positive and gram-negative bacteria and extrude molecules of various classes. They 
protect the efflux pump-expressing bacterium from harmful effects of exogenous agents 
by simply evacuating the latter. Perhaps the best characterized mechanism amongst 
these is that of the AcrA-AcrB-TolC efflux pump. Data is available in literature and 
perhaps also in proprietary databases available with pharmaceutical companies, 
characterizing this pump in terms of the minimum inhibitory concentration ratios (MIC 
ratios) for various antibiotics. We procured a curated dataset of 32 β-lactam and 12 
antibiotics of other classes from this literature. Initial attempts at studying the MIC ratios 
of β-lactam antibiotics as a function of their three dimensional topology via 3D-
xiv 
 
 
 
quantitative structure activity relationship (3D-QSAR) technology yielded seemingly 
good models. However, this methodology is essentially designed to address single 
receptor-ligand interactions. Molecules being transported by the efflux pump must 
undoubtedly be involved in multiple interactions with the same. Notably, such methods 
require a pharmacophoric overlap of ligands prior to the generation of models, thereby 
limiting their applicability to a set of structurally-related compounds. Thus, we designed 
a novel method that takes various interactions between antibiotic agents and the AcrA-
AcrB-TolC pump into account in conjunction with certain properties of the drugs. This 
method yielded mathematical models that are capable of predicting high/low efflux with 
significant efficiency (>93% correct). The development of this method, along with the 
results from its validation, is presented herein. 
A parallel aim being pursued by us is to discover inhibitors for hemagglutinin-
neuraminidase (HN) of human parainfluenza virus type 3 (HPIV3) by in silico screening. 
The basis for targeting HN is explored, along with commentary on the methodology 
adopted during this effort. This project yielded a moderate success rate of 34%, 
perhaps due to problems in the computational methodology utilized. We highlight one 
particular problem – that of emulating target flexibility – and explore new avenues for 
overcoming this obstacle in the long run. As a starting point towards enhancing the tools 
available to us for virtual screening in general (and for discovering antiviral compounds 
in specific), we explored the compatibility between sidechain rotamer libraries and the 
HINT scoring function. A new algorithm was designed to optimize amino acid residue 
sidechains, if provided with the backbone coordinates, by generating sidechain 
xv 
 
 
 
positions using the Dunbrack and Cohen backbone-dependent rotamer library and 
scoring them with the HINT scoring function. This rotamer library was previously used 
by its developers previously to design a very successful sidechain optimization 
algorithm called SCWRL. Output structures from our algorithm were compared with 
those from SCWRL and showed extraordinary similarities as well as significant 
differences, which are discussed herein. This successful implementation of HINT in our 
sidechain optimization algorithm establishes the compatibility between this forcefield 
and sidechain rotamer libraries. Future aims in this project include enhancement of our 
current algorithm and the design of a new algorithm to explore partial induced-fit in 
targets aimed at improving current docking methodology. 
This work shows significant progress towards the implementation of our 
hydropathic force field in theoretical modeling of biological systems in order to enhance 
our ability to understand atomistic details of inter- and intramolecular interactions which 
must form the basis for a wide variety of biological phenomena. Such efforts are key to 
not only to understanding the said phenomena, but also towards a solid basis for 
efficient drug design in the future. 
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CHAPTER 1 
HYDROPHOBICITY: THEORIES, ESTIMATION AND APPLICATIONS 
 
1.1 HYDROPHOBICITY AND BIOLOGICAL PHENOMENA 
Hydrophobicity (or lipophilicity) is a well-known and extensively studied 
phenomenon.  It is commonly understood to be the tendency of non-polar molecules to 
form aggregates in order to reduce their surface of contact with polar molecules such as 
water [1].  Its manifestations include simple observable macroscopic phenomena such 
as the immiscibility of oil and water or modern techniques such as chromatographic 
separation. The importance of hydrophobic interactions at the atomic or molecular scale 
has long been recognized in various areas of science [1].  While the concepts have 
changed and the applications have expanded, the fact remains that hydrophobic 
interactions are often the driving force in a variety of physical and biological 
phenomena, although they are often complemented by hydrophilic interactions. 
Our hypothesis is that a large majority of biological phenomena can be explained 
by explicitly addressing the hydrophobic and hydrophilic interactions between 
molecules. In fact, we suggest that predictive models can be developed in order to 
explain such phenomena by explicitly quantitating the extent of these interactions. This 
work is a compilation of results aimed at demonstrating the validity of this hypothesis. 
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To begin, the concept of hydrophobic interactions is presented here, along with a 
very short history and discussion of theoretical and experimental studies on the 
phenomenon.  The same set of forces and interactions that partitions a molecule 
between polar and hydrophobic solvent phases, i.e. determines its hydrophobicity, is 
pervasive in all biological interactions including small molecule binding and protein 
folding. An in-depth perspective on computational studies involving hydrophobic 
interactions is presented. These studies include methods for estimation of the 
hydrophobic nature of small and large biological molecules and applications of this in 
drug discovery or design.   
These are followed by an example of quantitative modeling in order to effectively 
address some complex biological phenomena, specifically antibiotic transport by efflux 
pumps, followed by an implementation of these interactions in drug discovery for 
antiviral agents. Finally, a weakness of current methodology used in the aforementioned 
discovery process is discussed, followed by laying grounds for development of new 
hydropathy-based tools to address the same. 
1.2   A BRIEF HISTORICAL OVERVIEW OF HYDROPHOBICITY 
Even before the turn of the 20th century, the importance of hydrophobic 
interactions in biological phenomena, particularly drug activity, was recognized by the 
work of Meyer and Overton [2,3,4].  In 1937, Butler showed a linear relationship 
between heat of hydration and entropy of hydration [5].  He estimated the energies of 
interaction of different functional groups with water and showed that the heats of 
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hydration are additive in nature.  He also explained that the heats of hydration do not 
determine the free energy of interactions, but that there is a direct proportionality 
between them.  The reasons were unclear at this point, but it was hypothesized that 
entropy might be dependent on the size of the ―cavity‖ that contains the molecule.  The 
importance of H-bonds was also briefly discussed as formation of H-bonds between 
polar parts of the molecule causes an increase in entropy, which favors dissolution of an 
otherwise non-polar molecule. 
Frank and Evans, in the middle of the 20th century, described the formation of 
―icebergs‖ of water around non-polar parts of molecules [6].  Their findings were based 
on the deviation of entropy of vaporization for certain substances when dissolved in 
aqueous and non-aqueous solutions.  The formation of a regularized lattice-like 
structure of water molecules surrounding non-polar moieties has been experimentally 
validated with crystallography [7] and is now more or less taken for granted.  This theory 
was extended to proteins by Klotz, who explained the variation in pKa, molecular 
volume, denaturation and the masking of expected behavior of protein functional groups 
in terms of this ―iceberg‖ formation [8].  In fact, the association of two molecules can 
become energetically favorable due to the increase in entropy when these ordered 
water molecules are scattered or disordered (see Figure 1.1). 
Kauzmann first coined the term ―hydrophobic bond‖ in 1959, which caught the 
attention of many scientists at the time; this notion was supported by a number of 
research investigations of that era [9].  The work of Némethy, Scheraga and Steinberg 
also supported the use of this term [10].  Perhaps it was the tendency of the non-polar  
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Figure 1.1 The Hydrophobic Effect. Hydrophobic molecules are surrounded by an 
ordered cage of water molecules. When two such molecules come together, they 
aggregate in order to reduce their surface area in contact with the polar water 
molecules.  This causes a number of water molecules to be removed from their ordered 
formation, thus increasing disorder (increased entropy) and potentially making the 
process energetically favorable. 
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substances to form aggregates that caused scientists to draw parallelisms with the 
general definition of a bond – ―the tendency of two atoms to stay together in space‖.  
Hydrophobic bonds have been described as endothermic, i.e., as temperature 
increases their strength increases until a maximum value is reached at approximately 
60˚C [10].  However, the stability of proteins depends on not only these hydrophobic 
―bonds,‖ but also hydrogen bonds.  These have an inverse behavior, i.e., they become 
weaker with increasing temperature.  Thus, as temperature increases beyond 60˚C, 
both H-bonds and hydrophobic interactions decrease in strength, causing proteins to 
unfold. 
In the 1970s, Robert Hermann published a series of three papers on ―the theory 
of hydrophobic bonding‖ [11-13] where the large negative entropy of partitioning a 
hydrophobic molecule into a non-polar solvent was explained by the loss of order in 
water molecules in direct contact with the hydrophobic surface.  The ordered 
arrangement of water molecules on the surface of a molecule is due to dipole-dipole 
interactions with the immediate next layer of waters. In effect, this phenomenon is 
similar to surface-tension where the first layer arranges itself in order to reduce contact 
with the hydrophobic air, while less order exists in the second and succeeding layers.  
Order continues to decrease in layers away from the hydrophobic surface and there is a 
linear, but inverse, correlation between hydrophobic surface area and its solubility in 
water [11].  Hermann also determined that the free energy for hydration of a 
hydrophobic molecule is linearly related to the number of water molecules that can be 
packed around it. This first study did not take into account cavity curvature and was 
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restricted to small molecules. Later work [12] described a correlation between a 
molecule‘s hydrophobic surface area and its solubility in water. Hermann also 
addressed hydrophobic interactions at a distance [13] taking into account not only 
solubility, but also the distances between hydrophobic entities with the Lennard-Jones 
potential as has also been suggested by Reynolds et al [14].  Leo, Hansch and Jow 
established a relationship between hydrophobicity and two other factors – the nature of 
the solute surface and the molecular (CPK) volume [15].  The major innovation of this 
study is that they used the partition coefficient for 1-octanol/water (LogPo/w) as a 
measure of hydrophobicity rather than solubility. This parameter has been used almost 
ubiquitously in studies thereafter.  Most importantly, these observations could not be 
explained by the simple concept of a ―hydrophobic bond‖, but rather as a complex 
phenomenon involving the interplay of flexible molecules and solvent under particular 
conditions. 
The argument on semantics over the use of the term ―hydrophobic bond‖ has 
continued ever since, but the fact that hydrophobic phenomena can explain a multitude 
of observations in science cannot be ignored.  Here, we attempt to describe how 
naming and characterizing this effect has changed the realms of computational 
chemistry and drug design.  A comprehensive review of the research on hydrophobicity 
is available elsewhere [1] for those interested in the intricacies of experimental 
approaches towards the phenomenon. 
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1.3   CALCULATIONS OF HYDROPHOBICITY AND THE HYDROPHOBIC EFFECT 
1.3.1 Estimation of LogPo/w 
Hansch and Leo published their seminal paper on the determination and uses of 
partition coefficients in 1971 [16]. This paper was and perhaps continues to be, the most 
comprehensive article on the subject. It explains the fundamentals of partition 
phenomena and provides detailed descriptions of the history and theory of the same. It 
also contains a very comprehensive tabulation of LogP values for various substances.  
However, most interesting to theoreticians is the discussion of additive-constitutive 
properties wherein the utilization of the Hammett equation in calculations of partitioning 
free energy and the effects of various stereoelectronic effects on the partition coefficient 
are described.  Also, various uses of partition coefficients for such diverse research 
topics as countercurrent distribution, measurement of equilibria, hydrophile-lipophile 
balance, drug dissolution and ―hydrophobic bonding ability‖ are outlined.  Of note, the 
partitioning of alcohols between water and red blood cells was compared to their 
partitioning between water and 1-octanol.  The energy of partitioning per methylene 
group was the same for both cases, i.e., approximately -690 cal mol-1.  The 
repercussions of this quantification of hydrophobic interaction energies have been key 
to drug design projects as well as computational chemistry.  The Hansch and Leo 
method for theoretical estimation of molecular LogP values, which is the basis of the C-
LOGP method (vide infra), is also described in great detail.   
A loose categorization of different methodologies for estimation of LogP is 
provided in Table 1, complete with a few typical examples of each.  Here, the discussion 
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of these methods will be limited to a general overview highlighting the application of 
these methods in drug design and the relevance of accuracy for these prediction 
methods in that context.  Several comprehensive reviews of the computational 
estimation of octanol-water partition coefficients are available [17-21].   
To commence, it is a monumental understatement to say that a lot of good 
research has been done in this field.   Many diverse empirical methods exist today that 
predict LogP of various molecules with different degrees of context-dependent certainty 
[17, 20].  Some of the major types are discussed below. 
Table 1.1 Various types of methods for LogP calculations. This table shows a rough 
classification of methods used for theoretical prediction of LogP for compounds. 
Examples of all the different types are included. 
Approach Methodology Example(s) 
Substructure 
approaches 
Fragment-based 
methods 
Rekker’s method [22], Leo’s C-LOGP method 
[23-27], ACD/LogP method [28] 
Atom-based methods XLOGP method [33-35], Ghose-Crippen 
method [29-32] 
Whole molecule  
approaches 
Molecular Lipophilicity 
Potential and related 
approaches 
MLP [107-108] 
Topology descriptions MS-WHIP [40] 
Molecular Property 
descriptions 
Toulmin’s LogP method [41] 
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Fragment-based methods – Rekker‘s fragment based system was the first 
fragment-based computational method to estimate LogP [22].  Fragment-based 
methods implement and statistically deconvolve empirical data from experimental LogP 
values of compounds.  Scheme 1.1 contains a short example of this approach.  In order 
to explain the effect of inter-fragmental interactions, certain additive correction factors 
are introduced.  Several other algorithms of this type exist including the C-LOGP [23-27] 
and ACD/LogP [28] methods.  The criticism most often applied to this methodology is 
that the fragmentation of the target molecule is ―arbitrary‖.  This is not actually true for 
C-LOGP as there is a complete and unambiguous set of rules. However, they can be 
difficult to visualize and fragments can be much more complex than organic functional 
groups.  Thus, fragments observed in new molecules can be missing from the C-LOGP 
database library, yielding poor predictions of LogP [17,20].  However, there are also 
advantages to these methods: significant and complex electronic interactions are 
automatically taken into account when they exist within a library fragment [20]; when the 
fragments coincide with real organic functional groups their interpretation is intuitive; the 
correction factors can be used to understand the relationship between functional groups 
or the effect of the observed feature on solubility, e.g., factors representing aliphatic 
chain branching explain the increased water solubility of branched hydrocarbons; and 
since fragment methods are based on empirical data, their associated algorithms are 
very fast and practical to implement in software. 
Atom-based methods – These are similar to the fragment-based methods, but 
assume the hydrophobicity of a molecule to be the sum of the individual atomic 
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contributions.  Scheme 1.2 provides an overview of the principle behind atom-based 
additive methodologies.  Again, several methodologies of this type exist, including the 
well known Ghose-Crippen [29-32] and XLOGP [33-35] methods.  Mostly these 
algorithms avoid correction factors by taking into account these sorts of contributions 
with a large set of atom types according to the individual environment it exists in within 
the molecule [20].  In order to somewhat reduce the atom type set the XLOGP algorithm 
implements a small number of correction factors.  The reduced dependence on 
corrections is the major advantage of these methods.  As described by Buchwald and 
Bodor, the major disadvantage of this method is that often the molecule is ―more than a 
sum of its parts‖ [17].  Furthermore, human interpretability is reduced as the size of the 
atom database set grows and the correspondence with organic and medicinal chemistry 
principles is lost. 
Molecular methods – Over the last two decades quantum mechanical 
calculations have been increasingly used in applied research including drug discovery, 
particularly with respect to estimations of interactions between solute and solvent 
molecules.  A number of studies have used quantum chemical principles for estimation 
of molecular hydrophobicity [17].  Early work includes that of Rogers and Cammarata 
[36,37] and also that of Hopfinger and Battershell [38].  Klopman and Iroff used charge 
densities to calculate partition coefficients [39].  More recently, Bravi and Wikel 
described a method to predict LogP using a technology called Molecular Surface – 
Weighted Holistic Invariant Parameters (MS-WHIP) [40].  Unfortunately, a relatively 
large standard deviation between predicted and actual LogP was observed [18].  
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Toulmin et al. described another prediction method for octanol/water partition 
coefficients [41] that correlated minimized molecular electrostatic potentials with the H-
bonding capability of molecules.  In this method ΔLogP is defined as the difference 
between LogPoct (logarithm of the 1-octanol/water partition coefficient) and their 
predicted LogPhxd (logarithm of the hexadecane/water partition coefficient).  H-bonding 
capability has a profound effect on partition coefficients with a strong correlation 
between ΔLogP and Vmin (minimized molecular electrostatic potential).  A strong 
correlation was also reported between ΔLogP or LogPhxd and CNS penetration of 
compounds, i.e., through the blood-brain barrier. This highlights the importance of H-
bond donors and acceptors in normal partitioning phenomena. 
Livingstone et al. described a method that uses neural networks (NN) to predict 
LogP values from a training set of electrotopological descriptors [42] of 900 drug and 
pesticide-like compounds [43].  Other studies involving artificial-intelligence utilize 
parameters calculated by various methods in unsupervised-learning processes to 
develop predictive models [44,45].  Taskinen and Yliruuski provide an in-depth analysis 
of such models in their review on NN modeling [46]. They note that, while NN methods 
are accurate in predicting LogP values of molecules within the size, functional group, 
etc. confines of the training set, they are less accurate in predictions for molecules 
outside the training set. However, this is the case for all LogP estimation methods. 
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Scheme 1.1 Fragmental methods for determination of LogP values. Rekker‘s 
method is highlighted with an example adapted from Mannhold and van de 
Waterbeemd [18]. 
Fragmentation Methods 
 
This approach breaks a molecule into 
fragments and assumes that the total 
LogP of a molecule is the sum total of all 
contributions of each fragment. However, 
the molecular environment affects the 
contributions by each fragment. Hence, 
correction factors are included in the 
calculation as shown by the following 
equation: 
 
        
 
   
      
 
   
   
 
where,  
LogP =      log of the partition coefficient 
a        =     the number of fragments, 
f         =    fragmental constant 
bj       =    frequency of Fj 
Fj       =    correction factor for the jth 
fragment 
 
A simple calculation by Rekker‘s 
fragmental method is illustrated in the 
panel at the right. The experimentally 
determined value of LogP for quinidine‘s is 
3.44. 
                    N
O
OH
N
H
quinidine 
 
Fragments: 
 
1 quinolinyl (-1H) 
1 O (aromatic) 
1 OH (aliphatic) 
1 N (aliphatic) 
SUM 
CH residual:       C11H18 
SUM 
Corrections:  
Proximity effect (+2CM),  
Electronegativity facing bulk (-
2CM),  
O-C-Ar (+1CM) 
LogP 
 
 
+1.617 
-0.450 
-1.448 
-2.074 
-2.355 
+4.893 
2.538 
 
+0.438 
-0.438 
+0.219 
 
2.757 
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Scheme 1.2 Atom contribution methods; the calculation of LogP for quinidine by 
atom contributions is shown (adapted  from Mannhold and van de Waterbeemd [18]).  
Atom Contribution Methods 
This is an extension of the fragmental 
contribution method. It is assumed that the total 
LogP of the molecule is a contribution by each 
individual atom comprising it (instead of a 
contribution by fragments). Calculation as shown 
by the following equation: 
           
where,  
ni       =     the number of atoms of type i 
ai       =    fragmental constant 
A simple calculation by the Ghose / Crippen 
method is illustrated in the panel at the right. The 
experimentally determined value of Log P for 
quinidine is 3.44. 
 
 
 
 
         N
O
OH
N
H
Quinidine 
Type Description Frequency Contribution 
2 C in CH2R2 2 -0.9748 
3 C in CHR3 2 -0.7266 
5 C in CH3X 1 -1.0824 
6 C in CH2RX 2 -1.6740 
8 C in CHR2X 2 -1.0420 
15 C in =CH2 1 -0.1053 
16 C in =CHR 1 -0.0681 
24 C in R--CH—R 4 +0.0272 
25 C in R--CR—R 2 +0.3200 
26 C in R--CX—R 2 -0.2066 
27 C in R--CH—X 1 +0.0598 
46 H attached to C0sp3 with no X next to C 1 +0.4410 
47 H attached to C1sp3 or C
0
sp3 16 +5.3488 
48 H attached to C2sp3, C
1
sp3 or C
0
sp3 1 +0.3161 
50 H attached to heteroatom 1 -0.3260 
52 H attached to C0sp3 with one X next to C 5 +1.8475 
56 O in alcohol 1 +0.1402 
60 O in Al - Al, Ar2O, R:R or R-O-C=X 1 +0.2712 
68 N in Al3N 1 +0.3954 
75 N in R--N--R or R--N—X 1 -0.1106 
LogP 2.852 
Key symbols: R is group connected to C; X is heteroatom; ―=‖ is double bond; ―:‖ is an 
aromatic single bond such as the C-N bond in pyrrole; subscripts give the hybridization 
state and superscripts the formal oxidation number. 
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Hydrophobicity of amino acids and proteins – Understanding the hydrophobic 
behavior of amino acids, peptides and proteins has implications far beyond the 
seemingly simple task of calculating LogP for twenty or so small molecules (the amino 
acids).  Abraham and Leo extended the Hansch and Leo fragment-based method of 
LogP calculation to amino acid zwitterions and side-chains [47].   Excellent agreement 
was reported for 19 out of the 20 natural amino acids.  Proline, however, was calculated 
to be more hydrophilic than in reality, probably due to poor fragment parameterization 
for its secondary cyclic amine.  With this method, hydrophobicity values for amino acid 
side chains were best predicted if a field effect was applied to the alpha-carbon.  The 
field effect is the sum total of polar proximity effects of both the backbone amidic 
(peptide) bonds surrounding the alpha-carbon atom of any given residue.  This field 
effect parameter accounts for the charge distribution on side-chain atoms and hence 
directly affects the hydrophobic/hydrophilic nature of the residue. Application of this 
effect allowed a higher correlation between predicted and calculated values of 
hydrophobicity for side-chains.  In additional studies, Buchwald and Bodor reported a 
correlation between the van der Waal‘s volume of peptides with their LogP values [48].  
Another approach was adopted by Steinmetz, where 3-D QSAR Comparative Molecular 
Field Analysis (CoMFA) studies were applied in a similar manner [49].  Experimentally 
determined LogP values of free and blocked di- and tripeptides were analyzed 
statistically to produce another set of parameters [50].  Akamatsu‘s work on the solvent 
partitioning of peptides using regression analysis of the experimental data to abstract 
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the hydrophobic parameters [51-54] is commonly regarded as the most convincing and 
accurate [55].  A comparison between software programs in predicting peptide LogPs 
was published recently [56].  In general, fragment-based methods are sensitive to 
composition but not to peptide sequence, which can be considered to be a major flaw of 
these programs.  Also, it is important to note that most current programs are inefficient 
and ineffective in calculating LogP values for long peptides.   
Summary of LogP estimation methods – A lot of effort has gone into devising 
methods for high prediction accuracy for LogP.  However, most methods are accurate 
for members or close relatives of their own training sets but continue to be less accurate 
outside their training sets.  It should also be pointed out that a considerable portion of 
the predictive inaccuracy may in fact lie with the data itself. Such data has often been 
obtained with experimental procedures whose accuracy varies with the method used 
[57].  One example brings this into focus: as many drugs and drug-like molecules 
contain ionizable functional groups, the conditions of measurement, particularly pH, are 
extremely relevant to measured LogP.  Thus, if a user attempts to estimate LogP for a 
molecule, e.g., by specifying a carboxylic acid-containing species, what LogP value 
should be reported?  The molecule in its acid form?  The molecule in its ionized 
(nominally pH 7) form?  Or the weighted average representing the equilibrium between 
the two forms?  (This is what the experiment, as performed on the molecules in the 
training set, measures.)  As other functional groups on the molecule can shift that 
equilibrium, how does this affect the contribution of the carboxylic acid/carboxylate 
fragment (or constituent atoms) to the predicted LogP? 
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While whole-molecule approaches are designed to estimate LogP values with 
great accuracy without extensive piecemeal (atom- or fragment-wise) empirical 
parameterization, their predictive nature in the end must also be compared to 
experimental data, limiting our ability to really judge the accuracy of predictions.  This 
begs the question: do we need to emphasize accuracy of predictions so much?  We 
suggest that when it comes to drug design, it is largely the ΔLogP changes between 
analogues that will drive the evolution in design with respect to physicochemical 
properties of the molecule.  Virtually all methods of estimating LogP can accurately 
describe the replacement of a proton by a hydroxyl, the halogenation of an aromatic 
ring, substitution of an amine for a methyl, or nearly any of the chemical modifications 
that would be performed in fine-tuning a lead compound.  The prediction of LogP for 
random organic compounds is probably not an important real world exercise.  Also, 
representing such an important physicochemical property as a simple scalar value 
underutilizes the information content of the molecule‘s 3-D topology and, particularly, its 
hydropathic structure.  The combination of topology and hydropathy provides us with 
structural details of immense importance, which play a direct role in intermolecular 
interactions, e.g., ligand binding, protein-protein associations, etc.  However, we do 
recognize the importance of LogP in QSAR studies and also in assessing the drug 
likeness of a compound, both of which will be discussed below.  
Can predictive methods for estimating the LogP of a peptide translate into a 
meaningful number for protein hydrophobicity?  The idea that an additive atom-based or 
fragment-based algorithm (or even a whole molecule approach) could describe the 
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dissolution of a protein into water and/or 1-octanol is probably preposterous.  To start, it 
is likely that a severe conformational change would occur if macromolecules pass from 
aqueous to organic solvents, e.g., hydrophobic residues would rearrange to the surface 
while the hydrophilic ones attempt to optimize hydrogen bonding and/or electrostatic 
interactions at the core.  In other words, a protein would be an entirely different 
chemical species when interacting with solvents of different polarity – if it could actually 
be solubilized.  However, the atomic, fragment or residue-level components of such a 
total LogP should be useful descriptors for understanding the forces and energetics of 
protein secondary, tertiary and quaternary structure and have been used in various 
schemes of describing and predicting protein folding for more than 20 years.    
While proteins might change their conformation drastically on partitioning 
between aqueous and 1-octanol phases, similar conformational changes are also 
expected in small molecules. Such changes occur regularly for small molecules in both 
aqueous and organic phases due to the comparatively lower energy barriers which 
separate these conformations. However, it is not hard to imagine that organic phases 
would stabilize conformations where intramolecular hydrogen bonds, ionic salt bridges 
or dipole-dipole interactions exist because Coulomb interactions are strengthened in 
these circumstances, while aqueous phases would stabilize those conformations which 
show a higher degree of hydrophobic interactions. On the other hand, LogP is a self-
contained parameter which accounts for all such conformational preferences because it 
is a bulk property and thus is the result of equilibrium between all such probable 
outcomes. 
  
18 
 
1.4   HYDROPHOBICITY SCALES AND PROTEIN FOLDING 
There has long been evidence that protein secondary structure is dependent on 
the hydrophobic properties of the amino acid residue side chains. There is, in fact, a 
reproducible pattern of these properties in well-defined secondary structural elements 
such as α helices and β sheets.  Thus, considerable effort has been expended in 
developing hydrophobicity scales that can aid in predictions of protein folding patterns.  
Some of these scales are based on water-ethanol transfer free energies [58,59], while 
others are based on partitioning between the bulk aqueous phase and the air-water 
interface [60], or on water-vapor partition free energies [61].  Kyte and Doolittle 
discussed the weaknesses of all three of these in a paper that also introduced their own 
hydrophobicity scale [62].  In their view, water-ethanol transfer free energy-based 
methods suffer because some amino acids are known to be insoluble in both water and 
ethanol and the latter may not be a truly inert solvent.  Using partition data from transfer 
between the aqueous phase and air-water interfaces was also problematical because 
the hydrogen bonds that must be broken and the charges that must be neutralized to 
remove a residue from the aqueous phase during the formation of the native structure 
probably remain unchanged at an air-water interface. Thus, they would not be a factor 
in the overall reaction. 
The ―hydropathy‖ parameter of Kyte and Doolittle [62] is an amalgam of water-
vapor transfer free energies and the interior-exterior distribution of amino acid side-
chains determined by Chothia [63].  A moving-segment approach that continuously 
determines the average hydropathy while it advances through a sequence is used to 
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obtain a plot of hydropathy as a function of sequence.  On this plot, any parts of the 
sequence that are above the average hydropathy for the sequence are termed 
hydrophobic and correspond well with experimentally determined ―internal‖ regions of 
proteins.  Conversely, sequence elements with hydropathy below the average are 
termed hydrophilic and correspond well with areas of the protein that are ―exterior‖ and 
likely to be in contact with the polar solvent.  The motivation is that analysis of these 
data may indicate the ―folding‖ pattern of the sequence.  To further exploit this, Wimley 
and White reported a new forcefield derived from partitioning two series of model 
peptides into the interface of neutral (zwitterionic) phospholipid membranes [64]. An 
alternative approach was introduced in 1986 by Eisenberg and McLachlan [65] for 
calculating the stability of protein structures in water based on atomic coordinates.  The 
contribution of each protein atom to the solvation free energy is estimated as the 
product of the solvent accessibility of the atom and an atomic solvation parameter.  
Li and Deber [66] used circular dichroism (CD) data to rank order helical 
propensity of proteins within membranes.  Residues such as Ile, Val and Thr, which 
usually exist as -sheets in an aqueous environment, prefer an -helical conformation in 
lipid membranes.  Thus, the helical propensity of amino acid residues correlates with 
the hydrophobic nature of the side chain.  More recently, Dyson, Wright and Scheraga 
have explained [67] how strict classification of side chains as polar or non-polar has 
obscured certain facts about protein folding.  For example, methylene groups present in 
large polar or charged amino acid side chains, like the four methylenes in the lysine side 
chain, can be considered non-polar.  Interestingly, this fact was imbedded as one of the 
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factors in the Hansch and Leo system for estimating LogP [68] nearly 30 years earlier!  
These methylenes can aggregate with other non-polar groups and assist in hydrophobic 
collapse of the sequence.   
Felitsky et al. introduced the use of a new parameter called ―average area buried 
upon folding‖ (AABUF) [69] that explains both local contacts and long-range 
interactions.  AABUF was used to study folding of apomyoglobin and provided 
additional insight into hydrophobic collapse and early folding events.  Studies on 
polyalanine and polyleucine helices in water by MacCallum et al. [70] confirmed that in 
folding many unfavorable enthalpic events are counterbalanced by favorable entropic 
contributions by the solvent. This indicates a very small free energy barrier for folding.  
Thus, folding is mainly a desolvation phenomenon.  Similarly, the Mardia and Nyirongo 
procedure for generating virtual protein Cα traces simulates the hydrophobic effect 
during folding [71] and produces models that are globular and compact. 
Another related application of hydrophobicity is in the development of algorithms 
to simulate folding of hydrophobic-polar (HP) models in 2 and 3 dimensions [72].  The 
concept is to simplify the complex problem of folding by reducing it to representing 
residues by spheres with H (hydrophobic) and P (polar) character.  The ensuing 
simulations are based on the observation that hydrophobic forces are the major forces 
determining native conformation of small globular proteins.  These model simulations 
have been used to develop mathematical strategies for solving the combinatorial 
explosion problem, rather than actually simulating the hydrophobic effect [73-74]. 
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As these studies have progressed over the past 20 years or so, the 
understanding of the hydrophobic effect and its impact on protein structure has 
matured.  The early emphasis of using hydrophobicity scales to define folding patterns 
has shifted to algorithms that define protein folding in terms of mathematical 
approaches to reduce the calculational combinatorial explosion caused by exhaustive 
sampling of conformational space.  However, it must be repeated that the same forces 
and energetics that drive solvent partitioning in the shake flask are at the core of protein 
folding.  The difficulty is to unravel them and define algorithms that can simulate folding 
in these terms. 
1.5   LogP IN DRUG DESIGN 
Small molecule hydrophobicity has long been a consideration in drug discovery 
and design.  The relationship between anesthetic effect of certain gases and their 
hydrophobicity has been extremely well established [4,75,76].  As described by Meyer 
in 1937 [3], chemically inert substances accumulate in ―lipoids‖ and at a certain 
concentration, produce narcosis.  The concentration itself is dependent on the animal, 
but independent of the narcotic itself.  Hansch et al. also confirmed the Meyer-Overton 
hypothesis about a direct relation between hydrophobic nature of a compound and its 
anesthetic capabilities [75] through statistical correlations.  However, Hansch suggested 
the additional involvement of a polar factor because molecules with polar hydrogens 
showed greater anesthetic action.  Hansch et al. also introduced a similar theory for the 
hypnotic effect of barbiturates [76].  Other studies also have shown the important 
correlation of partition coefficients with binding affinities of drugs to receptors [77,78].  
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McFarland used a very simple probabilistic treatment of drug diffusion from the site of 
administration to the site of action via a collection of hydrophobic and hydrophilic 
barriers (Scheme 1.3, [79]). His relationship included a ratio for the rates of permeation 
for drugs between aqueous and organic phases (k/l) which relates to the partition 
coefficient at equilibrium. Inclusion of the Hammett equation into this study gave an 
intuitively satisfying parabolic relationship between drug potency and hydrophobicity 
(Scheme 3): higher doses of drugs with unfavorable partition coefficients (either too high 
or else too low) are required for them to reach the site of action.  Recently, Kier has 
proposed a general theory of inhaled anesthetics [80]. 
1.5.1. The Lipinski “Rule of 5” 
Hydrophobicity, of course, has also been a key factor in Lipinski‘s ―rule of 5‖ 
[81,82].  In simple terms, Lipinski‘s rule can be stated as such: Poor absorption or 
permeation is more likely for a chemical entity when: a) there are more than 5 H-bond 
donors (sum of OHs and NHs); b) the molecular weight is over 500; c) the LogP is over 
5; or d) there are more than 10 H-bond acceptors (sum of Ns and Os).  The only 
exceptions to these rules were said to be substrates for biological transporters and 
natural products, which have a tendency to be highly complex molecules with multiple 
stereogenic centers and rarely contain nitrogen [83,84]. 
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Scheme 1.3 A parabolic relationship exists between drug potency and 
hydrophobicity. McFarland‘s equation relating probability and partition coefficient [79]. 
Model of n alternating aqueous phases and lipophilic membranes, in a hypothetical 
biological system is shown below: 
Aq0 Lip1 Aq2 Lip3 Aq4…………………………………………Lipn-2 Lipn-1 Aqn 
Assume that the rate of passage of molecules from aqueous to lipophilic zones is k, 
while the rate of passage of molecules in the opposite direction is given by l. Then, the 
partition coefficient of the molecule will be given by k/l. 
If Px,y is the probability of moving a molecule from layer x to layer y, the probability of 
moving a molecule from aq0 to aqn is given by: 
                                    
Although passage of molecules would actually be affected by a number of factors, 
unbiased passage of the molecule is assumed here. This reduces the entire problem to 
one of pure probability. So, we will have: 
                  
Similarly, the following equation can also be obtained: 
                
Combining all three above equations, we have: 
          
          
    
Now, the number of molecules being transferred from aq0 to lip1 is proportional to k.  
The total number of molecules is proportional to the sum of k and l.  The probability of a 
molecule moving from layer 0 to 1 is given by P0.1, which is mathematically defined as: 
     
 
   
 
Dividing both numerator and denominator on the right hand side by l, we get: 
     
   
     
 
If P1.0 is the probability of a molecule passing from lip1 to aq0, 
            
Since we have assumed equal probabilities, we have: 
            
Substituting this equation into the fourth equation described above, we have: 
          
   
         
    
     
   
     
 
   
    
   
     
 
   
 
     
   
      
 
   
  
 
      
 
   
 
    
        
         
 
This relationship will be parabolic, indicating that there is an optimum range of LogP 
with respect to drug potency. 
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In 2000 Lipinski introduced changes to address terms such as ‗drug-like‘ 
because it was predicted that ADME (Absorption, Distribution, Metabolism and 
Excretion) screening of molecules (into drug-like or non-drug-like) would precede 
screening for activity at biological receptors [82].  The rule of 5 was further extended 
[85] to define a number of useful parameters: a) the presence of greater than 10 
rotatable bonds reduces oral bioavailability; b) 0 < LogD < 3 enhances the probability of 
good intestinal permeability (LogD is logarithm of the distribution coefficient D, which is 
in turn defined as the ratio of the sum of concentrations of all forms, whether charged or 
neutral, or different functional conformations of the substance distributed between two 
mutually immiscible phases); c) a polar surface area (PSA) of less than 60-70 describes 
CNS active compounds; d) an N+O count of less than or equal to 5 enhances the 
probability of passing the blood-brain barrier; e) if LogP – (N + O) > 0, the molecule 
tends to be CNS active; f) orally-active drugs have lower molecular weight and fewer H-
bond donors, acceptors and rotatable bonds; g) pulmonary drugs tend to have a larger 
PSA; and h) if the molecular weight < 300, LogP < 3, H-bond donors and acceptors < 3 
and rotatable bonds < 3, the compound can be called ―lead-like‖. 
This revolutionary work, which brilliantly summarized over 100 years of Medicinal 
Chemistry trial and error, made possible a number of rational filters and screens that, in 
principle, would improve the likelihood that a compound with promising ―activity‖ could 
produce a ―lead‖ and eventually yield a ―drug‖.  Muegge described various methods for 
classification of drug-like compounds in his 2003 publication [86].  Similar publications 
addressing the terms ‗drug-like‘ and ‗tool-like‘ were also made [87,88].  Oprea et al. 
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reported the presence of a ―medicinal chemistry lead-like space‖ and urged careful use 
of Lipinski‘s rules [89].  A very interesting discussion [82] on how the properties of drug 
candidates from two pharmaceutical companies have varied across time pointed out 
that stress on rational methods of drug design in Merck laboratories caused no 
significant change in MLogP (Moriguchi LogP [90]) values across time.  In contrast, 
there was a measurable increase in MLogP values for candidates from Pfizer since 
almost 50% of their hits were discovered with high-throughput screening (HTS) 
methods.  Because the easiest method to increase in-vitro potency is to appropriately 
position a hydrophobic moiety onto a lead compound, HTS methods almost invariably 
select more hydrophobic candidates.  Similar trends were observed [91] in that more 
than half of the molecules reported to have high-activity towards the end of the last 
century had a high LogP (> 4.25), high molecular weight (>425) and log of solubility in 
its neutral state (estimated from its molecular weight and LogP values), i.e., LogSw (< -
4.25), only about 35% of the true lead compounds had these properties.  It was also 
noted that as these molecules go through clinical trials, there is a distinct decrease in 
LogP values for compounds that make it to the market.  One thing is clear from these 
studies and an analysis by Proudfoot of drugs currently on the market [92]: the 
lipophilicity of molecules that make it all the way to commercialization has remained in 
the same range for a number of years.  In other words, there is a delicate balance 
between the hydrophobic and hydrophilic nature of a molecule that is absolutely 
essential for it to be transported to the site of action by diffusion across membranes.   
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1.5.2   Hydrophobicity in QSAR 
Similarity between molecules is often perceived by chemists both qualitatively 
and quantitatively.  A synthetic chemist would describe two molecules as similar if they 
have similar topologies, bond connectivities, functional groups or maybe synthetic 
strategies.  Structure-Activity Relationships (SARs) are based on such comparisons in 
the context of physiological function, but are mostly limited to qualitative or semi-
quantitative treatments of biological phenomena or activities.  However, more stringent 
definitions of similarity have been formulated and can be used with chemical computing 
software to perceive (and even predict) chemical equivalence provided the likeness is 
scrutinized critically.  Thus, a more mathematical and quantitative approach called the 
Quantitative Structure-Activity Relationship (QSAR), wherein affinities of ligands for their 
binding sites, inhibition constants, rate constants and other biological activities are 
correlated to molecular properties such as lipophilicity, polarizability, electronic and 
steric properties, was developed.  Comprehensive reviews have been published on the 
subject in the past [93,94], which should be referred to by those wishing to learn about 
the QSAR concept in depth. Here, we will focus on the key role of hydrophobicity in 
these studies. 
There are many different approaches used in classical QSAR studies, including 
establishment of relationships between activity and physicochemical properties such as 
steric properties (Hansch analysis, extrathermodynamic approach), structural features 
(Free Wilson analysis) [94], or topological descriptors (Kier-Hall indices) [42].  3D QSAR 
methods, especially those such as CoMFA, consider three-dimensional ligand 
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structures and use those to propose the binding modes of those ligands at a common 
protein active site [94].  Data is often analyzed by statistical methods such as Multiple 
Linear Regression (MLR), Partial Least Squares (PLS) or by use of artificial intelligence 
(AI) methods such as Neural Networks (NN) or Support Vector Machines (SVM) [95] in 
order to detect correlations between a target activity and various descriptors (like LogP). 
Hansch and Fujita first introduced their method and coined the term QSAR, for 
correlation of biological activity to chemical structure in the 1960s [78,96-98].  The 
method correlated, by the use of regression analysis, ligand structural variations with 
the biological activities of those ligands.  In time, these studies would become a distinct 
scientific field and a mainstay of drug discovery and design research.  Many 
applications have been reported across the past five decades.  A review by Kubinyi has 
described, in great detail, the various subtleties of the science [99].  Indeed, in the 
absence of a detailed target or receptor structure, this ligand-based drug design method 
gives invaluable quantitative information to drug designers.  It is important to note that 
the first publication on QSAR in 1962 [78] showed the importance of hydrophobicity 
through LogP.  Scheme 1.4 explains the general concept behind the Hansch Analysis 
technique where the free energy-based substituent constant  is based on the Hammett 
function .  is dependent on the substituent‘s chemical nature and, since molecules 
must repeatedly partition between lipid membranes to be effective drugs, the 
constituting fragments of should be such that their additive effect would allow easy 
partitioning into either membranous or aqueous phases.  
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Scheme 1.4 Hansch Analysis; a method to relate physicochemical parameters to drug 
potency. For details, refer to Hansch and Fujita [95]. 
The ‗extrathermodynamic approach‘ relates various free energy-like descriptors in a 
model: 
   
 
 
                       
(C, LogP and σ are the inhibition constant, log of the partition coefficient and steric 
parameters respectively, while a,b,c and k are constants.) This model explains that drug 
transport from site of application to the site of action depends on the lipophilicity of the 
drug and is non-linear under typical conditions.  Although special conditions could 
reduce this equation into simpler forms [73], this equation surmises the behavior of any 
molecule under normal diffusion conditions. 
A novel parameter π defines the lipophilicity of substituent X: 
 
                 
 
where LogP is the log of the partition coefficient. This equation was a variant of the 
Hammett Equation, 
                 
 
where the reaction equilibrium constants have been substituted with partition 
coefficients. 
 
Values for LogP and σ of different molecules may be correlated with their IC50 or Ki 
values by statistical analysis such as multiple linear regressions (MLR) or partial least 
squares (PLS).  Artificial intelligence methods such as Neural Networks (NN) and 
Support Vector Machines (SVM) have also been used.  These analysis methods have 
pros and cons: While MLR and PLS do a good job of finding linear relationships 
between variables, they tend to oversimplify. On the other hand, artificial intelligence 
methods tend to pick up on minute non-linear trends and tend to over-fit models. 
It must be noted, however, that hydrophobicity is not always the principal 
parameter determining activity [100].  For example, when DNA is the drug target, e.g., in 
binding to the major or minor groove, QSAR analyses often show negligible 
hydrophobic terms because the negatively charged phosphate groups of DNA are 
hydrophilic.  On the other hand, DNA intercalation would likely be a hydrophobic effect.  
Radical reactions also typically lack hydrophobic terms in QSAR analyses, although 
these studies are mostly on small datasets and more thorough studies would be 
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desirable.  Finally, it has been suggested from QSAR studies on Multiple Drug 
Resistance that this process might be accomplished without hydrophobic assistance, 
although this conflicts with the fact that efficiency of efflux pumps is often correlated with 
the hydrophobicity of their substrates [101]. 
3D QSAR methods like Comparative Molecular Field Analysis (CoMFA) [102] 
generate 3D field maps around aligned molecules to display zones of steric, electronic 
and lipophilic tolerance or intolerance.  This gives a visual understanding of biological 
activity that contrasts well with the often messy collection of molecular descriptors in 
classical QSAR studies, thereby allowing easier interpretation of results.  This, in turn, 
may lead to a better basis for designing novel scaffolds and/or chemical substituents to 
the existing scaffold.  The basic idea behind this method is explained in Figure 2.  
Kellogg et al. introduced a method for hydrophobic field calculation for CoMFA [103] 
using an empirical force field (Hydropathic INTeractions or HINT, discussed in Section 
1.7).  This was one of the first attempts in 3D QSAR to modify the purely enthalpic 
treatment of ligand-receptor binding by inclusion of an implicit entropic term.  
References to the use of HINT-CoMFA in drug design are available [103-106].  Another 
attempt to include hydrophobicity into CoMFA was made by Gaillard, Testa and 
coworkers in their papers [107,108] describing the use Molecular Lipophilicity Potential 
(MLP) in 3D QSAR along with its applications.  This alternative method of using 
hydrophobicity in CoMFA studies has found a number of applications in molecular 
modeling and drug design work [109-111]. 
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Molecules are overlapped and placed in a grid, which is spread all around the 
overlapped molecules up to the extent of several Angstroms in all directions. Each grid 
point is treated as a probe; neutral Carbon atoms are used as probes for van der Waal‘s 
interactions, while charged atoms can be used as Coulombic interaction probes. Groups 
can also be used as probes, especially when trying to elucidate H-bond donors or 
acceptors. Simple physics equations for interactions of different varieties can calculate 
energy of each grid point, thereby extracting data for analysis. This data can then be 
checked for trends using PLS, MLR or AI algorithms.  
 
 
 
The resultant map, shown above, is a map of regions where certain physicochemical 
parameters are tolerated (or not tolerated), which serves as an aid to chemists.  
 
Figure 1.2 3D QSAR; 3 Dimensional Quantitative Structure Activity Relationships (3D 
QSAR) are models generated by taking into account the 3 dimensional positions of 
various physicochemical characteristics of a set of overlapped molecules and the effect 
they have on drug potency. Refer [71] for details. 
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1.6   QUANTIFICATION OF HYDROPHOBIC INTERACTIONS 
Equations calculating energy from structure, a.k.a. force fields, have been in use 
for many years in computational chemistry and molecular modeling [112].  Generally, 
force fields have been restricted to enthalpic terms that are simple to correlate with 
bond formation or bond breaking and simple Newtonian physical phenomena like bond 
stretches and bends, electrostatics and dispersion.  The hydrophobic effect is, in some 
measure, an entropic phenomenon and is not easily derivable from these first principles.  
Nevertheless, a few examples of quantifying lipophilicity and its effect on biomolecular 
energetics have been reported [12,113-119].  Hermann and Chothia [12,113], among 
others, proposed that hydrophobicity can be quantified by the calculation of hydrophobic 
surface area.  Oobatake and Ooi present an excellent review of this approach [114].  
Cramer and Truhlar introduced a solvation model [115] that included charge 
distributions on solute molecules, the energetic effects of cavity formation and 
restructuring of water around such cavities and even subtle variations in charge 
distribution due to interactions between solute particles and surrounding solvent 
molecules. Sharp and coworkers introduced a new solvation model illustrating the 
dependence of the hydrophobic effect on curvature of the site [116].  This was an 
attempt to explain the difference between the calculated energy for hydration of 
hydrocarbons (about 25 cal mol-1 Å-2) and the surface tension at the water-hydrocarbon 
interface (about 75 cal mol-1 Å-2).  This altered surface area measurement suggested 
that the ―macroscopic‖ hydration energy is 47 cal mol-1 Å-2.  Indeed, the assumption that 
the energy of hydrophobic interactions is dependent on the area of the hydrophobic-
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water interface is the mainstay of much research in the area.  However, alternative 
approaches have had some success.  Cesari et al. presented a model describing the 
hydrophobic interactions within globular proteins based on analysis of X-ray data [117] 
where fold definitions were clearly shown to be a function of hydrophobicity.  Hummer 
described the development of a hydrophobic force field as an alternative to surface-area 
models [118].  A highly developed model for quantitating hydrophobic interactions is the 
HINT (Hydropathic INTeractions) system that is discussed below.  
1.7   THE HINT PARADIGM 
A notably different approach was taken by Kellogg and Abraham [119,120] in designing 
the ―natural‖ force field HINT (see Scheme 1.5). This non-covalent interaction force field 
is derived from partition coefficients based on the Hansch and Leo LogP estimation 
method.  It is very empirical in nature and approximates all components of biomolecular 
interactions, including hydrogen bonding, Coulombic interactions along with entropy and 
solvation/desolvation effects in addition to hydrophobic interactions because all of these 
effects are inherent in the experiments that measure LogP [68].  Interestingly, the 
Hansch and Leo method encodes many interaction effects within the ―correction‖ 
factors.  For example, intramolecular hydrogen bonding within a small molecule, which 
would make the molecule less polar (and seemingly more hydrophobic) because the 
involved polar hydrogen and its partner acceptor are less able to interact with water 
solvent, is encoded with a factor that gives an internally calibrated indication of the 
energetics of hydrogen bonding (0.6 – 1.0 LogP units, i.e., 0.8 – 1.4 kcal mol-1).   
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Figure 1.3 HINT map for the molecule of tyrosine. This map shows a hydrophobic 
area on the molecule represented as a cage around the benzene ring. The polar areas 
on the map are further depicted: acidic (light grey lobes) and basic (dark grey lobe). 
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Scheme 1.5 The HINT Paradigm. A ―natural‖ free energy force field based on LogP.  It 
is available as a toolkit, allowing flexibility in development of applications.  Refer to 
Kellogg and Abraham [118] for details. 
 
 
 
A representation of a 
shake flask. Substances 
distribute themselves 
between the water and 
octanol layers with 
concentrations Cwat and 
Coct, respectively, in a 
particular ratio called the 
partition coefficient. 
By definition, 
   
    
    
 
LogP can be considered the sum total of individual 
lipophilic propensities of each atom called hydrophobic 
atom constant (ai), i.e. 
         
The values of ai are readily available from various 
methods, as described earlier; HINT itself uses an 
adaptation of the Hansch and Leo C-LOGP approach [23-
27].  The HINT method calculates scores (bij) of each atom 
against all other atoms according to the equation 
                       
Where, ai is the hydrophobic atom constant for the i
th atom 
and Sij is the solvent accessible surface area.  Tij is a 
variable which takes on the values of +1 or -1, depending 
on the acid and base properties of the pair of atoms being 
considered.  For example, if the atoms under consideration 
are both amino nitrogens, the interaction is unfavorable 
and Tij is -1.  In contrast, if one is a polar (amine) hydrogen 
and the other is a carboxyl oxygen, their interaction would 
be favorable and Tij is +1.  Rij is the exponential term e
-r, 
where r is the distance between the i and j atoms.  rij is a 
van der Waal‘s term. 
The total HINT score would be the sum total of each atom-
atom score thus calculated, i.e. 
                                     
If G is the change in Gibb‘s Free Energy, R is the gas constant and T is the absolute 
temperature,  
we know that                                               and                          ; 
thus,                                                                                   . 
Hence, HINT scores reflect free energy by taking into account both enthalpic and 
entropic factors.  Because the absolute value of HINT score may not be predictive of a 
discrete biological association event, these absolute scores are not as important or 
relevant as differences in HINT score values between analogous systems, much the 
same as differences in free energy, i.e., ΔΔG.  The difference in Gibb‘s Free Energy 
between two states is a very important parameter as it tells us about the spontaneity or 
likelihood of the change, whereas the value for any one state itself is often of less 
consequence. 
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A key principle behind HINT is that significant understanding of biological phenomena, 
particularly interactions, can be revealed by representing hydrophobicity as a 3D ―field‖ 
property rather than as a simple scalar (number) [121].  For example, consider the 
tyrosine molecule shown in figure 3. Hydropathic properties of the molecule are mapped 
in three dimensions around the structure of tyrosine, creating a HINT map. The use of 
these maps creates a visual representation of properties that are often mentioned 
casually, such as hydrophobic or polar nature of functional groups. Not only does this 
methodology allow a chemist to form a qualitative understanding of the molecular 
topology, but also forms the basis for quantitative estimation of physicochemical 
properties by using the HINT force field.  This may further be used in the depiction of 
molecular interactions, which has a direct repercussion in drug design. 
1.7.1 Intermolecular Interaction Analysis  
Perhaps the most important application of HINT is in the assessment of 
intermolecular interactions.  HINT calculations derive an interaction score that in 
numerous studies [122-125] has been shown to correlate with free energy of interaction.  
Although it is data set dependent, i.e., for specific protein-ligand or polynucleotide-ligand 
systems, it is estimated that on average, 515 HINT score units correspond to 1 kcal mol-
1 free energy of binding [119].  A recent report indicated the value of the HINT score in 
ligand docking studies by a comparison to the scoring functions within FlexX, AutoDock 
and GOLD [123].  The most important advantage of the HINT methodology is that it 
inherently estimates enthalpic as well as entropic contributions to binding (Scheme 5).  
It has been shown [122,126] that errors in prediction for very diverse sets of protein-
  
36 
 
ligand complexes are approximately ± 2.6 kcal mol-1, although within a family of ligands 
binding to the same protein this error can approach ± 1 kcal mol-1. There often is an 
order of magnitude difference between values of Ki measured by different laboratories 
on the same protein-ligand complex, which corresponds to a possible 1.0-1.5 kcal mol-1 
experimental uncertainty.  Thus, the error value reported above between experimental 
results and HINT scores indicates that HINT is a robust method for binding affinity 
predictions.  Further sources of error include uncertainties in positions of atoms in 
models, incorrectly assigned atom types, or (often) missing solvent molecules in the 
source crystallographic structure data.  The HINT method has been used successfully in 
quite a number of projects [122,126-129].  In a recent example, Tripathi et al. generated 
a model capable of predicting antiproliferative activity of pyrrole derivatives against 
cancer cell lines.  In this study, experimentally determined IC50s of a number of 
compounds were correlated with HINT scores from docking these ligands to αβ-tubulin 
to generate molecular models that could be scored and yielded a significant correlation.  
This correlation could distinguish active molecules from inactive ones by the HINT score 
value and, thus, provides a basis for design of novel molecules with anticancer activity.  
In another interesting application the sequence specificity of anthracycline groove-
binding intercalators was evaluated and predicted by HINT score [130]. This work 
illustrated that the HINT score could be parsed into relevant free energy subsets that 
can be ranked and compared for particular intercalator functional groups and/or 
nucleotide bases in DNA double helix strands. 
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1.7.2   Computational Titration  
An extension of the HINT force field known as Computational Titration [124] is 
used to evaluate the ionization states of functional groups on ligands or residues at the 
binding site.  It is well known that these variations can have a strong influence on 
binding affinities.  The method models, in parallel, multiple ionization states for both 
ligand and protein creating a collection of ionization state ensembles.  Each distinct 
protonation state ensemble is optimized for hydrogen bonding, including water positions 
and analyzed by HINT score.  The best scoring complex indicates the optimum state for 
binding and suggests the corresponding pH for that optimum binding.  However, the pH 
at which crystals are grown and analyzed can be different from this optimum pH.  The 
resulting model can help reconcile the differences between in silico models and data. 
However, at room temperature, where binding data is measured, there are likely to be 
many protonation models of similar, accessible energy.  Computational Titration 
analysis helps develop an understanding of the relationship between these states.  
There is now a computational titration server for public use at 
http://hinttools.isbdd.vcu.edu/CT [131].  
1.7.3 Analysis of Bridging Waters  
Another factor relating to the stability of biomolecular complexes is the 
contribution of water molecules within the binding site and bridging between the ligand 
and biomolecule [125,132].  The presence of these bridging water molecules can be a 
very important factor in binding of molecules, but water molecules can play a variety of 
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roles as they facilitate biomolecular interactions and stabilize structure.  Often, due to a 
variety of experimental reasons, positions of water molecules in crystal structures are 
not well defined, even after x-ray crystallographic analysis. This mischaracterization and 
non-detection of water positions can be correlated with x-ray crystallographic resolution, 
with better resolution both locating a larger number of water molecules and placing their 
positions more accurately.  Thus, to thoroughly evaluate structure, it is often necessary 
to verify water molecules systematically with tools such as the GRID program of 
Goodford [133].  Concomitantly, it is desirable to know which of these waters are 
subject to displacement by ligands and which are conserved.  Using HINT score 
combined with a metric based on geometry, Amadasi et al. developed a robust method 
to calculate the relevance of binding site waters; those with particularly high relevance 
score would be expected to yield extra entropy if a ligand was designed to displace it, 
i.e., similar to the cyclic HIV-1 protease inhibitors [134].  In another study, the 
contribution of bridging water molecules to overall free energy of binding has been 
derived and quantitated [132].   
1.7.4   3D QSAR with HINT  
A very early application of the HINT force field was the introduction of field 
hydrophobicity parameters into 3D QSAR technology, to complement the original steric 
and electronic fields in CoMFA [103].  The steroid data set originally reported by Cramer 
et al. [102] was reexamined with the addition of a HINT-derived field.  While this study 
provided little advantage in terms of statistical improvement due to a variety of reasons 
described previously [119], it provided a distinct advantage in chemical interpretability 
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for chemists aiming to design new molecules based on such a QSAR study.  Quite a 
few reports of studies based on the HINT-CoMFA methodology have been reported 
since then [104-106,135-140] and some, particularly where the ligands or active sites 
are particularly non-polar, do show significant statistical improvement when hydrophobic 
fields are included.  Fields in 3D QSAR are another class of descriptor that often needs 
to be optimized for the data set [141] in that each data set has forces and structures that 
may be best represented hydrophobically, sterically, electrostatically, or with other types 
of fields. 
1.8   AIMS AND OVERVIEW OF WORK 
The overall aim of computational chemistry is manifold: (1) to develop bioactive 
agents, (2) to help understand and quantify complex biological phenomena and (3) to 
develop tools that aid in computational exploration of biological interaction events. The 
major tool used by us in order to achieve all three objectives is the HINT forcefield. 
Herein, we employ our in-house computational tools (HINT and the HINT Toolkit), which 
are an amalgamation of experimental and theoretical methods to explore biological 
functions of molecules and discover biologically active agents in this work. We also 
outline strategies to enhance already available computational tools here. 
As described earlier in the chapter, the HINT paradigm has been successfully 
applied in exploring biological phenomena, particularly in binding of macromolecules 
and also in drug design (vide supra). In most projects reported thus far in literature, the 
HINT forcefield has been applied to simple binding phenomena, i.e. interactions 
between macromolecules or those between a drug and its target. Given this fact, we 
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asked ourselves whether it is possible to explain complex biological phenomena (such 
as transporter-facilitated molecular efflux) in terms of hydropathic interactions using the 
HINT forcefield. In other words, our hypothesis is that HINT can explain protein-
mediated molecular transport in terms of successive, but independent binding events? 
One major field of interest for us is to explore new avenues and develop tools for 
exploration of chemical space in an attempt to simulate the motion of proteins during 
their interaction with ligands and its application in drug design. In accordance with this 
aim, we commenced a project to explore the compatibility between existing knowledge-
based databases of amino acid residue sidechains and the HINT scoring function. The 
major aims of this project were to set up grounds for the development of a novel 
algorithm that will assist in simulation of partial active site flexibility. With this in mind, 
we hypothesize that HINT can address intramolecular interactions as well as 
intermolecular ones. 
Herein, chapter 2 describes different approaches adopted in order to predict 
efflux of antibiotic substrates by the AcrA-AcrB-TolC efflux pump. A 3D-QSAR study of 
efflux yielded ostensibly predictive models, which were validated within a dataset 
obtained from literature. An alternative methodology was designed due to the inherent 
problems of 3D-QSAR, which have also been described. This alternative method led to 
interesting quantitative predictions of high/low efflux for substrates. 
Chapter 3 describes a virtual screening approach towards identification of agents 
which inhibit hemagglutinin-neuraminidase (HN) of human parainfluenza virus type III 
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(HPIV3). The current status of this project is discussed therein, along with problems with 
sidechain placement during the docking process. 
The following chapter expounds early attempts at development of a sidechain 
optimization algorithm aimed at creating a basis for the development of improved 
docking simulation tools in the future. The current status of the algorithm, along with 
future directions, is delineated. 
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CHAPTER 2 
PREDICTING EFFLUX OF ANTIBIOTICS BY ACRA-ACRB-TOLC PUMPS: 
A ‗SYSTEMS HYDROPATHY‘ APPROACH. 
 
2.1   Introduction 
Antimicrobial drugs have been crucial tools of healthcare for decades due to their 
effectiveness in control of bacterial infections.  However, soon after their discovery it 
was realized that some pathogens rapidly developed resistance to antibiotics [1,2].  
Initially, this problem was overcome by discovery of new classes of antibiotics such as 
aminoglycosides, macrolides and glycopeptides, but it soon became clear that bacteria 
had an impressive array of defensive mechanisms that conferred on them, resistance to 
many modes of attack [1].  Organisms that cause pneumonia and cutaneous infections, 
Streptococcus pneumonia, Streptococcus pyogenes and staphylococci, are now 
resistant to almost all of the older, first generation, β-lactam antibiotics [2] like penicillin, 
which were discovered through screening of mold samples and act in general by 
mechanically weakening cell walls and making them susceptible to osmotic lysis [3-5].  
Members of the Enterobacteriaceae and Pseudomonas families, which cause diarrhea, 
urinary infection and sepsis, are also resistant [2].  The development of bacterial 
resistance to antibiotics has mostly been attributed to their excessive use in the clinic as 
well as at home [1,2].  However, semisynthetic modifications of β-lactam antibiotics 
have given us second- and third-generation antibiotics that have prolonged the 
therapeutic usefulness of the drug class.   
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One primary mechanism of antibiotic resistance is extrusion of the foreign chemical, 
which is termed efflux.  In 1980, it was reported that tetracycline could be actively 
effluxed from the bacterial cell [6].  Since then, many efflux-related mechanisms have 
been discovered.  Efflux pumps are transporters involved in extrusion of toxic 
substances from cells, thereby limiting the detrimental effects of these substances [7].  
They may be substrate-specific and responsible for transporting biological compounds 
such as bile salts, or may be promiscuous and transport structurally-diverse compounds 
such as various classes of antibiotic drugs [8].  Overexpression of these structurally 
complex and versatile proteins may thus lead to antibiotic resistance.  While efflux pump 
proteins are present in both Gram-positive and Gram-negative bacteria and also in 
eukaryotes, antibiotic resistance due to efflux is more of a problem in Gram-negative 
bacteria than in Gram-positive bacteria [9]. This is due to the presence of an outer 
membrane in Gram-negative bacteria that demonstrates comparatively lower 
permeability and complements the efflux activity of these pumps. 
Several such pump systems have been described: Campylobacter jejuni (CmeABC) 
[10-11], Escherichia coli (AcrAB-TolC, AcrEF-TolC, EmrB, EmrD) [12], Pseudomonas 
aeruginosa (MexAB-OprM, MexCD-OprJ, MexEF-OprN and MexXY-OprM) [12], 
Streptococcus pneumonia (PmrA) [13], Salmonella typhimurium (AcrAB) [14] and 
Staphylococcus aureus (NorA) [15].  These pumps basically fall into five major families, 
including the MF (major facilitator), MATE (multidrug and toxic efflux), SMR (small multi-
drug resistance), ABC (ATP-binding cassette) and RND (resistance-nodulation-division) 
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families [16].  It has been shown that co-expression of multiple types of efflux pumps 
can cause an additive or even multiplicative effect on drug resistance [17]. 
AcrAB was first described as an efflux system in 1995 [18].  AcrB is responsible for 
efflux of bile salts, thus protecting enteric E. coli from the detrimental effects of these 
powerful detergents [19].  As is typical with other members of the RND-type efflux 
protein systems, AcrAB is also a proton antiporter.  AcrA and AcrB homologues in 
Haemophilius influenzae HI0894 and HI0895 respectively, are also responsible for drug 
efflux [20].  The importance of AcrAB in multidrug resistance has been described in 
several publications, [21-27] where knock-out, knock-in and mutation studies were used 
to describe the extent to which the AcrA-AcrB-TolC transporter is responsible for 
expulsion of structurally diverse antibiotics from bacterial cells.  
One important observation from all these studies was that efflux pumps seem to 
preferentially extrude hydrophobic ligands [24].  However, despite extensive studies on 
the efflux of antibiotics by the AcrA-AcrB-TolC efflux pump, reliable and generalizable 
predictions for efflux by this pump continue to be elusive.  Such predictions would 
obviously be of tremendous interest to those engaged in design/discovery of antibiotics, 
as this would allow them to more efficiently channel effort and resources.  Interestingly, 
despite the tremendous importance of efflux as an ancillary consideration in drug 
discovery, very few computational studies designed to predict the effect on proteins 
other than P-glycoprotein [28-30] have been reported.  However, two-dimensional 
quantitative structure-activity relationship (QSAR) studies performed previously [31,32] 
yielded what appeared on the surface to be remarkable regression equations for efflux 
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of β-lactam substrates by the AcrA-AcrB-TolC pump from Salmonella thypimurium (16 
compounds, target: minimal inhibitory concentration for three strains, reported r2 from 
cross validation (q2) > 0.9).  No surprising conclusions were made in this study, i.e., 
molecules showing more hydrophilic character, including hydrogen bonding capability, 
were likely to be poor efflux substrates and that efflux correlated with properties like 
LogP (for partitioning the drug between 1-octanol and water), the y-axis component of 
electrostatic dipole moment, the surface area of hydrophobic carbons, the number 
fractions of carbons and heteroatoms and the number of charged groups and the 
number of nitrogen and sulfur atoms, all of which would supposedly influence 
interactions between pump and substrate [31].  However, the number of descriptors in 
the equations (up to 9) suggests serious overfitting of such a small data set and the 
inclusion of multiple methods of LogP prediction within the same QSAR equation is also 
a concern: while LogPs calculated by different methods do not necessarily encode 
exactly the same information about a molecule, they must be largely correlated and 
some of the other descriptors, e.g., surface area of hydrophobic carbons, also likely 
correlate with LogP.  Most importantly, it does not appear that this type of model has 
been embraced by potential users of efflux prediction in drug design, possibly because 
of its poor chemical and physical interpretability. 
In the present contribution, we describe a computational modeling method that 
allows us to successfully identify the extent of efflux of individual ligands by taking into 
account interplay between properties of the ligands as well as their molecular-level 
interactions with the AcrA-AcrB-TolC efflux pump.  Although an initial 3D-QSAR study 
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produced seemingly predictive models for the β-lactams, we decided to ―invent‖ a new, 
largely intuitive method based on what is known about efflux and found a successful 
prediction of efflux values for a structurally diverse dataset, composed of both -lactam 
and non--lactam antibiotics.  Our approach holds a superficial similarity to the ‗systems 
biology‘ approach, where the effects of a factor on multiple pathways are taken into 
account by compartmentalization in order to explain observed gross phenomena and 
we are thus calling our method ―systems hydropathy‖ (vide infra).  It is also interesting to 
note that our results suggest certain novel mechanistic details of efflux, hitherto 
untested and unreported. 
We further propose that this method may be extended to several complex 
transporter systems such as the ABC proteins, which are suspected to cause resistance 
to anticancer drugs [33].  
 
2.2 EXPERIMENTAL SECTION 
2.2.1 Crystal structures of AcrB and TolC.   
The crystal structures of AcrB and TolC (PDB codes 2drd and 1ek9 respectively) 
are available in the RSCB database [34,35].  The protein structures were modeled using 
Sybyl version 8.1 (Tripos International) [36].  Hydrogens were added, followed by 1000 
steps of Powell minimization with Gasteiger-Hückel charges while keeping the heavy 
atoms still. Then the entire structure was minimized to a gradient of 0.005 kcal mol-1 Å-1.  
Visual inspection revealed no unrealistic steric clashes between residues.  Where 
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required, the ligand was removed from the protein binding state (from PDB code 2drd) 
to void the docking region.  
2.2.2   Efflux data and substrate molecules.   
A review of literature produced a curated set of 32 β-lactam antibiotics (Scheme 2.1) 
and 12 non-β-lactam antibiotics (Scheme 2.2), for which efflux data has been reported 
[23-25,27,37].  This data was in the form of minimum inhibitory concentration (MIC) 
ratios (i.e., ratio of MIC in the presence of efflux pump to the MIC in the absence of 
efflux pump through knockout).  All reported MIC ratios for these compounds were 
taken and an average MIC ratio was obtained.  Because the experimental data are 
reported as powers of 2, i.e., 1, 2, 4, 8, 16, etc., logarithms (base 2) were calculated for 
these average MIC ratios and these logarithmic values were used as the dependent 
―efflux‖ parameter in our analyses (Table 2.1).  The range of MIC values for wild type 
(WT) pumps across all sources is also reported here. The narrow range of WT MIC 
values for each antibiotic clearly indicates that similar if not identical pump strains were 
used during experimental procedures reported in these referenced works such that 
these MIC ratios are directly comparable. 
As all of the substrate antibiotic molecules have acid and/or base functionalities, the 
structures were modeled in Sybyl in both their neutral (non-ionic) and charged (usually 
zwitterionic) forms and minimized to a gradient of 0.005 kcal mol-1 A-1.  An attempt was 
made to initially place each compound in its lowest energy conformation by manually 
selecting from available rotamers. 
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Scheme 2.1.  Chemical structures for the -lactam antibiotic compounds in the study.  
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Scheme 2.2.  The chemical structures for the non--lactam antibiotic compounds used 
in the study. 
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2.2.3   Docking and scoring.   
The initial methods development for this study was performed with only the β-lactam 
ligand set (Scheme 2.1) and then applied to the full, extended dataset.  All compounds 
were docked in both their neutral and charged forms using GOLD version 3.0 [38].  
When docked to different parts of the TolC cavity (see Figure 2.1 and Results and 
Discussion for further description), 100 positions for each compound in Scheme 2.1 
were obtained at each of eleven different overlapping areas of the protein, giving us a 
total of 1100 solutions per compound. However, a total of 2000 positions were obtained 
per compound when docked into the binding state or extrusion state of AcrB. The 
antibiotics in Scheme 2.2 were docked at four different positions as selected by the 
model found for the β-lactam compounds (see Results and Discussion), using identical 
procedures and parameters.  All docked positions were scored using the Hydropathic 
INTeractions (HINT) forcefield [39-41] as reported in previous work [42-43].  The HINT 
forcefield has been previously shown to not only estimate enthalpic contributions 
towards binding but also entropic and solvation contributions [39-43]. The pose 
corresponding to the highest HINT score for each ligand at each position was selected 
for further analysis. GOLD scores were ignored because the software is known to fail for 
hydrophobic systems [38]. The best docked positions were combined into protein-ligand 
structures that were minimized with 500 iterations. The interactions were re-scored at 
the minimized positions and these HINT scores were used as descriptors. Further 
explanation regarding application of the various HINT scores as utilized in this 
manuscript is given below.  
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Table 2.1.  Efflux and molecular parameters for data set molecules (see text for further description). 
No. Antibiotic 
Reported MIC ratiosa MIC range 
for WT 
pump  
(µg/ml) 
Avg 
MIC 
ratio 
Log2(avg. 
MIC ratio) 
LogP 
(AlogPs)c 
Mol. 
Width 
(Å)d 
Ref 
23b 
Ref 
24b 
Ref 
25b 
Ref 
27b 
Ref 
37b 
1 Cefoxitin 4 4    4 4 2 0.22 8.82 
2 Cefalothin 1 4    2-8 2.5 1.322 0.63 7.87 
3 Cephaloridine 2 2    2-8 2 1 1.67 8.47 
4 Ceftazidime 1     0.12 1 0 0.78 8.52 
5 Cephalosporin C  1    16 1 0 -2.18 8.16 
6 Cefotaxime  4 2   0.12 3 1.585 0.14 7.62 
7 Cefepime 1 1    0.0075 1 0 -1.54 8.73 
8 Cefpirome 1,2     0.015 1.5 0.585 1.57 8.99 
9 Ceftriaxone 1 2    0.015-0.12 1.5 0.585 -0.01 8.66 
10 Cefuroxime 16  8   1.56-2 12 3.585 -0.24 8.82 
11 Cefamandole 4, 8  4   4 5.33 2.415 -0.05 8.28 
12 Cefoperazone 2     0.03 2 1 -0.11 11.03 
13 Cefmetazole 1 1 2   0.05 1.33 0.415 -0.38 8.44 
14 Cefazolin 1 1    0.39-0.5 1 0 -0.4 8.32 
15 Cefsulodin 1 1    16-64 1 0 0.6 9.54 
16 Penicillin G 2 32    8-16 17 4.087 1.92 6.99 
17 Penicillin N  1    8 1 0 -1.43 7.82 
18 Carbenicillin 1, 4 4 1   1.56-8 2.5 1.322 1.13 7.07 
19 Ampicillin 2  2 4  0.78-12.5 2.67 1.415 0.88 7.07 
20 Amoxicillin 1     4 1 0 0.75 7.79 
21 Oxacillin 512  256   1024 384 8.585 2.05 8.77 
22 Sulbenicillin  4 1   8 2.5 1.322 0.37 7.33 
23 Mezlocillin 32     1 36 5.170 0.21 10.16 
24 Nafcillin  128 128   200 128 7 3.21 8.84 
25 Cloxacillin 128 256 128   256-512 171 7.415 2.61 8.56 
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Table 2.1 continued… 
26 Azlocillin 4, 8     16 6 2.585 0.2 9.92 
27 Piperacillin 16     4 16 4 0.67 10.92 
28 Aztreonam   1   0.05 1 0 0.06 7.87 
29 Mecillinam 2     0.5 2 1 1.41 6.95 
30 Faropenem   4   0.39 4 2 0.24 6.98 
31 Imipenem 1     0.12 1 0 -0.19 7.36 
32 Latamoxef  1    0.12 1 0 0.22 8.43 
33 Chloramphenicol    8 4 4-6.25 6 2.585 0.11 7.27 
34 Florfenicol    8  6.25 8 3 0.98 8.45 
35 Methotrexate    8  640 8 3 -0.91 9.48 
36 Acriflavine    128  400 128 7 2.56 9.39 
37 Proflavine    8  100 8 3 2.10 5.99 
38 Tetracycline    8  1.25 8 3 -0.56 8.88 
39 Sulfacetamide    1  2000 1 0 0.15 6.27 
40 Novobiocin 32  64 64  32-100 53.3 5.736 3.07 8.68 
41 Nalidixic acid    2  3.125 2 1 0.95 9.62 
42 Ethidium bromide    256  800 256 8 4.33 9.01 
43 Ciprofloxacin    4  0.01 4 2 -0.57 9.07 
44 Norfloxacin    1  0.004 1 0 -0.47 9.46 
aThe MIC ratio is the ratio of minimum inhibitory concentration (MIC) in the presence of efflux pump to the MIC in the absence of the 
pump. All reported MIC ratios are for the E. coli AcrAB-TolC pump, or the closely related S. typhimurium homolog.  
bAll WT strains used include JC7623, SH5014, TG1, HS414 and ECM1194 while all pump knockout strains include JZM120, 
SH7616, KAM3/pHSG398 or pHSG299, HS832 and ECM1694. 
cLogP was predicted by the ALogPs method [41-43].  
dThe molecular width of each efflux substrate was calculated by performing a molecular dynamics simulation of 1 ns duration, 
followed by aligning the farthest atoms along the Z axis and measuring the projection of all other atoms on the XY plane. Assuming 
that the molecule spins rapidly, the largest such projection gives us a rough measure of its molecular width. 
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Figure 2.1. Docking Efflux Substrates Into Different Regions of AcrB and TolC. All 
32 -lactam and 12 non--lactam structures were docked into AcrB and several 
overlapping regions of TolC. (A) The hydrophobic pocket of AcrB is shown for both 
binding state (blue) and extrusion state (green) conformations.  The numbered arrows 
indicate the specific locations of AcrB in which the substrate molecules were docked: 1) 
binding state, 2) intermonomer region, 3) the extrusion state.  (B) Molecular surface of 
the TolC channel shown colored according to cavity depth. The peaks are shown in 
copper brown, while troughs are shown in blue. (C) Ribbon cartoon of a TolC monomer, 
depicting its twisted shape. (D) The straightened cartoon avatar of one TolC monomer, 
showing different zones where antibiotic structures were docked. All the zones 
overlapped sufficiently to ensure a thorough investigation of molecular interactions 
between the entire TolC lumen surface and each antibiotic. 
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2.2.4 LogP calculations.   
LogP was calculated by using an online server [44], which gave values of multiple 
LogP prediction methods including ALogPs, ALogP, MLogP, XLogP2 and XLogP3 [44-
46] that are based on different principles and yet are known to predict LogP values quite 
well.  Our regressions, however, stipulated that only one set of LogP values could be 
used in any resulting equation in order to avoid using multiple highly correlated 
descriptors, which would have led to models with exaggerated statistical parameters.  
The best correlation between predicted LogP and efflux was shown by ALogPs values.  
For comparison and to evaluate the significance of differences between LogP calculated 
for charged and uncharged forms of the molecules, LogP values were also calculated 
for the β-lactams using HINT [39] (―calculate method‖, ―essential‖ hydrogens only).   
2.2.5 Prediction of molecular width by molecular dynamics simulations.   
Considering an efflux pump to be a tubular passage, one descriptor that we 
expected to correlate with efflux was molecular width, i.e., it should have a negative 
correlation with efflux, akin to a very large ball not being able to pass through a tubular 
pipe.  For this purpose, we used molecular dynamics simulations to calculate the 
effective width of the efflux substrates.  Figure 2.2 describes the physical concept 
behind our calculations: we aligned each structure with the z-axis and calculated the 
projections of its atoms on the x- and y-axes.  The largest projection for each structure 
was taken as its width.  For completeness, we ran a 1 ns simulation for each molecule 
using the Sybyl molecular dynamics module at 300K, recording snapshots every fs and 
performed width calculations every 100 fs of simulation.  The resulting average of 
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widths, calculated using 10,000 conformers for each ligand, was used as the molecular 
width descriptor.  
 
Figure 2.2. Calculation of Molecular Width. The figure shows ampicillin depicted in a 
3D coordinate system, with the longest pair of atoms aligned with the Z axis. Projection 
of an atom on the XY plane is shown and its length is depicted by R0. The largest X or Y 
component of all such projections was taken as the radius of a cylinder C that can hold 
the entire structure, which is an approximate measure of the width of the structure. 
 
2.2.6 3D-QSAR methods.   
The 3D-QSAR analyses were performed using the Comparative Molecular Fields 
Analysis fields (CoMFA) module of Sybyl.  The β-lactam molecules were manually 
aligned based on the common -lactam substructure and re-minimized to ensure no 
structures with high internal strain energy were present during analysis.  The set of 32 
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-lactams was divided into two sets, a training set of 24 compounds and a test set of 8 
compounds using a random number generator to avoid any bias in selecting training 
and test sets.  3D-QSAR studies were performed for the charged and neutral forms 
separately.  All compounds thus aligned were placed in a grid (spacing 1 Å, margin 4 
Å).  Both standard CoMFA fields (hydrogen bonding, electrostatic and steric 
parameters) and HINT fields (hydropathic) were calculated at each grid point.  Partial 
Least Squares (PLS) and Sample-distance Partial Least Squares (SAMPLS) [47] 
analyses were performed to correlate positions/properties of various chemical 
substituents with efflux values.  Various descriptor field combinations were 
comprehensively explored, creating several models to explore the predictability of each.  
The selected best models, i.e., those showing highest cross-validated r2 (q2) at a 
minimum (optimum) number of components, identified the descriptor field sets to be 
used for further analysis.  
 
2.2.7  The systems hydropathy method.   
Using solely the 32 β-lactams, a statistical analysis of docking/scoring scores and 
substrate physicochemical properties as descriptors was performed using PLS and 
SAMPLS.  During this investigation, only one predicted LogP value was used in any 
given regression equation to avoid using multiple correlated descriptors. An exhaustive 
search through the various HINT score sets calculated, as described above, for 
substrate binding to the various pump zones, singly and in combination, was performed 
to find the best possible descriptor combination.  This model (vide infra), i.e., the 
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combination of descriptors that best quantified β-lactam efflux values, was then 
extended to the non-β-lactam set. The complete set of 44 compounds was separated 
into training sets of 33 compounds and test sets of 11 compounds.  Cross-validation 
was performed on these training sets and test sets to confirm internal stability of the 
models. 
2.3  RESULTS AND DISCUSSION 
The intrinsic function of efflux pumps is to expel extraneously acquired molecules 
that could harm the cell.  These are promiscuous proteins that are largely responsible 
for antibiotic resistance in Gram-negative bacteria.  In contrast to normal receptors and 
enzymes that bind or else catalyze reactions involving small molecules at a specific site, 
the function of these proteins is to transport these small molecules – usually over fairly 
large distances.  Perhaps due to this difference in function and the multiple steps 
involved in what is clearly a dynamic rather than static process, their activity has been 
resistant to computational chemistry/biology attempts at prediction.  In fact, for a long 
time, the only useful known trait of the AcrA-AcrB-TolC efflux pump was that it 
transports hydrophobic molecules more easily [24].  However, recently available 
crystallographic data for the AcrB and TolC components of this efflux pump has enabled 
a more systematic and structural evaluation of the efflux mechanism [34].   
We believed that this emerging structural information for pump molecules, combined 
with modeling tools that effectively characterize hydrophobic interactions and related 
effects, could illuminate the process of efflux.  Our key technology is the HINT model 
[39-41], which is an empirical modeling tool based on the free energy of solvent transfer 
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between two phases, 1-octanol and water, representing hydrophobic and polar 
biological environments, respectively.  HINT has been used to evaluate ligand binding 
[42,43], protein-protein associations [48-50] and other phenomena involving biological 
molecules [51,52] and has been generally successful in quantitating the free energies of 
these interactions.  In addition, qualitative representations of biological processes 
involving molecular associations have been developed within the HINT paradigm; e.g., 
we recently developed molecular models validating previously proposed dual site 
mechanisms for inhibition of paramyxovirus hemagluttanin-neuramindase [53,54].   
In obtaining and curating a high quality and relevant data set for our analysis, we 
restricted this study to 32 -lactam compounds (see scheme 2.1) and 12 non-β-lactams 
from several families (see scheme 2.2), whose efflux data was available in published 
reports [23-25,27,37].  Although similar data for them is available, the aminoglycoside 
and macrolide classes of antibiotics are not included in the curated set; the former 
because they are hydrophilic and therefore not effluxed as readily by the AcrAB pump - 
the AcrD pump is apparently more responsible for their efflux than the AcrB pump 
[55,56] and the latter because of their large size relative to that of the AcrB entrance.  
However, we cannot discount the possibility that these antibiotics might enter TolC via a 
different route [57], thus still involving parts of the AcrA-AcrB-TolC pump (and 
concomitantly being affected by the pump knockout mutants).  We recognize that a 
much larger but proprietary set of data is very likely available within pharmaceutical 
companies, but wanted the entire data set to be available from the primary literature for 
this initial work.  The experimental measure of efflux used in this study is Log2(MIC 
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ratio), where the MIC (minimum inhibitory concentration) ratio is the MIC for a cell with 
an intact AcrA-AcrB-TolC pump normalized by the MIC for that cell with the pump 
knocked out.  Using this ratio in lieu of MIC itself has benefits as it more clearly 
represents the change in effectiveness of an antibiotic.  In contrast, MIC is a poorer 
target metric as it is dependent on a number of factors such as concentration of cells 
per unit volume of culture and is thus more laboratory and procedure-dependent.  
2.3.1  3D-QSAR.   
It seemed possible that binding in the AcrB pocket would affect the efflux of 
substrates more than binding elsewhere in the pump because it has been shown that 
this protein must undergo a conformational change in order to pass substrates into TolC 
[34].  One way to test this is to perform 3D-QSAR analyses where the interactions 
between substrates and a hypothetical but undefined receptor are simulated by the 
molecular fields of the substrates.   This approach was applied to the β-lactam data set 
after conformationally aligning these molecules to simulate their putative binding modes 
within a binding site presumed to be AcrB.  If such an analysis provided predictive 
results with respect to efflux, then we could at least partially address our goal of 
predicting high or low efflux.  We performed this 3D-QSAR study of the β-lactam data 
set with molecules in both their charged and neutral forms using the Comparative 
Molecular Field Analysis (CoMFA) method of Cramer [58].  The results seem promising 
for neutral compounds, with a cross-validated r2 (q2) = 0.53 (4 components) on the 
training set of 24 compounds and a (predictive) r2 = 0.80 for the test set of 8 
compounds, as illustrated for a typical run in Figure 2.3.  This model used the CoMFA 
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Standard Steric field, H-bond Steric field and H-bond Electrostatics field (0.35), with 
relative contributions of 27%, 38% and 35%, respectively.  Although their internal 
statistical metrics were initially acceptable, CoMFA models for β-lactam substrates in 
their charged state could not be validated.  
However, 3D-QSAR experiments are dependent upon the alignment of a common 
substructure, in this case the β-lactam.  Thus, this model formalism would not be 
utilizable for the extended dataset including the non-β-lactams.  Furthermore, these 
experiments are based on the assumption that substrates bind to a single site in the 
pump, whether in AcrB as we proposed or elsewhere, when in fact AcrB changes 
conformation between its binding and extrusion states [34].  Thus, there must be a 
dynamic change in its interactions with ligands as they are processed.  In fact, the 
binding pocket of AcrB is lined with a number of hydrophobic phenylalanine residues 
[34], indicating a preference for hydrophobic or, at a minimum, less polar substrates – 
suggesting that ligands would more favorably bind in their uncharged forms.   
    At the same time, we cannot ignore the possibility that the phenylalanine rings could 
also be acting as receptors for -cation interactions.  The 3D-QSAR results above 
support the assertion of ―neutral state‖ binding to AcrB and may be interpreted as 
evidence of at least transient binding at this site being a rate-limiting initial step.  In 
contrast, the TolC lumen is exposed to the extracellular environment due to its position 
on the bacterial outer membrane and this lumen is very likely solvated – suggesting that 
ligands bound here would favor their charged form.  The translocation of substrates 
from AcrB to TolC must expose them to water, providing a mechanism for transforming 
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them from their uncharged to charged forms.  Substrates by necessity interact with 
various parts of AcrB and TolC during their efflux extrusion and the process of efflux is 
certainly affected by a multitude of different interactions and thus cannot be completely 
addressed by simple methods such as 2D or 3D-QSAR that are based on molecules in 
a single state, bound within a single well-behaved binding site/mode with the 
concomitant assumption of a pharmacophore recognition-driven process.     
While the 3D-QSAR model is unfortunately not extensible to other substrate families 
because of the requirement that the molecules in the model have a common alignment, 
the results for the β-lactam data set are an indicator of key principles behind the pump 
mechanism. 
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Figure 2.3 Training set and test set validations for 3D-QSAR models. Two runs 
show variable predictions of efflux values of substrates.  The (A) training set and (B) 
test set for the first run are shown along with the (C) training set and (D) test set for the 
second run.  The cross-validated r2 (q2) is indicated for the training sets and the 
predictive r2 is indicated for the test sets.  While the first run shows a useful model, the 
second signifies instability of the model. 
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2.3.2   What factors might affect efflux?   
The extrusion of ligands through an efflux pump such as AcrA-AcrB-TolC must 
depend on a number of factors, including certain properties of the substrates 
themselves as well as their interactions with the protein complex as measured by 
docking/scoring calculations.   
First, the size of the substrate molecules would seem to be one of their most critical 
features.  Molecular widths were calculated by molecular dynamics simulations, as 
described above in the Experimental Section.  These values for each molecule are 
listed in Table 2.1.  In designing this parameter, we had presumed that there would be a 
negative correlation, i.e., molecules with larger cross sections would be effluxed with 
more difficulty.  Also, the previous reports of a correlation between LogP and efflux [31] 
mandated the use of this descriptor.  Although it would definitely be preferable to 
incorporate experimental LogP values in our study, they are not uniformly available.  
The LogP calculations were performed using several methods, but the best correlation 
between predicted LogP and efflux was shown by ALogPs (Table 2.1).  LogP alone (see 
Figure 2.4) is clearly insufficient to describe efflux effectively.  In addition, to account for 
the dynamic nature of efflux, intermolecular interactions between efflux substrates and 
various zones or compartments of the pump must be coordinated in order to transport 
the substrates through the pump.  Thus, the substrate molecules were docked into 
various locations within AcrB and TolC.  These docked positions are direct 
representations of interactions between substrate and the efflux pump subunits. Using 
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the HINT model to score these interactions gives us an additional advantage of taking 
desolvation energy and entropy into account at these loci [39].  
2.3.3 Systems hydropathy.   
Since efflux pumps conduct substrates from the periplasmic space to the extracellular 
medium, this process is affected in multiple ways by interactions of the substrates with 
the transporter protein, which can be simulated by docking the substrates in the AcrA-
AcrB-TolC pump.  However, as there are not specific and well-defined docking region(s) 
within the pump, the substrates were docked into multiple zones or compartments, in 
both their charged and uncharged forms, as illustrated in Figure 2.1.  Important sites 
were thus initially surveyed with -lactams within the binding and extrusion states of 
AcrB. Since the TolC lumen is open to the extracellular space, ligands present here 
should be solvated and exist mostly in their charged forms.  Again, the -lactams were 
used to survey the potential sites within TolC.  Compartmentalization of individual 
events (albeit of a different variety and on a different size scale) is also seen in the 
‗systems biology‘ approach; each compartmentalized effect is recorded individually, but 
the effects are viewed on a holistic level in order to study trends that cannot be 
observed by the reductionist approach.  Similarly, we interpret the larger efflux effect as 
partially being a result of compartmentalized hydropathic interactions between substrate 
and pump, leading us to call our method ‗systems hydropathy‘.  
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Figure 2.4 Correlation Between ALogPs Predicted LogP Values and Efflux. The 
plot of predicted LogP values versus efflux shows an r2 value of 0.48, illustrating the fact 
that LogP alone does not allow prediction of antibiotic efflux.  Also shown is the 
quadratic fit of Efflux with respect to LogP (Efflux = a + b*LogP + c*Logp2), which shows 
an r2 value of 0.55. 
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A partial least squares (PLS) analysis was conducted to explore the interplay 
between the substrate molecular properties and the interactions between the 
charged/uncharged -lactam antibiotics and the AcrB and TolC proteins.  Multiple 
equations of correlation were obtained through exhaustive exploration of the descriptor 
space.  Only those descriptors that showed both interpretable trends and significant 
contributions to a model fitting the set of 32 β-lactam molecules were retained.  With the 
important descriptors and binding sites thus identified, the 12 non-β-lactam substrates 
were docked and scored at those sites.  The best combination of descriptors yielded the 
final multilinear model: 
Efflux = - 1.31 – (1.7x10-4)*HINTnB – (5.3x10
-4)*HINTcE + (6.9x10
-4)*HINTAcrB(hole) – 
(1.0x10-3)*HINTZ3 + 1.10*LogP + 0.43*MolWidth                         (eq. 1) 
Here, HINTnB is the HINT score of the neutral substrate docked to the AcrB binding 
state. Similarly, HINTcE is the HINT score of the charged substrate in the AcrB extrusion 
state. HINTAcrB(hole) and HINTZ3 represent the HINT scores of the charged substrate at 
the intermonomeric space of AcrB and zone 3 of TolC, respectively.  LogP values are 
as predicted by the ALogPs algorithm, chosen as described above due to their better 
correlation with efflux and MolWidth is the molecular width. A table with all descriptor 
values for each compound is given in appendix B. 
Cross-validation with leave-one-out on the data set yielded a q2 of 0.56 and an r2 of 0.66 
with 2 components for equation 1.  Figure 2.5A displays the predictive model of 
equation 1 and table 2.2 sets out the predicted efflux and deviations calculated.  To 
further evaluate the predictive ability of the model, the data set of 44 compounds was 
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randomly divided into training sets of 33 compounds and test sets of 11 compounds.  
New models were built with leave-one- out cross-validation over the training sets and 
used to predict the efflux of their corresponding test sets.  The predicted test set efflux 
for a typical run of this nature is illustrated in Figure 2.6.  
It is probably more important to classify substrates as being susceptible or not to 
efflux than to predict their numerical MIC ratio.  Thus, using a definition of ―high‖ efflux 
as ≥ 4, the equation 1 model was able to identify low/high efflux molecules with a 
93.18% (41/44) success rate.  Other results, i.e., with different high/low cutoffs, are 
summarized in Table 2.3.  Note that even the predictions in error in terms of this binary 
classification scheme are often fairly close to the experimental efflux (Table 2.2).  In 
summary, this method allows reliable predictions for whether a given antibiotic is a good 
substrate for efflux by the AcrA-AcrB-TolC pump.  
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Table 2.2.  Efflux predictions for data set molecules. 
Antibiotic 
Average 
MIC ratio
a
 
MIC ratio prediction (Equation 1) MIC ratio prediction (Equation 2) 
MIC ratio Error MIC ratio Error 
1 4 3.34 -0.66 2.78 -1.22 
2 2.5 4.00 1.50 2.34 -0.16 
3 2 10.13 8.13 6.48 4.48 
4 1 3.31 2.31 2.73 1.73 
5 1 0.42 -0.58 1.22 0.22 
6 3 2.35 -0.65 1.89 -1.11 
7 1 0.69 -0.31 2.18 1.18 
8 1.5 6.21 4.71 6.39 4.89 
9 1.5 2.37 0.87 2.57 1.07 
10 12 3.64 -8.37 3.11 -8.89 
11 5.33 1.19 -4.15 1.45 -3.88 
12 2 3.46 1.46 4.97 2.97 
13 1.33 1.50 0.16 1.44 0.11 
14 1 1.61 0.61 1.28 0.28 
15 1 2.32 1.32 2.43 1.43 
16 17 13.70 -3.30 9.06 -7.93 
17 1 1.21 0.21 1.39 0.39 
18 2.5 8.77 6.27 5.16 2.65 
19 2.67 1.72 -0.94 1.55 -1.12 
20 1 2.88 1.88 1.48 0.48 
21 384 59.84 -324.17 83.29 -300.72 
22 2.5 2.09 -0.41 1.62 -0.88 
23 36 4.88 -31.12 4.04 -31.97 
24 128 64.80 -63.20 101.62 -26.38 
25 171 133.07 -37.60 437.76 267.10 
26 6 8.33 2.33 5.30 -0.70 
27 16 14.55 -1.45 8.80 -7.20 
28 1 1.80 0.80 1.33 0.33 
29 2 12.73 10.73 10.01 8.01 
30 4 4.49 0.49 4.25 0.25 
31 1 0.41 -0.59 0.79 -0.21 
32 1 3.49 2.49 2.46 1.46 
33 6 0.76 -5.24 1.67 -4.33 
34 8 11.73 3.73 5.61 -2.39 
35 8 2.89 -5.11 3.26 -4.74 
36 128 34.78 -93.22 30.80 -97.20 
37 8 9.09 1.09 6.29 -1.71 
38 8 4.35 -3.65 3.38 -4.62 
39 1 1.78 0.78 1.28 0.28 
40 53.3 43.32 -9.98 47.34 -5.96 
41 2 9.12 7.12 6.78 4.78 
42 256 100.92 -155.08 307.41 51.41 
43 4 2.56 -1.44 3.33 -0.67 
44 1 3.18 2.18 3.53 2.53 
a
The MIC ratio is the ratio of minimum inhibitory concentration (MIC) in the presence of efflux pump to the 
MIC in the absence of the pump. 
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Table 2.3  Classification accuracy of efflux predictive model. 
Definition of “High” 
Efflux 
% Correct 
Predictions (Eqn. 1) 
% Correct 
Predictions (Eqn. 
2) 
≥4 93.18 (41/44) 93.18 (41/44) 
≥3 79.55 (35/44) 84.09 (37/44) 
≥2 72.73 (32/44) 70.45 (31/44) 
≥1 77.27 (34/44) 72.73 (32/44) 
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Figure 2.5 Correlation Plots for Predicted vs. Experimental Efflux as Obtained 
with the Systems Hydropathy Approach. Predicted versus experimental efflux values 
plotted for all 44 ligands based on (A) equation 1 and (B) equation 2. 
 
r² = 0.66
-3
0
3
6
9
0 3 6 9
P
re
d
ic
te
d
 E
ff
lu
x
Experimental Efflux
A
r² = 0.73
-3
0
3
6
9
0 3 6 9
P
re
d
ic
te
d
 E
ff
lu
x
Experimental Efflux
B
  
80 
 
 
 
 
Figure 2.6 Systems Hydropathy Validation. Predicted Versus Experimental Efflux For 
Training and Test Set Substrates.  (A) Correlation between the predicted and 
experimental efflux values for training set of 33 compounds using leave-one-out cross-
validated model built with descriptors of eq. 1.  (B) Correlation between the predicted 
and experimental efflux values for independent test set of 11 compounds using equation 
of (A).  (C) Correlation between the predicted and experimental efflux values for training 
set of 33 compounds using leave-one-out cross-validated model built with descriptors of 
eq. 2 (D) Correlation between the predicted and experimental efflux values for 
independent test set of 11 compounds using equation of (C). 
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2.3.4 Model and descriptor interpretation.   
A key requirement for a universally useful predictive model is that the 
physicochemical implications of the model‘s descriptors are interpretable and intuitive.  
The descriptors must yield not only statistical information but also chemical information 
that can be applied to fruitful drug design.  However, when considered together, as in a 
regression equation, the model should have more value than the sum of its parts, i.e., 
the individual descriptors.  Table 2.4 shows the fractional contribution of each descriptor 
for the model.  All descriptors were found to have a significant contribution in the 
prediction of efflux values, with LogP having the largest, a nearly 41% contribution, to 
the model.  In this section the descriptors and their qualitative and quantitative 
contributions to the overall model are described.  
First, we should describe the roles that effects represented by LogP may play in the 
biological process.  LogP represents more than solubility and related phenomena. This 
is especially true in the study of MIC ratios because the phenomenon is composed of 
two independent events: influx of the antibiotic through the outer membrane, followed by 
extrusion of the same by an efflux pump. LogP plays an important role during 
permeation of the antibiotic through the outer membrane, as has repeatedly been 
described by Lipinski‘s rules [59,60]. Also, since the AcrB binding pocket, which 
captures antibiotics and other substrates to commence efflux, is hydrophobic, it is not 
hard to imagine the importance of this descriptor in the process of efflux.  Especially 
when the range of compounds is large, LogP can often be better represented in a 
quadratic form in QSAR equations, i.e., a + b*LogP + c*LogP2 [61,62].  This form allows 
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for the likely scenario that both too high and too low LogP are detrimental to the 
biological effect being modeled and that there is an optimum range of LogP.  In the case 
of efflux (i.e., log2[MIC ratio]), even though the linear relationship between LogP and 
efflux, i.e., Efflux = a + b*LogP, is fairly good (r2 = 0.48), there is a modest improvement 
with the quadratic to r2 = 0.55 (see Figure 2.4).  Both forms of the regression support 
our expectation that more hydrophobic moieties are more easily effluxed by the pump. 
The quadratic probably provides a better fit due to the peculiarities of the data – in that 
there is no negative efflux – presumably, compounds with very negative LogP would 
have an efflux of zero.  Overall, both support the model that ligands are initially captured 
by AcrB and then transported into the solvated TolC lumen and that those ligands with 
highly negative LogP values will be unable to enter the hydrophobic AcrB binding 
pocket.  We hypothesize that ligands with highly positive LogP values (more positive 
than in this data set) would be able to easily enter AcrB but then resist deposition into 
the polar environment of the TolC lumen and thus ―clog‖ the pump.  
Table 2.4.  Fractional contribution of descriptors to models.  
Descriptor 
Percent 
Contribution 
(Equation 1) 
Percent 
Contribution 
(Equation 2) 
LogP2 - 20.5 
LogP 40.9 22.0 
HINTZ3
2 - 12.7 
HINTZ3 18.2 10.9 
HINTAcrBhole
 2 - 4.2 
HINTAcrBhole 11.9 3.5 
HINTnB 2.6 0.7 
HINTcE 13.0 13.3 
MOLWIDTH 13.5 10.6 
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It is likely that HINTnB appears in the equation because these substrates should bind 
to the AcrB protein‘s binding state in their neutral form.  It has previously been proposed 
that efflux pumps capture antibiotics from the periplasmic region [34].  Since this region 
is lined on either side by lipid bilayers, this environment is less polar than that of the 
cytosolic medium.  This would, thus, partially shift the acid-base equilibria for ligands in 
the periplasmic space towards their non-ionic (more hydrophobic) forms.  As there are 
several phenylalanine residues in the AcrB binding pocket, it is thus quite hydrophobic 
and this, the entrance to the pump, would preferentially bind less polar ligands, or those 
that are in a non-ionic form at the time of capture.  This would suggest that a number of 
substrate molecules linger near the entrance and only pass within when their 
equilibrium-mediated ionization state matches the requirements of the AcrB binding 
pocket.  Confusingly, this term has a negative correlation coefficient that suggests 
strong binding here disfavors efflux.  This, in a sense, would appear to be true, as very 
strong binding to this site should cause the substrate to be ―stuck‖ and not effluxed.  Of 
course, negligible binding to this site should also be a negative factor, but presumably, 
intermediate binding should favor efflux.  Much as above, this should be a classic case 
for using quadratic descriptors (e.g., a + b*HINTnB + c*HINTnB
2) in constructing 
regression models, but as the contribution of HINTnB in the model of equation 1 is quite 
small (see Table 2.3), we should not expect a strong correlation in models using only 
this independent variable in any case.  Thus, as observed in figure 2.8A, the attempt to 
fit efflux with only the HINTnB quadratic descriptor yielded a poor regression (r
2 = 0.030) 
compared to the linear fit of efflux with HINTnB (r
2 = 0.028).  Moreover, it must be noted 
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that while a high HINTnB score would favor the capture of antibiotics by AcrB, this 
phenomenon can also be facilitated, at least in part, by simply ―partitioning‖ molecules 
into the AcrB binding pocket, a phenomenon that is likely encoded in the dominant LogP 
descriptor.  
After AcrB captures a ligand, it undergoes a conformational change as observed 
in its crystal structure (PDB code 2drd) [34], where both ligand-bound and unbound 
states were observed in the same multimeric structure.  The conformational change 
opens up the binding pocket towards the TolC lumen.  The ligand would now likely be 
bathed in water entering the AcrB binding pocket from the extracellular environment 
through TolC.  This (suddenly) now polar environment would shift the acid-base 
equilibria towards favoring charged forms of the ligands.  Thus, we propose the 
significance of the HINTcE descriptor that represents binding in the AcrB extrusion state 
in our models.  Similar to above for HINTnB, the HINTcE descriptor also has a negative 
correlation coefficient in the models and thus also represents a complex effect.  In this 
case the effect was not better modeled in this data set by using a quadratic 
representation: a + b*HINTcE + c*HINTcE
2 (r2 = 0.148) cf. linear (r2 = 0.148, figure 2.8B), 
so the simple explanation is that tight binding here is detrimental to efflux.  Substrate 
ligands washed out of the hydrophobic pocket of AcrB in their charged forms would 
have a higher affinity towards the intermonomeric region that has a higher density of 
charged residue sidechains.  The positive coefficient of HINTAcrBhole is indicative of the 
―pull‖ exerted on ligands by this region, enabling it to exit the extrusion state of AcrB 
towards the TolC channel.  For this descriptor, the quadratic representation (r2 = 0.044) 
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gives a slightly better correlation than that of the simple linear model (r2 = 0.003), but 
both are poor, in concert with the small contribution of this descriptor to the model.  This 
does suggest the possibility that both weak and tight binding can inhibit efflux. Linear 
and quadratic relationships between efflux and HINTAcrBhole are demonstrated in figure 
2.8C. 
On traversing through the TolC lumen, the substrate would successively interact with 
multiple positions on the protein. In accordance with our theory that stronger 
interactions slow down extrusion of ligands, the term HINTZ3 correlates negatively with 
efflux in our regression equations. This is easily explained by looking at the inner 
surface map of TolC (figure 2.9A). Zone 3, which happens to be a deep pocket, is found 
in the center of the TolC lumen surface (figure 2.9B).  Although a transient attraction 
between the substrate and the residues at this site may favor the substrate‘s passage, 
strong interaction with this deep pocket would slow or halt the passage of ligands 
through the TolC lumen, thereby reducing the extent of efflux by the pump.  This effect 
is somewhat better modeled with a quadratic descriptor (r2 = 0.219) rather than linear (r2 
= 0.192), which are delineated in figure 2.8D.  
Molecular width (MolWidth) appears in equation 1 and possesses an unexpected 
positive correlation coefficient; i.e., larger substrates are more favorably extruded by the 
pump.  We are proposing that this effect arises from ‗induced fit‘ of larger substrates on 
AcrB, thus forcing AcrB to transform from the unbound and flaccid access state to the 
much larger binding state.  Also, the substrate bulk could force a change in tertiary 
structure that causes AcrB to assume the extrusion state. There is experimental 
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evidence to support this hypothesis: the crystal structure (PDB ID 2drd) of AcrB clearly 
shows that the binding pocket is shrunken in the access state, while in the binding state 
it is wide open with an entrenched ligand [34].  After releasing the ligand, the pocket 
returns to its shrunken conformation in the extrusion state.  It has previously been 
suggested that the proton pump mechanism provides energy for conformational change 
[63].  We propose that binding of larger ligands might supplement (or trigger?) this effect 
by providing steric ―encouragement.‖ However, in agreement with our initial assumption, 
we still believe that transitioning beyond a certain size should also be detrimental for 
efflux. In other words, this descriptor also should be better represented in quadratic 
form. However, as observed in figure 2.8E, the quadratic relationship (r2 = 0.055) 
yielded only a small improvement when compared to the linear model (r2 = 0.054). This 
is possibly due to the small range of molecular width possessed by the compounds in 
our dataset. 
To consolidate the above information, we suggest equation 2, in which LogP, 
HINTAcrBhole and HINTZ3 are modeled in their quadratic forms: 
Efflux = - 2.09 – (4.9x10-5)*HINTnB – (6.1x10
-4)*HINTcE + (2.3x10
-4)*HINTAcrBhole – 
(6.8x10-4)*HINTZ3 + 0.66*LogP + 0.44*MolWidth + 0.22*LogP
2 + (2.1x10-
7)*HINTAcrB(hole)
2 + (1.04x10-7)*HINTZ3
2                                                                (eq. 2) 
This model has q2 = 0.63 and r2 = 0.73 with 2 components.  Its results are presented in 
Figures 2.5B, 2.6C and 2.6D and Tables 2.2, 2.3 and 2.4.  While a noteworthy 
improvement in statistical parameters was observed, no apparent change in the model‘s 
ability to correctly predict high/low efflux (Table 2.3).  However, it must be 
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acknowledged that this model is at higher risk of being statistically invalid because of 
the addition of three more fitted parameters for the coefficients of the squared terms. 
 
 
Figure 2.7 Surface Maps for TolC. (A) An electrostatic surface map of TolC shows the 
surface of the TolC lumen (enclosed by the red circle) (B) Zone 3 of the TolC efflux 
pump is a deep cavity on the wall of the lumen, with blue depicting peaks while blue-
green depicts troughs.  
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Figure 2.8  Relationship between Efflux and Individual Descriptors. Linear and quadratic 
models for the relationship between efflux and each descriptor used in this study are 
demonstrated. Efflux as a function of (A) HINTnB and (B) HINTc# are demonstrated. 
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Figure 2.8 continued. Efflux as a function of (C) HINTAcrBhole and (D) HINTZ3 are 
demonstrated. 
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Figure 2.8 continued. Efflux as a function of (E) molecular width. 
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Figure 2.9 summarizes our proposed mechanism for the AcrA-AcrB-TolC efflux 
process. The dielectric environment within the periplasmic region is unknown, but it is 
likely that there is less water present between the two lipid bilayers than in either the 
extracellular or cytoplasmic regions (see Figure 2.9A that indicates the color scales 
used in the remaining panels of Figure 2.9).  Furthermore, the periplasmic space is 
occupied by peptidoglycan chains and a gel containing a wide variety of enzymes, 
which should tend to reduce the polarity.  Efflux substrates in the periplasm would exist 
in a reversible equilibrium between their charged and uncharged forms that slightly 
favors the uncharged forms (Figure 2.9B, inset) in this (slightly) more hydrophobic 
region.  The uncharged forms will be more likely captured by the AcrB hydrophobic 
pocket (Figure 2.9B), upon which AcrB will assume the extrusion state (Figure 2.9C) 
partly due to the bulk of the substrate, as indicated by the positive correlation between 
efflux and molecular width.  It should be pointed out that if a substrate molecule binds 
too tightly to the binding state form of AcrB, or if it cannot sterically trigger the extrusion 
state of AcrB, that substrate would appear to be immune from extrusion and may block 
the pump‘s function.  The absence of favorable substrate binding at this state would 
also preclude efflux.  Once the extrusion state is formed, the AcrB entrance is closed 
and thus isolated from the periplasmic space but now open towards TolC, exposing the 
substrate to water present in the TolC lumen (Figure 2.9C).  Similarly, the ligand‘s 
ionization equilibrium is concomitantly shifting towards the charged form (Figure 2.9D, 
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Figure 2.9 Proposed Efflux 
Mechanism. (A) Color ramps 
for hydrophobic-polar (green 
to purple) and acid-base 
(blue to red) spectra.  (B) 
Antibiotics present in the 
periplasmic region exist in 
equilibrium between their 
charged and uncharged 
states (inset). The uncharged 
forms predominate due to the 
local environment and are 
captured by the AcrB 
hydrophobic pocket. (C) AcrB 
assumes extrusion state 
partly due to the bulk of the 
substrate and is isolated from 
the periplasmic space. The 
cavity is now open towards 
TolC, exposing the substrate 
to water present in the TolC 
lumen. (D) The ionization 
equilibrium shifts towards the 
charged form (inset) and the 
substrate is released into the 
intermonomeric space of 
AcrB. (E) The charged efflux 
substrate is now able to 
diffuse through the water 
present in the TolC lumen. 
The electric field present 
inside the TolC lumen causes 
orientation of the substrate 
such that negatively and 
positively charged groups 
point towards opposite ends 
of the protein. (F) The efflux 
substrate is released into the 
extracellular space. 
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inset), leading to release of the substrate into the intermonomeric space of AcrB (Figure 
2.9D).  Again, if the substrate ligand binds too weakly or too tightly to the AcrB extrusion 
state, it may not be effluxed and, in fact, may in the latter case block the pump.  
However, both these ―clogging‖ events involve equilibria that may reverse to unclog the 
pump.  The charged efflux substrate can now diffuse through water present in the TolC 
lumen (Figure 2.9E).  Ultimately the substrate will be extruded into the comparatively 
polar extracellular medium (Figure 2.9F). 
 
2.4  CONCLUSIONS 
Despite the engineering of Nature to facilitate the extrusion of undesired molecules 
within a cell, there are likely to be multiple reasons why a particular substrate is 
resistant to efflux.  In addition to the obvious descriptors of hydrophobicity (LogP) and 
size (although the correlation with molecular width we observed was initially 
counterintuitive), the ligand‘s ability to bind and release from various pockets within the 
pump machinery is at least as critical as the aforementioned descriptors that are not 
cognizant of its interactions with the pump.  However, despite the relatively successful 
predictions of efflux by these models, there are a number of considerations inherent in 
the approach that should be discussed.  Primary is the dataset itself.  Unfortunately, the 
available data is both relatively small in quantity and skewed towards the lower efflux 
range, which corresponds to the range of molecules of more clinical interest.  Our 
development of regression model equations with six descriptors on 44 substrates using 
PLS is not ideal, while our expanded model with three of these variables represented in 
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quadratic form is potentially bordering on overfitting.  Although we have some comfort 
from the fact that these models were subjected to cross-validation, which yielded good 
statistical parameters, Wold and Dunn [64] state that, even when using PLS, regression 
studies are only valid when the number of independent variables is far less than the 
number of dependent target values. Clearly, we would like to have a larger data set, but 
restricted this analysis to the -lactam class of antibiotics and some non-β-lactam 
antibiotics because of their loose chemical similarities that, in turn, suggest efflux 
extrusion by the same pump and mechanism.  Data from a wider class of antibiotics are 
potentially available, but their use may be premature in testing a new computational 
method. 
In conclusion, we have proposed the systems hydropathy approach, which has been 
used in this work to predict efflux values of the AcrA-AcrB-TolC efflux pump.  The 
analogy to systems biology stems from our combining the various compartmentalized 
functions of the pump‘s protein components into a holistic model that has more value 
than a reductionist analysis of the pump.  Nevertheless, the model suggested some 
interesting mechanistic details about the efflux process that seem intuitively true.  On 
further development, this approach could be expanded to more non--lactam antibiotics, 
other efflux systems affecting antibiotic efflux and potentially mammalian efflux systems 
that have been shown to extrude, among other molecules, anticancer chemotherapeutic 
agents.  The key puzzle piece is obtaining structural data for the protein components of 
additional pump molecules. 
  
95 
 
2.5   REFERENCES 
1. Gold, H.S.; Moellering Jr., R.C. Antimicrobial-drug resistance N. Engl. J. Med. 
1996, 335, 1445-1453. 
2. Neu, H.C. The crisis in antibiotic resistance. Science 1992, 257, 1064-1073. 
3. Walsh, C. Molecular mechanisms that confer antibacterial drug resistance. 
Nature 2000, 406, 775-781. 
4. Spratt, B.G. Penicillin-binding proteins and the future of -lactam antibiotics. J. 
Gen. Microbiol. 1983, 129, 1247-1260. 
5. Broome-Smith, J.; Spratt, B.G. An amino acid substitution that blocks the 
deacylation step in the enzyme mechanism of penicillin-binding protein 5 of 
Eschiricia coli. FEBS Lett. 1984, 165, 185-189. 
6. McMurry, L.; Petrucci, R.E., Jr.; Levy, S.B. Active efflux of tetracycline encoded 
by four genetically different tetracycline resistance determinants of Eschericia 
coli. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 3974-3977. 
7. Webber, M.A.; Piddock, L.J.V. The importance of efflux pumps in bacterial 
antibiotic resistance. J. Antimicr. Chemother. 2003, 51, 9-11. 
8. Bambeke, V.F.; Balzi, E.; Tulkens, P.M. Antibiotic efflux pumps. Biochem. 
Pharmacol. 2000, 60, 457-470. 
9. Nikaido, H. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 1996, 
178, 5853-5859. 
10. Lin, J.; Michel, L.O.; Zhang, Q. Cme ABC functions as a multidrug efflux system 
in Campylobacter jejuni. Antimicrob. Agents Chemother. 2002, 46, 2124-2131. 
11. Pumbwe, L.; Piddock, L.J.V. Identification and characterisation of CmeB, a 
Campylobacter jejuni multidrug efflux pump. FEMS Microbiol. Lett. 2002, 206, 
185-189. 
12. Poole, K. Efflux mediated resistance to fluoroquinolones in gram-negative 
bacteria. Antimicrob. Agents Chemother. 2000, 44, 2233-2241. 
13. Gill, M.J.; Brenwald, M.P.; Wise, R. Identification of an efflux pump gene pmrA, 
associated with fluoroquinolone resistance in Streptococcus pneumoniae. 
Antimicrob. Agents Chemother. 1999, 43, 187-189. 
14. Nikaido, H. Preventing drug access to targets: cell surface permeability barriers 
and active efflux in bacteria. Seminars Cell. Developmental Biol. 2000, 12, 215-
233. 
15. Kaatz, G.W.; Seo, S.M. Inducible NorA-mediated multidrug resistance in 
Staphylococcus aureus. Antimicrob. Agents Chemother. 1995, 39, 2650-2655. 
16. Saier, M.H., Jr. Molecular phylogeny as a basis for the classification of transport 
proteins from bacteria, archaea and eukarya. Adv. Microbiol. Physiol. 1998, 40, 
81-136. 
17. Lee, A.; Mao, W.; Warren, M.; Mistry, A.; Hoshino, K.; Okumura, Y.; Ishida, H.; 
Lomovskaya, O. Interplay between efflux pumps may provide either additive or 
multiplicative effects on drug resistance. J. Bacteriol. 2000, 182, 3142-3150. 
18. Ma, D.; Cook, D.N.; Alberti, M.; Pon, N.G.; Nikaido, H.; Hearst, J.E. Genes acrA 
and acrB encode a stress-induced efflux system of Escherichia coli. Mol. 
Microbiol. 1995, 16, 45-55. 
  
96 
 
19. Thanassi, D.G.; Cheng, L.W.; Nikaido, H. Active efflux of bile salts by Escherichia 
coli. J. Bacteriol. 1997, 179, 2512-2518. 
20. Sánchez, L.; Wubin, P.; Viñas, M.; Nikaido, H. The acrAB homolog of 
Haemophilus influenza codes for a functional multidrug efflux pump. J. Bacteriol. 
1997, 179, 6855-6857. 
21. Gotoh, N.; Murata, T.; Ozaki, T.; Kimura, T.; Kondo, A.; Nishino, T. Intrinsic 
resistance of Escherichia coli to mureidomycin A and C due to expression of the 
multidrug efflux system AcrAB-TolC: comparison with the efflux systems of 
mureidomycin-susceptible Pseudomonas aeruginosa. J. Infect. Chemother. 
2003, 9, 101-103. 
22. Yang, S.; Clayton, S.R.; Zechiedrich, E.L. Relative contributions of the AcrAB, 
MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J. 
Antimicr. Chemother. 2003, 51, 545-556. 
23. Mazzariol, A.; Cornaglia, G.; Nikaido, H. Contributions of the AmpC b-lactamase 
and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli 
K-12 to b-lactams. Antimicr. Ag. Chemother. 2000, 44, 1387-1390. 
24. Nikaido, H.; Basina, M.; Nguyen, V.; Rosenberg, E. Multidrug efflux pump AcrAB 
of Salmonella typhimurium excretes only those -lactam antibiotics containing 
lipophilic side chains. J. Bacteriol. 1998, 180, 4686-4692. 
25. Nishino, K.; Yamada, J.; Hirakawa, H.; Hirata, T.; Yamaguchi, A. Roles of TolC-
dependent multidrug transporters of Escherichia coli in resistance to -lactams. 
Antimicr. Ag. Chemother. 2003, 47, 3030-3033. 
26. McMurry, L.M.; Oethinger, M.; Levy, S.B. Overexpression of marA soxS or acrAB 
produces resistance to triclosan in laboratory and clinical strains of Escherichia 
coli. Fed. Euro. Microbiol. Soc. Microbiol. Lett. 1998, 166, 305-309. 
27. Sulavik, M.C.; Houseweart, C.; Cramer, C.; Jiwani, N.; Murgolo, N.; Greene, J.; 
DiDomenico, B.; Shaw, K.J.; Miller, G.H. Hare, R.; Shimer, G. Antibiotic 
susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump 
genes. Antimicr. Ag. Chemother. 2001, 45, 1126-1136. 
28. Hou, T.; Wang, J.; Zhang, W.; Wang, W.; Xu, X. Recent advances in 
computational prediction of drug absorption and permeability in drug discovery. 
Curr. Med. Chem. 2006, 13, 2653-2667. 
29. Johnson, S.R.; Zheng, W. Recent progress in the computational prediction of 
aqueous solubility and absorption. AAPS J. 2006, 8, E27-E40. 
30. Clark, D.E. Computational prediction of ADMET properties: recent developments 
and future challenges. Annu. Re. Comput. Chem. 2005, 1, 133-151 
31. Ferreira, M.M.C.; Kiralj, R. QSAR study of b-lactam antibiotic efflux by the 
bacterial multidrug resistance pump AcrB. J. Chemometrics, 2004, 18, 242-252. 
32. Kiralj, R.; Ferreira, M.M.C. Molecular graphics approach to bacterial AcrB 
protein-b-lactam antibiotic molecular recognition in drug efflux mechanism. J. 
Mol. Graph. Model. 2006, 25, 126-145. 
33. Borst, P.; Oude Elferink, R. Mammalian ABC transporters in health and disease. 
Annu. Rev. Biochem. 2002, 71, 537-592. 
  
97 
 
34. Murakami, S.; Nakashima, R.; Yamashita, E.; Matsumoto, T.; Yamaguchi, A. 
Crystal structures of a multidrug transporter reveal a functionally rotating 
mechanism. Nature 2006, 443, 173-179. 
35. Kononakis, V.; Sharff, A.; Koronakis, E.; Luisi, B.; Hughes, C. Crystal structure of 
the bacterial membrane protein TolC central to multidrug efflux and protein 
transport. Nature 2000, 405, 414-419. 
36. Tripos Sybyl molecular modeling suite, version 8.1. www.tripos.com/sybyl 
37. Lee, A.; Mao, W.; Warren, M.S.; Mistry, A.; Hoshino, K.; Okumura, R.; Ishida, H.; 
Lomovskaya, O. Interplay between efflux pumps may provide either additive or 
multiplicative effects on drug resistance. J. Bacteriol. 2000, 182, 3142-3150. 
38. Jones, G.; Willett, P.; Glen, R.C.; Leach, A.R.; Taylor, R. Development and 
validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-
748. 
39. Kellogg, G.E.; Abraham, D.J. Hydrophobicity: is LogPo/w more than the sum of its 
parts? Eur. J. Med. Chem. 2000, 35, 651-661. 
40. Cozzini, P.; Fornabaio, M.; Marabotti, A.; Abraham, D.J.; Kellogg, G.E.; 
Mozzarelli, A. Simple intuitive calculations of free energy of binding for protein-
ligand complexes. 1. Models without explicit constrained water. J. Med. Chem. 
2002, 45, 2469-2483. 
41. Spyrakis, F.; Amadasi, A.; Fornabaio, M.; Abraham, D.J.; Mozzarelli, A.; Kellogg, 
G.E. The consequences of scoring docked ligand conformations using free 
energy correlations. Eur. J. Med. Chem. 2007, 42, 921-933. 
42. Tripathi, A.; Fornabaio, M.; Kellogg, G.E.; Gupton, J.T.; Gewirtz, D.A.; Yeudall, 
W.A.; Vega, N.E.; Mooberry, S. Docking and hydropathic scoring of 
polysubstituted pyrrole compounds with antitubulin activity. Bioorg. Med. Chem. 
2008, 16, 2235-2242. 
43. Simoni, D.; Invidata, F.P.; Eleopra, M.; Marchetti, P.; Rondanin, R.; Baruchello, 
R.; Grisolia, G.; Tripathi, A.; Kellogg, G.E.; Durrant, D.; Lee, R.M. Design, 
synthesis and biological evaluation of novel stilbene-based antitumor agents. 
Bioorg. Med. Chem. 2009, 17, 512-522. 
44. Tetko, I.V.; Gasteiger, J.; Todeschini, R.; Mauri, A.; Livingstone, D.; Ertl, P.; 
Palyulin, V. A.; Radchenko, E. V.; Zefirov, N. S.; Makarenko, A. S.; Tanchuk, V. 
Y.; Prokopenko, V. V. Virtual computational chemistry laboratory - design and 
description, J. Comput. Aid. Mol. Des. 2005, 19, 453-463. 
45. VCCLAB, Virtual Computational Chemistry Laboratory, http://www.vcclab.org, 
2005. 
46. Tetko, I.V. Computing chemistry on the web, Drug Discov. Today, 2005, 10, 
1497-1500. 
47. Bush, B.L.; Nachbar, R.B. Jr. Sample-distance partial least squares: PLS 
optimized for many variables, with application to CoMFA. J. Comput.-Aided Mol. 
Des. 1993, 7, 587-619. 
48. Abraham, D.J.; Kellogg, G.E.; Holt, J.M.; Ackers, G.K. Hydropathic analysis of 
the non-covalent interactions between molecular subunits of structurally 
characterized hemoglobins. J. Mol. Biol. 1997, 272, 613-632. 
  
98 
 
49. Burnett, J.C.; Kellogg, G.E.; Abraham, D.J. Computational methodology for 
estimating changes in free energies of biomolecular association upon mutation. 
The importance of bound water in dimer-tetramer assembly for 37 mutant 
hemoglobins. Biochemistry 2000, 39, 1622-1633. 
50. Burnett, J.C.; Botti, P.; Abraham, D.J.; Kellogg, G.E. Computationally accessible 
method for estimating free energy changes resulting from site-specific mutations 
of biomolecules: systematic model building and structural/hydropathic analysis of 
deoxy and oxy hemoglobins. Prot. Struct. Funct. Gen. 2001, 42, 355-377. 
51. Cashman, D.J.; Kellogg, G.E. A computational model for anthracycline binding to 
DNA: tuning groove-binding intercalators for specific sequences. J. Med. Chem. 
2004, 47, 1360-1374. 
52. Cashman, D.J.; Rife, J.P.; Kellogg, G.E. Docking and hydropathic analysis of 
Hoechst 33258 with double-stranded RNA. Med. Chem. Res. 2003, 12, 445-455. 
53. Porotto, M.; Fornabaio, M.; Greengard, O.; Murrell, M.T.; Kellogg, G.E.; 
Moscona, A. Paramyxovirus receptor-binding molecules: engagement of one site 
on the hemagglutinin-neuraminidase protein modulates activity at the second 
site. J. Virol. 2006, 80, 1204-1213. 
54. Porotto, M.; Fornabaio, M.; Kellogg, G.E.; Moscona, A. A second receptor 
binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase 
contributes to activation of the fusion mechanism. J. Virol. 2007, 81, 3216-3228. 
55. Rosenberg, E.Y.; Ma, D.; Nikaido, H. AcrD of Escherichia coli is an 
aminoglycoside efflux pump. J. Bacteriol. 2000, 182, 1754-1756. 
56. Elkins, C.A.; Nikaido, H. Substrate specificity of the RND-type multidrug efflux 
pumps AcrB and AcrD of Escherichia coli is determined predominantly by two 
large periplasmic loops. J. Bacteriol. 2002, 184, 6490-6498. 
57. Yu, E.W.; Aires, J.R.; McDermott, G.; Nikaido, H. A periplasmic drug-binding site 
of the AcrB multidrug efflux pump: a crystallographic and site-directed 
mutagenesis study. J. Bacteriol. 2005, 187, 6804-6815. 
58. Cramer III, R.D.; Patterson, D.E.; Bunce, J.D. Comparative molecular field 
analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. 
Am. Chem. Soc. 1988, 110, 5959-5967. 
59. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and 
computational approaches to estimate solubility and permeability in drug 
discovery and development settings. Adv. Drug Deliv. Rev. 1997, 46, 3-26. 
60. Lipinski, C.A. Drug-like properties and the causes of poor solubility and poor 
permeability. J. Pharmacol. Toxicol. Meth. 2000, 44, 235-249. 
61. Hansch, C; Fujita, T. -- Analysis. A Method for the Correlation of Biological 
Activity and Chemical Structure.  J. Am. Chem. Soc. 1964, 86, 1616-1626. 
62. Romanelli, G.P.; Cafferata, L.F.R.; Castro, E.A. An improved QSAR study of 
toxicity of saturated alcohols. J. Mol. Struct. (Theochem). 2000, 504, 261-265. 
63. Su, C.-C.; Li, M.; Gu, R.; Takatsuka, Y.; McDermott, G.; Nikaido, H.; Yu, E.W. 
Conformation of the AcrB multidrug efflux pump in mutants of the putative proton 
relay pathway. J. Bacteriol. 2006, 188, 7290-7296 
  
99 
 
64. Wold, S.; Dunn III, W.J. Multivariate quantitative-structure activity relationships 
(QSAR) – conditions for their applicability. J. Chem. Inf. Comput. Sci. 1983, 23, 
6-13. 
 
 
 
  
  
100 
 
CHAPTER 3 
TARGETING PARAINFLUENZA VIRUS TYPE 3 BY VIRTUAL 
SCREENING; THE NEED FOR NEW TOOLS 
3.1 AN INTRODUCTION TO HUMAN PARAINFLUENZA VIRUSES 
Among the four human serotypes of parainfluenza viruses, Human Parainfluenza 
Viruses (HPIV) 1, 2, 3 and 4, HPIV3 is mostly implicated in bronchial pneumonia [1]. All 
the serotypes are known to be causative agents of acute lower respiratory diseases in 
infants and children [1,2]. HPIV3, which belongs to the Paramyxoviridae family of 
negative-stranded RNA viruses, is responsible for approximately 11% of the 
hospitalizations of pediatric patients in the United States [2]. Cell mediated immunity is 
important for preventing parainfluenza related diseases. For example, HPIV3 infection 
in T-cell deficient children can cause fatal giant-cell pneumonia and HPIV pneumonia 
shows 30% mortality in bone-marrow transplant patients [2]. 
Unlike other viral diseases, HPIV primary infections are known to not confer 
permanent immunity [1]. For example, 30% of children with relatively high neutralizing 
antibody counts were reinfected with the virus [2]. In fact in the 1960s, clinical trials of 
the inactivated HPIV 1, 2 and 3 vaccines showed variable amounts of antibody 
responses in seropositive and seronegative individuals, but failed to produce immunity 
[1]. This inability of the human immune system to provide protection against these 
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versatile viruses is a worrying factor, especially due to fears raised by a recent flurry of 
related fatal avian and porcine influenza disease occurrences around the world. 
The plausible impact of these viruses on healthcare (especially pediatric 
healthcare) clearly delineates the importance of drug discovery efforts against the 
human parainfluenza virus. Such an effort has been undertaken, the procedures and 
results of which are described herein. 
3.2 HEMAGGLUTININ-NEURAMINIDASE IN HPIV3 REPLICATION 
The life cycle of HPIV3 starts with the recognition of sialic acid containing 
receptors on the host cell by hemagglutinin-neuraminidase (HN), which then triggers 
another membrane protein (F) [3]. The F protein is responsible for fusion of the viral 
membrane with the host cell membrane [2]. Although sialic acid alone is sufficient to 
trigger HN mediated F protein activity, it must be noted that not all sialic acid-containing 
receptors are recognized equally effectively [4]. Moreover, the neuraminidase function 
of HN is responsible for the release of new virions from the host cell [5] and thus is 
responsible for persistent infectivity of the virus. 
It has been shown that mutations on HN cause modulation of immune responses 
toward this pathogen [2]. However, it is amply clear that unlike the Influenza A virus, 
parainfluenza viruses do not evolve by mutation of this membrane glycoprotein [1]. In 
fact, these viruses show a high sequence homology of 75% between even the human 
and bovine variants. The hemagglutinin and neuraminidase epitopes of HN are 
conserved across both these strains of the virus [1], which suggests the importance of 
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this protein in its life cycle. It is thus logical to devise strategies in order to inhibit this 
protein. 
3.3 INHIBITION OF HEMAGGLUTININ-NEURAMINIDASE STOPS VIRAL ACTIVITY 
In order to understand the inhibition of HN and its mechanism, one must first 
understand the biology behind the assays used to study this phenomenon. Following is 
a description of assays described in literature, which are used to distinguish 
hemagglutination and neuraminidase functions of HN. 
3.3.1 Neuraminidase Assays 
Potier and coworkers introduced a simple fluorometric assay for the quantitative 
assessment of neuraminidase activity [6]. The basic principle of this assay is to 
spectroscopically measure the release of 4-methylumbelliferone from the sodium salt of 
2‘-(4-methylumbelliferyl)--D-N-neuraminic acid, when the substrate is exposed to a 
neuraminidase enzyme (figure 3.1). 
OO OH
O
HO
OH
OH
O
OH
O
HN
O
OH
O
O Neuraminidase
E x c i t a t i o n: 365 nm
E m i s s i o n :   450 nm  
Figure 3.1 Principle of the Fusion Assay. Release of 4-methylumbelliferone as a result of 
hydrolysis of 2‘-(4-methylumbelliferyl)-a-D-N-neuraminic acid by neuraminidase is measured by 
fluorescence spectroscopy 
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A similar assay was also developed by Warner and O‘Brien in the same year [7]. 
This method is accurate, with up to a 3% variation [6] observed in the original literature 
by these authors. 
This assay is used to assess the ability of the virus to cleave neuraminic acid 
from receptors of host cells, leading to the destruction of these proteins and enabling 
movement of new virions towards uninfected cells. Those viruses which lack 
neuraminidase activity (or else whose neuraminidase activity is reduced due to the 
presence of neutralizing agents such as antibodies and small molecule inhibitors) are 
unable to travel towards new plausible host cells in order to spread infection. Therefore, 
the most common use of this assay is to ascertain the persistent infective capabilities of 
the virus.  
3.3.2 Fusion Assay 
Horvath et al. have shown that the F protein can mediate membrane fusion of 
cells under the influence of HN [8]. However, in spite of the fact that both proteins are 
expressed by cells persistently infected with HPIV3, they do not fuse with each other, 
but readily fuse with non-infected cells [9]. This is because of the neuraminidase activity 
of HN, which cleaves neuraminic acid from receptors, thereby inhibiting cell fusion 
mediated by the protein. Further support for this theory comes from the fact that 
neuraminidase treated uninfected cells do not fuse with persistently infected cells [9]. 
This phenomenon has been utilized in the development of an effective and 
accurate assay in order to study the recognition of sialic acid (N-acetylneuraminic acid) 
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containing receptors by HN [10]. Cells containing the LacZ gene (genetic code for 
production of -galactosidase) under the control of HIV LTR (HeLa-LTR-gal cells) are 
infected with HPIV3 in order to cause a persistent infection, but as explained above, 
these infected cells do not fuse with one another. These persistently infected cells are 
then exposed to cells engineered to express the HIV Tat protein (HeLa-Tat cells). Only 
when these cells fuse does the Tat protein interact with the HIV LTR, thereby promoting 
the production of -galactosidase by expression of the LacZ gene. The expression 
levels of this enzyme can be measured readily, thereby revealing the extent of cell 
fusion as an indirect measure of HN-receptor interactions.  
3.3.3 Plaque Reductions Assay  
When Bloom, Jimenez and Marcus first introduced the plaque assay [11], it was 
aimed at studying the effect of various antigens on antigen-sensitive cells. Observations 
clearly suggested that on antigen activation, such cells became more capable of 
supporting viral replication. A monolayer of such cells was grown in a petri dish and 
then exposed to live viral cultures. Any free virus was washed away post inoculation 
and the infected cell culture was incubated. Infectious centers were observed as 
plaques, which were directly related to the degree of activation of the antigen-sensitive 
cells. A similar technique was also reported in later years [12]. 
Across time, this technique has been converted to a purely virology technique, 
where the degree of plaque formation suggests the ability of the virus to replicate [10]. 
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The number of plaques being formed is directly proportional to the degree to which the 
virus can replicate. 
 
3.3.4 Hemadsorption Assay 
When persistently infected cell lines are exposed to erythrocytes, whose cell 
membrane contains sialic acid containing receptors, they are adsorbed onto the surface 
of the infected monolayer [10]. An interesting fact is that the persistently infected cells 
fail to fuse with erythrocytes, perhaps because of a difference in membrane composition 
or cytoskeletal stiffness of the latter [13]. After incubation for a short time, washing 
removes any erythrocytes which are not adsorbed. Such adsorbed cells can then be 
visualized by phase contrast microscopy. The degree of adsorption is a direct 
representation of the HN expression levels of the infected cells and hence is a measure 
of hemagglutinin activity. 
3.3.5 Neuraminic Acid Interaction with HN Mediates Membrane Fusion 
It has been shown that cell fusion is mediated by the interaction between HN and 
sialic acid containing cell receptors [13]. When uninfected cells were treated with 
neuraminidase to destroy sialic acid containing receptors on their surface, membrane 
fusion was not observed in a fusion assay. Similarly, cells which do not produce sialic 
acid containing receptors did not show fusion with persistently infected cells in the 
fusion assay. Moreover, it has also been demonstrated that HN is specific in its 
selection of sialic acid containing receptors [4]. 
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3.3.6 DANA and GANA inhibit Hemagglutinin Function of HN 
2,3-dehydro-2-deoxy-n-acetyl neuraminic acid (DANA) is known to inhibit viral 
neuraminidase activity and its mode of action was investigated [10]. It was found that 
DANA blocked fusion as well as gal production at 10 mM concentrations. The abolition 
of hemadsorption in the presence of DANA suggests that it blocks HN-receptor 
interactions (hemagglutinin function). DANA could inhibit 90% of plaque formation at 
25mM concentrations. 
Similar assays with 4-guanidino-DANA (GANA, a.k.a. Zanamivir) revealed 
mechanistic details of this compound as well [14]. It blocked hemadsorption in C28a, a 
variant of the HPIV3 virus that lacks neuraminidase activity, attesting to its HN-receptor 
interaction blocking abilities. The plaque forming capabilities of both WT and C28a 
viruses were blocked by DANA, demonstrating its ability to block fusogenic activity of 
HN. The lack of neuraminidase function of C28a was corrected by adding exogenous 
neuraminidase, which cleaves the host cell sialic acid-containing receptors. Thus, newly 
formed virions are able to avoid attachment to the host cell and were released into the 
environment. GANA also allowed release of new virions into the environment, palpably 
by blocking HN mediated recognition of host cell receptors. In contrast, when cell lines 
were exposed to WT HPIV3, virion release could not be blocked by addition of GANA. 
This proves GANA inhibits HN by preventing binding to host cell receptors. 
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3.4 VIRTUAL SCREENING FOR HN INHIBITORS 
The above studies clearly showed the utility of sialic acid derivatives in inhibiting 
HN activity and also HPIV3 by consequence. Therefore, inhibition of HN is a plausible 
mode for antiviral activity. We therefore embarked on a search for inhibitors of HN. 
Following is a description of the methods adopted for the search, along with a 
discussion about problems encountered in the process. 
3.4.1 Pharmacophore Identification 
The crystal structures of HN in its unliganded form, bound to sialic acid, DANA 
and GANA were published by Lawrence et al. in 2004 (PDB ID: 1v3b, 1v3c, 1v3d and 
1v3e respectively) [15]. The protein shows a six-blade -propeller shape and was 
crystallized in a dimeric form.  
The unliganded binding pocket of HPIV3 HN is similar to that of influenza virus 
neuraminidase, which is published elsewhere [16]. Figure 3.2 shows the interactions 
between HN and its ligands. In spite of differences between sidechain positions of all 
three HN-ligand complexes, the core sidechain positions of HN itself remain similar: 
Three arginine residues (R192, R424, R502) project into one side of the cavity, while 
the floor of the same side contains a tyrosine sidechain (Y530) hydrogen bonded to 
E409. The sidechain position for Y530 varies across different forms of HN crystals 
obtained, perhaps an effect caused by the variety of crystallization conditions used. 
However, it is interesting that in one of the two observed sidechain positions of Y530, it 
is ―slotted in‖ so as to form interactions with two highly conserved residues – 
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hydrophobic pi-pi interactions with Y478 and hydrogen bonds with the P194 backbone. 
In the same conformation, Y530 also forms a hydrogen bond with a water molecule. 
R424 is also hydrogen bonded to E409. Another face of this cavity is partially 
hydrophobic due to the presence of Y319. All in all R192, R424, R502, Y530, E409, 
E549 and D216 form the active site residues. 
When crystals of HN were soaked in 5-acetylneuraminic acid (sialic acid), the 
crystal structure thus obtained (figure 3.2A) reveals that the carboxylate group on the 
ligand interacts favorably with the three arginine cluster (R192, R424 and R502), 
although only two of these (R192 and R502) are hydrogen bonded with it. The hydroxyl 
group of Y530 and the glycosidic oxygen of sialic acid are less than 2.3 Å apart, while 
the latter is only 3.5 Å away from the carboxylate group of E409. This suggests 
hydrogen bond formation between these residues and the sialic acid glycosidic hydroxyl 
group. The C7 and C9 hydroxyl groups of sialic acid are hydrogen bonded to E276, 
while the N-acetyl group forms a hydrophobic interaction with Y319. The largest 
structural perturbation caused by binding of sialic acid to HN observed in these crystal 
structures is the movement of Y530 into the binding site cavity, which was observed in 
the ―tucked in‖ conformation within the unliganded form in 30% of the crystals formed. A 
water molecule also exists near the triarginyl cluster and the ligand carboxylate group. 
The triarginyl cluster remains almost in the same position in the structure of HN 
bound to GANA, except for a short movement of the guanidino group of R192 closer 
towards the substrate carboxylate group (figure 3.2B). This suggests that an additional 
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hydrogen bond might be formed between the protein and ligand due to the change in 
position of the carboxylate caused by introduction of unsaturation in the pyranose ring. 
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 The water molecule observed in the HN-sialic acid complex was not observed in 
this complex, which perhaps contributes towards increased ligand affinity. The hydrogen 
bonds formed between the glycosidic hydroxyl group of sialic acid and the two residues 
E409 and Y530 are now lost, but these sidechains are stabilized by formation of an 
intramolecular hydrogen bond. The hydrogen bonds between the sidechain hydroxyl 
groups of sialic acid and E276 remained with DANA. 
The binding of GANA to HN causes a reversal of certain effects observed in the 
complex with DANA (figure 3.2C). The R192 sidechain guanidino group now moves 
away from the carboxylate of GANA, but forms a stacking interaction with the latter‘s 
guanidino group. The sidechain of Y530 now extends towards the guanidino group of 
GANA, forming a hydrogen bond with it. T193 is also hydrogen bonded with the 
guanidino group of GANA. All other interactions remain similar to those with DANA and 
sialic acid. The structures of sialic acid, DANA and GANA bound to HN are shown in 
figure 3.2. 
Based on these interactions, it was clear that hydrogen bond acceptors were 
desirable in the triarginyl region of the HN binding pocket, while a hydrogen bond donor 
in the region where the GANA guanidino group is bound also increases affinity. Also, 
the hydrogen bonds between the C7 and C9 of sialic acid were maintained throughout 
the three structures of GANA and DANA with HN. These observations helped identify 
key features of the pharmacophore for the creation of queries. 
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3.4.2 Design of Queries 
Two queries were designed based on the above pharmacophoric model. The 
pyranose ring of GANA was defined as a hydrophobic center, which was surrounded by 
three hydrogen bond donor features at the C7 and C9 hydroxyl groups and the 
guanidino group. A negative center was defined in the vicinity of the carboxylate group. 
The hydrophobic center was not defined for a query based on DANA, but was 
supplemented with an acceptor atom in the vicinity of the pyranose oxygen. Also, an 
acceptor atom and a steric feature were defined at the acetyl amino oxygen and methyl 
group respectively. Both queries are delineated in figure 3.3.  
3D flex searches were run on the ZINC database, which contained 3,820,641 
compounds at the time when this work was performed. These searches utilize a 
torsional minimizer in order to identify molecules which might adopt a conformation that 
fits the query being used. Approximately 3000 hits were identified from the queries, 
including a wide variety of chemical scaffolds.  
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Figure 3.3 Queries on the ZINC Database. Orange spheres represent hydrophobic 
centers. The following features were defined: DA, donor atom; HC, hydrophobic center; 
NC, negative center; AA, acceptor atom; SF, steric feature.  
 
3.4.3 Segregation of Drug-Like and Non Drug-Like Compounds 
Not all the hits contained drug-like properties. Hence, these hits were carefully 
screened for non drug-like properties. The molecules were segregated based on three 
criteria: (1) drug-like versus non drug-like scaffolds and (2) Lipinski‘s rule of five.  
3.4.3.1 Identification of drug-like and non drug-like scaffolds 
Although the ZINC database is regularly used for virtual screening in order to 
identify drugs, our hits contained a number of molecules which do not seem drug-like. 
These molecules were identified by visual inspection and eliminated from further study. 
A few examples of such hits are shown in figure 3.4. 
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3.4.3.2 Lipinski’s rule of five 
Lipinski published a set of rules which increase the chances of finding molecules 
with favorable permeation and absorption characteristics which have been outlined in 
Chapter 1 (vide supra). This set of rules has been implemented in the UNITY module of 
Sybyl, which was used for datamining purposes in this project. The inbuilt molecular 
screen identifies agents with less than 5 hydrogen bond donors and 10 hydrogen bond 
acceptors. Moreover, it identifies molecules with a molecular weight less than 500 D 
and a CLogP of less than 5. 
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Figure 3.4 Structures Rejected by Visual Inspection. Some examples of molecules that were 
deemed nondrug-like and excluded from further analysis. 
 
After trimming the list of ligands using these criteria, 1513 compounds remained. 
3.4.4 Docking 
The ability to theoretically predict interactions between molecules based on 
chemo-spatial considerations and the principles of physics has been of immense 
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interest to scientists across the decades. Research across several decades has given 
us multiple algorithms known as docking algorithms. Kuntz aptly described his docking 
algorithm as a method to explore geometrically feasible alignments of ligands and 
receptors of known structure [17]. The first examples of docking were perhaps those 
published by Levinthal et al. in 1975 and Salemme in 1976 [18,19], describing attempts 
at predicting structures of complexes in order to understand macromolecular 
interactions.  Kuntz‘s algorithm [17] was perhaps the first description of a program that 
attempted to address docking of small molecules into proteins. This is a problem of 
immense complexity due to the large number of degrees of freedom and the resultant 
local minima an algorithm has to explore in order to obtain appropriate and accurate 
predictions.  
Several strategies have evolved in order to address this complex and 
multifaceted problem, including incremental construction approaches such as FlexX 
[20], shape-based algorithms such as DOCK [21], genetic algorithms such as 
GOLD[22], systematic searches such as Glide [23], Monte Carlo simulations such as 
LigandFit [24] and surface-based molecular similarity methods such as Surflex [25]. In 
spite of the availability of several such algorithms, ligand docking does suffer from 
several problems [26]. However, its utility in computational ligand design is undeniable, 
especially due to the high benefit/cost ratio. 
We utilized GOLD 3.0 to dock those hits which remained from visual inspection 
of virtual screening results into the HN binding pocket. One hundred genetic algorithm 
(GA) runs per compound were executed in order to obtain multiple poses of putative 
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ligands within the binding site. The total number of ligands remaining after visual 
inspection of hits obtained from UNITY was 1513, thus resulting in 151,300 protein-
ligand complexes that needed to be scored. 
3.4.5 Scoring of Docked Positions 
The HINT forcefield [27,28] was used to score all protein-ligands complexes 
obtained via docking because scores obtained from this forcefield are known to 
correlate with binding free energy [29-32]. A list of top scoring compounds, along with 
their ZINC codes, is displayed in appendix A. The crystallographic structures of HN with 
Sialic Acid, GANA and DANA [15] showed HINT scores of 111, 1283 and 1673 
respectively. These compounds were suggested for purchase and biochemical 
evaluation. The decision to test these 137 compounds was based on the comparison of 
HINT scores with those of the ligands bound to the crystal structures. An increase of 
515 HINT units is associated with a 1kcal/mol increase in affinity; hence, many of these 
structures were expected to be strong binders of HN. 
3.5 PROBING ANTIVIRAL MECHANISM 
Anne Moscona‘s group at Weill-Cornell Medical School tested 50 of the 137 
compounds (vide supra) and found 17 inhibitors of HN. In order to probe the mechanism 
of action of these inhibitors, a further docking study was conducted. Selected 
compounds were docked into site II (vide infra) of HN. 
Previous studies by the Moscona and Kellogg research groups had already 
predicted the possibility of a second site on HN, which might interact with sialic acid 
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containing receptors [33-35]. It has been shown that mutations on this site of HN can 
cause premature triggering of the F-protein, thereby rendering the virus noninfectious 
[35]. In order to probe the possible effects of one of the 17 inhibitors of HN 
(ZINC02857325, Figure 3.5) identified by virtual screening, it was docked into site II and 
the HINT scores were compared to those of GANA at both sites (table 3.1). 
Table 3.1  HINT analysis of inhibitors at site I and II of HN 
Compound HINT Score 
HPIV3 HN Site I HPIV3 HN Site II 
GANA 2769 660 
ZINC02857325 2260 1108 
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Based on these scores, it is possible that both GANA and ZINC02857325 will 
bind site I of HN. However, it is possible that this compound will bind site II with a higher 
affinity compared to GANA based on its HINT score at the same site. It has already 
been shown that site II is resistant to GANA [33] and therefore validates our docking 
results, therefore strengthening our belief that this compound might interact at site II of 
HN. 
Furthermore, in the best docked position of GANA at site II of HN the guanidino 
group protrudes out of the protein into the surrounding medium and presumably 
interacts with water (figure 3.6A). It is highly possible that this causes the ligand to be 
solvated and thereafter vacates the binding site. It is possible that such an effect will not 
be observed with the much more hydrophobic ZINC02817325. 
3.6 PROBLEMS WITH DOCKING 
Several cases were identified, in which the rotation of sidechains could improve 
HINT scores. An example is delineated in figure 3.7. 
This test case is a complex of ZINC02857325 docked into HN. The docked 
position itself showed a HINT score of ~ -106. This was basically due to a clash between 
the phenolic hydroxyl of Tyr337 and the sulfonamidic hydrogen. This situation could 
easily be remedied by a simple rotation of the chi1 angle to alleviate the steric clash. 
When this was performed manually, an additional hydrogen bond was formed between 
the phenolic group of Tyr337 and the sulfonamidic hydrogen. This complex was then 
rescored using HINT and an improvement of over 106 HINT units was observed. Of 
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course, this was mostly due to the removal of the steric clash. An additional 
improvement was also visible when a different rotamer of Lys254 was placed, causing 
the formation of an additional H-bond between the triazole nitrogen and the protonated 
amino group of the residue. 
 This example clearly indicates the possibility that docking may not be able to 
accurately recreate the most probable binding pose for ligands without addressing 
target flexibility. Even after minimization, which would alleviate steric clashes, there is a 
chance that the most favorable binding pose may not be predicted because of the 
nature of minimization algorithms; they are designed to traverse downwards along the 
energy potential function and as a result will not overcome barriers in attaining the 
global minimum. In essence, it is probably not realistic to expect identification of the 
global minimum every time, but a reasonable investigation into target flexibility is 
required. We suggest rotating residue sidechain chi angles as a method for exploring 
induced fit. 
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Figure 3.6 Interactions of GANA and ZINC02857325 with site II of HPIV3 HN. (A) 
and (B) show the best docked positions of GANA and ZINC02857325 at site II of HN. 
(C) shows the depth of both ligands; the guanidino group of GANA protrudes into the 
surrounding environment, while the more hydrophobic ZINC02857325 shows no such 
protrusion. 
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3.7 SUMMARY 
A virtual screening for inhibitors of HPIV3 HN was conducted using datamining 
techniques, docking procedures and the HINT scoring function. This process identified 
several inhibitors of the protein, which are as of yet being tested for their mode of action 
in the Moscona laboratory at Weill Medical College of Cornell University. A 34% 
success rate has been observed so far (calculated as number of compounds found 
active for every 100 compounds tested experimentally). 
It is common knowledge that virtual screening is, as of yet, only in its infancy; a 
lot of work has to be done in order to improve the tools and procedures which are 
currently in use. These problems [30] include a number of issues, such as protein and 
ligand flexibility, role of water in binding and solvation, the combinatorial issue of 
protonation/deprotonation of ligand and residues and perhaps the biggest problem of all 
– scoring functions. Serious and long-term research needs to be performed in order to 
address this multi-faceted problem. 
In our quest to identify hits against HPIV3 HN, one problem we noticed was 
target flexibility; although some docking programs already take this into account, this led 
us to try and develop our own new tools. Chapter 4 addresses the current status of our 
attempts in this direction. 
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Figure 3.7 Rotation of residue sidechains improves docking scores. A situation is shown 
where simple rotation of amino acid sidechains increased HINT scores for ZINC02857325 
docked into site I of HPIV3 HN. This clearly indicates the possibility that the ―correct‖ binding 
pose for this ligand may not have been identified.  
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CHAPTER 4 
SIDECHAIN OPTIMIZATION USING BACKBONE-DEPENDENT 
ROTAMER LIBRARIES AND HINT 
4.1 THE INDUCED FIT THEORY 
In today‘s world of drug discovery/design that depends significantly on 
understanding intermolecular interactions, the contributions of Emil Fischer and Daniel 
Koshland are vital. Fischer first introduced the ―lock and key mechanism‖ in the late 19th 
century [1-2] and was revolutionary in many respects; it was perhaps the most important 
description of enzymatic activity as a result of precise and specific intermolecular 
interactions. However, theories are created in order to explain all facts known at the 
time of their formulation and must be modified intermittently to include explanations for 
all future discoveries that bring about discrepancies in them. Koshland wrote a review 
on his modifications of Fischer‘s ―key-lock mechanism‖ in the late 20th century [3], 
wherein he paid homage to the author while describing the then current status of his 
―induced fit theory.‖ While Fischer‘s key-lock theory described enzyme activity in terms 
of the analogy of a key fitting into a lock, thereby allowing the enzyme to act on it, 
Koshland‘s theory specifically expounded on the importance of structural changes in the 
protein at the same time. In his own words, the induced fit theory can be stated as ―a) 
the precise orientation of catalytic groups is required for enzyme action, b) the substrate 
causes an appreciable change in the three-dimensional relationship of the amino acids 
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at the active site and c) the changes in the protein structure caused by the substrate will 
bring the catalytic groups into the proper alignment, whereas a nonsubstrate will not.‖ 
4.2 EMULATING INDUCED FIT IN COMPUTATIONAL ALGORITHMS 
The importance of induced-fit is not restricted to enzymatic activity, but also to 
binding of non-competitive small molecule inhibitors or binding of drugs to non-
enzymatic proteins such as GPCRs, as well as between interacting macromolecules. 
Cozzini et al. describe the importance of the induced fit theory in drug discovery in their 
perspective [4]. They describe multiple theoretical and experimental methods used to 
explore induced fit in target-drug binding, laying special emphasis on the current status 
of applications that take target flexibility into consideration during the drug 
discovery/design procedure. The transition of molecular docking from its earliest 
incarnations, in which rigid molecules were docked into a rigid receptor, to the current 
algorithms and strategies employed to address this issue, has been described therein. 
For example, a popular docking program Autodock [5-7] has the ability to explore 
sidechain flexibility at the active site [8,9]. GOLD, FlexE, SLIDE and DOCK also use 
algorithms in order to explore sidechain flexibility in a variety of ways [10-13]. 
Incorporation of target flexibility in such popular docking programs is indicative of the 
importance of exploring induced fit in drug design endeavors. 
4.2.1   Basic Structure of Algorithms for Emulating Target Flexibility 
The degree of induced fit may vary between different protein-ligand interactions 
and the introduction of even partial flexibility at the protein binding site is a challenging 
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and computationally expensive task. This is especially true because exploring low 
energy conformations of the protein is a combinatorial problem even when sidechain 
flexibility alone is addressed. The overall algorithm for sidechain optimization can be 
broken down into independent but equally important components: 1) selecting a method 
for sidechain selection and positioning, 2) choice of a forcefield for evaluating sidechain 
positions and 3) deciding an approach to solve the combinatorial problem of sorting 
through the various permutations and combinations of sidechain positions in order to 
achieve reasonable results.  
4.3   DESIGNING OUR OWN ALGORITHM - THE COGS AND WHEELS 
In order to create our own sidechain optimization method, in this work we explore 
rotamer libraries as a source for sidechain coordinates. The choice of rotamer libraries 
is a conscious one, based on the following reasons: 1) These libraries contain 
coordinates for sidechain positions covering naturally occurring conformations and are 
thereby likely to place residues in reasonable positions and 2) having preordained 
positions for sidechains will probably translate into faster algorithms compared to 
randomized placement methods (e.g., Monte Carlo methods or molecular dynamics 
simulations) for achieving sidechain movement. 
Several studies of sidechain rotamer distributions have been reported, including 
those by James and Sielecki [14], Ponder and Richards [15], Janin et al [16], Dunbrack 
and Karplus [17] and Dunbrack and Cohen [18]. These studies vary in scope and width; 
for example, while James and Sielecki [14] described their findings about rotameric 
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preferences of residue sidechains from a single protein crystal structure, Ponder and 
Richards [15] described the development of a complete rotamer library and an algorithm 
meant to place sidechains on a protein backbone. 
4.3.1   Rotamer Libraries 
The different amino acid rotamer libraries in existence can be categorized as 
backbone-dependent and backbone-independent. 
4.3.1.1   Backbone-Independent Rotamer Libraries 
The most important feature of backbone-independent rotamer libraries is that the 
rotamer position is not related to the backbone geometry in any way. The Ponder and 
Richards rotamer library [15] is an example of this category; the authors demonstrated 
that only 67 sidechain rotamers are adequate to place 15 of the 18 naturally occurring 
amino acid residues in which sidechain positioning is required (Ala and Gly do not fall 
under this category). Met, Arg and Lys residues were not addressed in this study due to 
their inherent flexibility. They used a rotamer library based on only 19 PDB files and a 
simple van der Waal‘s term in order to pack these atoms. 
Another example of a backbone independent rotamer library was reported by 
Janin et al. [17] who, like Ponder and Richards, used a set of 19 PDB files as their 
source data for calculations. They described the preferred conformations for several 
protein sidechains. The fact that most of the χ1 angles for a variety of amino acid 
residues coincided with two of three steric energy minima calculated for a blocked Lys 
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was interesting. A blocked Lys residue is defined as one that is allowed to rotate along 
the Cα-Cβ bond to translate through χ1 angles, but all other χ angles are held constant. 
It was clear from these studies that sidechain geometry is severely restricted for 
a given main chain geometry. This fact is exemplified by the fact that more than 60% of 
sidechains adopted only one or two rotameric positions [17]. Moreover, the number of 
configurations adopted also depends on the position of the residue relative to the 
protein surface. Also, the rotamers which are rare for a surface residue are even rarer 
for an internal residue, implying a strong preference for certain values of the χ1 angle. 
Most importantly, steric energy was established as an important factor in sidechain 
rotamer placement. 
4.3.1.2   Backbone-Dependent Rotamer Libraries 
The major difference between backbone-dependent and backbone-independent 
rotamer libraries is the calculation of χ1 and χ2 probabilities as a function of Φ and Ψ 
angles.  
Dunbrack and Karplus introduced their sidechain optimization method based on 
a backbone-dependent rotamer library [18] from a study based of 126 structures from 
the Brookhaven Protein Database. The library was generated by assessing the 
probability of χ angle values for a specific range of Φ and Ψ angles, i.e. the Φ and Ψ 
angles were divided into bins incremented by 20˚ (0˚ to 20˚, 20˚ to 40˚, 40˚ to 80˚, etc.). 
It was observed that several regions of the Φ, Ψ map were underpopulated due to 
geometric restrictions on the backbone and the small bin size. For all amino acid 
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residues except Ala, Pro and Gly, the χ1 values were binned into the -120˚ to 0˚, 0˚ to 
120˚ and the 120˚ to -120˚ bins. Amongst the residues not covered, no χ values exist for 
Ala and Gly due to the absence of the C atom. The same bin values were used for χ2 
angle calculations for those residues where the χ2 angle exists, except for Pro, Asn, 
Asp, Phe, Tyr and Trp. For Pro, the χ1 angle was binned only into two bins – positive 
and negative values, corresponding to the two Pro conformations. The χ2 angles for 
Phe, Tyr and His were found to be mostly concentrated around the ±90˚ region, which 
were treated as equivalent by adding 180˚ to any negative χ2 angles. These residues 
show C2 symmetry across the C-C bond, which allows such equivalent treatment of 
these rotamers. Again, Asp and Asn χ2 and χ2+180˚values were treated as equivalent 
due to the symmetrical positions of the  atoms, but were binned into -90˚ to -30˚, 30˚ to 
-30˚ and 30˚ to 90˚ divisions.  Trp χ2 angles were binned into 0˚ to 180˚ and -180˚ to 0˚ 
because its rigid aromatic rings does not allow for more sterically favorable positions. χ3 
and χ4 angles were also binned for more flexible residues. Table 4.1 shows the χ1 and 
χ2 bin limits described above. The probability of finding χ1 in each bin was calculated for 
each Φ and Ψ bin combination. Similarly, the probability of finding χ2 in each of its bins 
was calculated, given that χ1 was in one particular bin. This is usually designated as 
χ1+2. Such binning and calculation of probabilities is the crux of backbone-dependent 
rotamer libraries.  
The authors observed specific preferences of sidechain conformations not only 
for α-helices and β-sheets, but also for other regions. Mostly, residues preferred either 
one sidechain conformation or else two nearly-equally favored conformations.  
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Dunbrack and Karplus designed a sidechain optimization algorithm using the 
CHARMM forcefield and probabilities calculated by the above method. Overall, it was 
observed that using backbone-dependent rotamer libraries enhanced the number of 
correct sidechain predictions. When compared to an optimization method that utilizes a 
backbone-independent rotamer library [19] it was found that most of the differences in 
predictions were due to χ1 allocation. 
Table 4.1. χ1 and χ2 bin limits are shown. These limits define the bin size during 
probability calculations, which were made for each 120˚ bin of Φ and Ψ angles. 
χ1 limits χ2 limits χ1 limits χ2 limits 
Lys, Arg, Met, Gln, Glu, Ile and Leu Ser, Thr, Cys, Val, Phe, His and Tyr 
0˚ to 120˚ 0˚ to 120˚ 0˚ to 120˚  
0˚ to 120˚ 120˚ to -120˚ 120˚ to -120˚  
0˚ to 120˚ -120˚ to 0˚ -120˚ to 0˚  
120˚ to -120˚ 0˚ to 120˚ Pro 
120˚ to -120˚ 120˚ to -120˚ 0˚ to 60˚ -60˚ to 0˚ 
120˚ to -120˚ -120˚ to 0˚ -60˚ to 0˚ 0˚ to 60˚ 
-120˚ to 0˚ 0˚ to 120˚ Asp and Asn 
-120˚ to 0˚ 120˚ to -120˚ 0˚ to 120˚ -90˚ to -30˚ 
-120˚ to 0˚ -120˚ to 0˚ 0˚ to 120˚ -30˚ to 30˚ 
Trp 0˚ to 120˚ 30˚ to 90˚ 
0˚ to 120˚ 0˚ to 180˚ 120˚ to -120˚ -90˚ to -30˚ 
0˚ to 120˚ -180˚ to 0˚ 120˚ to -120˚ -30˚ to 30˚ 
120˚ to -120˚ 0˚ to 180˚ 120˚ to -120˚ 30˚ to 90˚ 
120˚ to -120˚ -180˚ to 0˚ -120˚ to 0˚ -90˚ to -30˚ 
-120˚ to 0˚ 0˚ to 180˚ -120˚ to 0˚ -30˚ to 30˚ 
-120˚ to 0˚ -180˚ to 0˚ -120˚ to 0˚ 30˚ to 90˚ 
 
It was found that predicted sidechain positions were more accurate for buried 
residues. The predictions were accurate for hydrophobic residues except Leu and 
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aromatic residues except Trp. Cys residues were well predicted, perhaps because most 
of these were present in pairs and formed disulfide bonds, which were specifically 
identified before other sidechains were optimized. Thr sidechains were placed more 
accurately compared to Ser, perhaps because there is less room for maneuvering due 
to the presence of an extra C atom. Asp and Glu were least well placed by this 
algorithm because these are mostly on the surface and have a lot more freedom to 
move. Moreover, contacts between successive units which exist in crystals were 
completely ignored in the optimization process. 
Dunbrack and Cohen introduced an enhanced version of the Dunbrack and 
Karplus backbone-dependent rotamer library in 1997. They used Bayesian statistics in 
order to address the likelihood of obtaining one rotamer, given an original probability 
distribution similar to that of the Dunbrack and Karplus rotamer library. The analysis was 
simple in terms of assumptions; only one was employed – that the probability of one 
particular dihedral is dependent only on the value of the previous dihedral. For example, 
the probability of obtaining a χ1 value depends on what the Φ and Ψ dihedrals are. 
Likewise, the probability of obtaining a particular χ2 value depends only on what the χ1 
value is. The same assumption can be made for χ3 and χ4 as well. Using this rotamer 
library, Bower, Cohen and Dunbrack created a sidechain optimization algorithm - 
SCWRL [20]. 
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4.3.2   Choice of Scoring Function 
Traditionally, sidechain optimization algorithms have employed scoring functions 
that pack atoms together. This is especially advantageous because the function of 
these packing methods is quite complementary to the nature of crystal structures – in 
both cases, atoms are packed as tightly together as possible. However, such packing 
algorithms usually overlook phenomena such as electrostatic interactions, hydrophobic 
interactions, H-bond formation and pi-cation interactions. 
One obvious improvement in such algorithms would be to explore the effect of 
force fields that can address these currently neglected interactions. We decided to use 
our in-house HINT scoring function [21,22]. Our hypothesis is that HINT will be 
complementary to steric-based potential functions for a number of reasons: (A) HINT 
employs a van der Waal‘s interaction function quite similar to the steric-based Lennard-
Jones potential of SCWRL-like programs, (B) HINT addresses hydrophobic interactions, 
which have been shown to depend on surface area contacts [23,24], which is quite 
similar to traditional contact-based scoring functions and as explained above, (C) HINT 
takes several different types of interactions such as hydrogen bonding into account, 
while packing methods do not share this capability. 
4.4 THE SCWRL ALGORITHM 
Dunbrack‘s group introduced a popular program called SCWRL [20] (SideChain 
optimization With Rotamer Libraries) whose main aim was to predict crystal structure 
sidechain positions, given the backbone coordinates. This program was based on a 
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backbone-dependent rotamer library [18] and employed a modified Lennard-Jones 
potential equation for energy calculation purposes. In order to solve the combinatorial 
problem of parsing through rotamers, each sidechain is initially placed in its most 
favorable rotamer and clashes are identified as those residues which exceed a cutoff 
value for the steric potential. ―Clusters‖ of clashing residues are identified as those that 
clash with each other and are solved by a combinatorial parsing of rotamer 
permutations and combinations. 
4.4.1 SCWRL “Successfully” Identifies “Correct” Sidechain Positions 
Dunbrack et al. have shown considerable success in identification of sidechain 
positions, if provided with the coordinates of backbone atoms [20]. The structure of this 
algorithm is highlighted below. 
4.4.1.1 Initial Sidechain Rotamer Placement 
The initial step used by SCWRL is very simple: after the backbone atoms have 
been read in, it places the sidechain atoms in their most probable form which does not 
clash with the backbone. Backbone clashes are detected by using a modified (linear) 
van der Waal‘s equation, which calculates a minimum value of 0 kcal/mol for no steric 
interaction or 10,000 kcal/mol for steric clashes. Favorable van der Waal‘s interactions 
were sacrificed to improve search speed. 
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4.4.1.2 “Cluster” Parsing Method 
―Clusters‖ of clashing residues are identified and solved by a combinatorial 
parsing of rotamer permutations and combinations, intermittently employing a cluster-
dividing technique if the number of residues within a ―cluster‖ exceeds 15 residues. In a 
case where the number of residues does exceed this number, the residue whose 
sidechain has most clashes is identified and placed in its most probable position which 
does not clash with the backbone, thereby dividing the large cluster into smaller clusters 
that are more easily manageable. Each such division of the large cluster is then treated 
as a smaller cluster and a combinatorial search for sterically favorable sidechain 
rotamers is conducted. A favorable combination of rotamers is defined as one which 
has zero steric energy, as decided by the modified Lennard Jones potential equation. 
However, if no such combination is found, the set of rotamers showing lowest steric 
clashes is selected. 
4.4.1.3 Criteria for “Success” 
The authors of the SCWRL program compare χ1 angles directly with the original 
PDB files in order to measure the success of their algorithm. However, their metric for 
comparison is whether the program correctly identifies this dihedral angle within ±40˚ of 
the actual χ1 value from the original crystal structure. However, seeing that it uses 
backbone-dependent rotamer libraries, which are essentially programmed with the 
probabilities of χ angles existing given the Φ and Ψ angles of the backbone, it is hardly 
surprising that these angles were successfully predicted. Moreover, the χ2 angles are 
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only compared for those cases in which χ1 angles are ―correctly‖ predicted (χ1+2 
predictions).  
Overall it was shown that the χ1 angle was correctly predicted 77% of the time, 
while χ1+2 predictions were correct on 66% occasions. The percent correct predictions 
varied between different types of amino acid residues. For aromatic residues such as 
Phe and Tyr, the χ1 determination was 90% accurate. SCWRL also accurately predicted 
the χ1 values for residues with β- and - branched sidechains such as Val, Thr, Ile, Leu, 
His and Trp (>80% correct). SCWRL performed less well with Ser and those residues 
with long unbranched sidechains such as Met, Glu, Gln, Arg and Lys (60 to 72% 
correct). The χ1 values for both Asp and Asn were predicted correctly over 73% of the 
time. An evaluation of χ2 prediction showed that the degree of accuracy was lower than 
that for χ1. However, this is expected because SCWRL is a method that depends on 
packing. As the distance of a sidechain atom from the backbone increases, the ability of 
the atom to move also increases due to lower steric interactions with the backbone. It 
can hardly be expected that the atoms responsible for the χ2 dihedral angle will be 
packed as tightly as the C atom unless these are completely buried within the bulk of 
the protein. 
4.4.2 Can the HINT Scoring Function Complement the SCWRL Rotamer Library? 
The ability of SCWRL to predict correct sidechain positions in crystal structures 
perhaps can, at least partially, be attributed to the inclusion of rotamer probabilities. 
When conducting molecular modeling or drug discovery studies, it becomes more 
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important to study proteins in their native state, e.g., the dominant state of a cytosolic 
protein in an aqueous environment. This cannot be achieved by using SCWRL‘s 
modified Lennard-Jones potential scoring function, because it completely ignores intra-
protein interactions other than sterics. In accordance with our long term goal of creating 
an algorithm that can simulate sidechain flexibility in docked structures, we decided to 
test the compatibility between Dunbrack‘s backbone-dependent rotamer library [18] and 
the HINT scoring function, which should theoretically be able to address those 
interactions within the protein that are completely neglected by SCWRL. However, it 
must be noted here that the newest version of SCWRL (ver. 4.0 [25]) is capable of H-
bond detection. The results of our pilot study aimed to analyze whether or not the 
SCWRL 1.0 rotamer library is compatible with the HINT scoring function are reported 
herein.  
One way of approaching this question is to try to emulate SCWRL‘s original 
function of sidechain prediction for known crystal structures. If the HINT scoring function 
is at least as successful as SCWRL, or even if it comes close to doing so, we can 
perhaps safely conclude that HINT may be used to complement the SCWRL backbone-
dependent rotamer library, or, in other words, that these two technologies are 
synergistic in molecular model-building applications. 
4.5 THE HINTASCWRL ALGORITHM 
The HINTaSCWRL (HINT assisted SCWRL/Hydropathic INTeractions Assisted 
SideChain optimization With Rotamer Libraries) Algorithm was designed using a 
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backbone-dependent rotamer library and a hydropathic forcefield, whose pseudocode is 
described below: 
 
Read input PDB 
Select protein from PDB 
Calculate Φ and Ψ angles 
Get χ values from sidechain data 
Build multiple sidechain conformations for all residues 
Check all rotamers for backbone clashes 
Find best rotamer 
{ 
 for all residues 
 { 
 Add Hydrogens 
 For each rotamer with no backbone clashes 
{ 
  Calculate HINTaSCWRL score 
  Keep rotamer with highest HINTaSCWRL score 
 } 
} 
} 
Perform second round of optimization 
Delete any Hydrogens present 
Write output PDB 
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The program was written in C, using the HINT toolkit and the backbone-
dependent rotamer library from SCWRL 1.0 (referred as SCWRL hereon). The 
algorithms are still in a very preliminary state and come with no additional features 
aimed at improving prediction capabilities; no mathematical strategies have been 
adopted in order to solve combinatorial issues, nor has any special modification been 
made in order to obtain optimum predictions. Indeed, this is the very first form of our 
protocol, which will need many cycles of refinement in order to improve its functioning. 
4.5.1 The Backbone-Dependent Rotamer Library 
HINTaSCWRL employs the same backbone-dependent rotamer library as 
SCWRL. The selection of the Cohen-Dunbrak backbone-dependent rotamer library was 
chosen in order to enable direct comparison with SCWRL generated sidechain 
positions. 
4.5.2 The HINTaSCWRL Scoring Function 
The HINTaSCWRL scoring function that was employed in this program can 
mathematically be denoted as follows: 
                 
                   
                         
 
The Log values of probabilities were taken because that linearizes the data. 
However, this caused a problem because probability values were all fractional and 
yielded negative values when converted to Log form, thereby reversing the sign 
(favorable/unfavorable) of the final score that should be supplied by HINT. This problem 
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is easily solved by normalizing against log(probability) of the most probable rotamer. 
This also allows us to measure the comparative likelihood of obtaining the current 
rotamer against the most probable rotamer.  
A similar approach where the probability of the current rotamer was multiplied 
with its HINT score was also considered, but was not found to be as useful as the above 
scoring function because a few rotamers were frequently found to be several times 
more probable than all other rotamers combined. This caused probability to dominate 
the decision making process, thus making the HINT score virtually redundant (except in 
the case of a sign change facilitated by it). Additionally, it effectively reduced the 
conformational space explored because the lowest probability conformations (with 
probabilities ranging up to the 10-6 region) were virtually never considered. 
4.5.3 Sorting Through Clashes and Bad Interactions 
After the initial placement of sidechains, the residues with the worst scores were 
identified and optimized a second time. While the initial placement of sidechains took 
probability into account, this time only the HINT score was used. 
4.6 THE TEST SET 
A data set of 129 PDB files containing no ligands and with resolutions between 1-
1.5 Å were downloaded from the RSCB Protein Data Bank and prepared by removal of 
all alternative conformations for sidechains. The PDB list is as follows: 
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2BCM, 2BN3, 2BOG, 2BZV, 2CG7, 2CIT, 2CL2, 2CYG, 2DF6, 2DPL, 2E0Q, 2E10, 
2E3H, 2E3Z, 2ERF, 2ERW, 2FHZ, 2FQ3, 2FR2, 2FRG, 2FWG, 2G69, 2G7O, 2GBJ, 
2GEC, 2GKG, 2GKT, 2GOM, 2GQV, 2GRC, 2GUV, 2GXG, 2GZV, 2H3L, 2H8E, 2HLR, 
2I3F, 2IBL, 2IC6, 2ICC, 2IGD, 2IPR, 2IVY, 2IWN, 2IXM, 2J6B, 2J73, 2J8B, 2JCP, 2JIC, 
2JLJ, 2LIS, 2NRR, 2NWD, 2O37, 2OCT, 2OEI, 2OHW, 2OKT, 2OLX, 2OVA, 2OZF, 
2P4H, 2PMR, 2PND, 2PPO, 2PV2, 2QHT, 2QOL, 2QT4, 2QVK, 2R6Q, 2RB8, 2RK3, 
2RK5, 2VC8, 2VIM, 2VY8, 2W1R, 2W2A, 2W6A, 2WJ5, 2WLV, 2YXF, 2YZ1, 2ZO6, 
3A7L, 3BA1, 3BB7, 3BOI, 3BPV, 3BQS, 3BZT, 3BZZ, 3C8P, 3CA7, 3CJW, 3CKF, 
3CT5, 3CTG, 3CX2, 3CZZ, 3D9X, 3DFG, 3DS4, 3DWV, 3EVP, 3EXV, 3EY6, 3EYE, 
3FKE, 3FPO, 3FTD, 3FTK, 3FVA, 3HFO, 3HNX, 3HNY, 3HZ8, 3I4O, 3IVV, 3KB5, 
3KGK, 3KJT, 3KTP, 3L32, 3L3E, 4EUG and 4PTI. 
The algorithm was not trained on any of these structures, which contain up to 
919 residues.  
4.7 HINTASCWRL OUTPUT ANALYSIS 
Since the main aim of this project was to test the ability to use the HINT forcefield 
with rotamer libraries and not necessarily to improve sidechain placement algorithms 
such as SCWRL, the most important aim of the HINTaSCWRL algorithm is to predict 
structures approximately as well as SCWRL. If this were true, it would demonstrate the 
ability to use HINT in conjunction with rotamer libraries. On the other hand, it would 
definitely be advantageous if we could improve sidechain predictions. With these aims 
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in mind, the output of HINTaSCWRL will be compared with the same from SCWRL 
through the rest of this chapter. 
4.7.1 Analysis of Sidechain RMSD 
The RMSD for each sidechain of the HINTaSCWRL and SCWRL output PDBs 
from the original PDB were calculated. Figure 4.1 shows line plots of RMSD for all 
residue sidechains across all 177 test structures. The first column consists of RMSD for 
each amino acid residue for HINTaSCWRL output PDB files, while the second column 
shows the same for SCWRL output files. The third column shows an RMSD difference 
between HINTaSCWRL and SCWRL output files. It must be noted at this point that 
these residues have been sorted in order of their solvent accessible surface area 
(SASA) before the plots were generated. 
HINTaSCWRL results – Cys, Pro, Ser, Thr and Val residues showed the lowest 
deviation (up to 1.5 Å) from the original PDB, while Asn, Asp, Gln, Glu, Ile, Leu and Met 
showed a higher RMSD value (up to 2.5 Å) in comparison. Arg, His, Lys, Trp and Tyr 
showed the highest deviations (up to 5 Å) from the original crystal structures.  
Comparison with SCWRL output files – All amino acid residues showed similar 
deviations from the original PDB, as is witnessed by the similarity between the first two 
columns (Figure 4.1). The third column shows the deviation of HINTaSCWRL output 
structures from SCWRL predicted ones. Most of the residues show very low to no 
deviation, which means that the output structures are extremely similar to each other. 
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Figure 4.1 RMSD values for individual amino acid residue sidechains. (A) RMSD 
for HINTaSCWRL output PDB files (B) RMSD for SCWRL output. (C) RMSD between 
HINTaSCWRL and SCWRL output files. 
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Figure 4.1 continued. 
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Figure 4.1 Continued 
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Figure 4.1 continued 
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Figure 4.1 continued. 
 
4.7.2 RMSD as a Function of Solvent Accessible Surface Area 
Figure 4.2 shows RMSD of amino acid residue types as a function of Log(SASA) 
in HINTaSCWRL predicted structures. A prominent increase in the RMSD of residues is 
observed with increase in SASA. Therefore, residues closer to the outer surface of a 
protein have higher solvent accessibility. Such residues which are closer to the outer 
surface have a higher degree of steric freedom, resulting in poorer predictions. 
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Figure 4.2 RMSD as a function of Log(SASA) in HINTaSCWRL output files.  
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Figure 4.2 continued 
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Poor predictability is expected in these cases; solvent accessible residues would 
have a higher degree of movement in their native environment. Hence, the inability of 
HINTaSCWRL to predict exact positions for these residues does not raise any 
concerns. However, Phe, Tyr and Trp show a regular trend of poor predictions 
irrespective of the SASA of any particular residue, but the increased incidence of poor 
predictions with increase in SASA is clearly visible in these residues. 
The trend of increased RMSD compared with original PDBs is clearly visible in 
figure 4.3, where RMSD for all residues has been plotted against their SASA for both 
HINTaSCWRL and SCWRL predicted structures. 
 
Figure 4.3 Overall RMSD across all residues as a function of Log(SASA). (A) is for 
the HINTaSCWRL output structures, while (B) shows the same data for SCWRL 
predicted structures. 
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4.7.3 Analysis of Average RMSD per Residue Type 
The plot of average RMSD for each residue type in each structure is shown in 
figure 4.4. The red lines depict average RMSD for each residue type in HINTaSCWRL 
generated output structures, while the same for SCWRL output files are illustrated with 
a blue line. While smaller residues such as Cys, Ile, Leu, Ser, Thr and Val, along with 
sterically restricted residues like Pro, demonstrate lower average RMSD values, others 
such as Arg show a much higher value.  
The higher average RMSD value for hydrophilic residues such as Arg, Lys, His, 
Asp, Glu, Asn and Gln is expected because they are usually found on the solvated 
surfaces of proteins. However, aromatic residues Phe, Tyr and Trp show a range of 
average RMSD values; from high to low. This could possibly be because of their 
equivocal distribution; they exist on the surface of proteins and also in their bulk. This 
would explain why these residues demonstrate a wide range of average RMSD values. 
It is remarkable that all types of amino acid residues show very similar average 
RMSD value for both HINTaSCWRL as well as SCWRL. 
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Figure 4.4 Average RMSD for each type of amino acid residue. HINTaSCWRL 
output is depicted by the red line, while SCWRL output is shown in blue. 
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Figure 4.4 continued 
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4.8 SELECTED HINTASCWRL OUTPUT STRUCTURES 
4.8.1 Specific Case Studies 
Considering the aims of this project, it is of immense interest to compare the 
output structures of HINTaSCWRL and SCWRL with the original PDB and then to 
compare both output structures to each other. This will tell us how successful either 
program is in predicting sidechain positions. More importantly, since we are mainly 
interested in assessing the compatibility between Dunbrack‘s rotamer library and the 
HINT scoring function, we would ideally like to see similar predictions by both 
algorithms. It would be even better if HINTaSCWRL is able to predict structures that are 
closer to the original PDB. 
Thus, the minimum expectations from the structures predicted by our algorithm in 
order to claim success are: (A) the structures should be very close to the SCWRL 
predicted structures, unless they are closer to the original PDB and (B) most of the 
deviations should be localized near the surface of the structures, where residues enjoy 
a greater steric freedom that allows greater movement. Three randomly chosen protein 
structure predictions are presented with these aims in mind. 
Only a few residues show a high RMSD in both HINTaSCWRL and SCWRL 
programs, designated in red, while most residues have a low RMSD. For 2CYG, the 
predicted residue positions are exactly the same for both programs, as visible by the 
entirely green color in figure 4.5 (C). In retrospect, the output created by both programs 
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were not always exactly the same and varied to a certain degree, as is visible from 
figure 4.5 (F) and (I). However, the similarity between the two programs is striking 
despite a small degree of differences. 
The degree of structural deviation is described by the plots of RMSD for each 
structure in figure 4.6. While parts (A), (C) and (E) show plots of RMSD for each residue 
when compared with the original crystal structure, (B), (D) and (F) show the how much 
the two output structures deviate from each other. 
Both algorithms show similar RMSD profiles when compared to the original PDB, 
as witnessed in figure 4.6 (A), (C) and (E). In two of the three test cases showed here, 
the structures produced by HINTaSCWRL and SCWRL are very similar to each other. 
However, these two algorithms predicted vastly different structures for 4EUG, as shown 
by figure 4.6 (F). A visual inspection of the structure of 4EUG demonstrated that most of 
the RMSD between the output structures predicted by both algorithms was due to 
residues on the surface of the protein, shown in figure 4.5 (I) and hence is quite 
acceptable. 
While there was no difference between the HINTaSCWRL and SCWRL output 
structures for 2CYG, there were differences between the same for 2VC8 and 4EUG. 
The residues with the largest RMSD values for both 2VC8 and 4EUG were identified: 
Asn13 for 2VC8 and Lys171, which were both found to be on the surface. A close 
inspection of these two residues showed differences in interactions. While Lys171 for 
the HINTaSCWRL output structure showed formation of an extra H-bond, as observed 
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Figure 4.6 RMSD values plotted for each residue of 2CYG, 2VC8 and 4EUG in the 
first, second and third rows respectively. (A) (C) and (E) show RMSD values for 
HINTaSCWRL and SCWRL predicted structures in red and blue respectively. (B) (D) 
and (F) show deviations between the structures predicted by both programs in green. 
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in figure 4.7 (B). Interestingly, as is visible in figure 4.7 (A), Asn13 in the SCWRL output 
structure showed formation of an extra H-bond, which was unexpected. In contrast, the 
HINTaSCWRL output structure avoided bad hydrophobic-hydrophilic interactions with a 
nearby Ile. The formation of an additional H-bond in Asn13 within the SCWRL output 
structure must be a coincidence because this program only considers van der Waal‘s 
interactions. 
4.9 CONCLUSIONS 
The performance of our algorithm was comparable to that of SCWRL. The trend of 
RMSD distribution across 129 high resolution structures was similar for both programs, 
as was the dependence of RMSD values on solvent accessibility of the residue 
involved. It is remarkable that a number of residues were predicted very near their 
native conformations in the original PDB itself, as was shown by the random test cases 
(vide supra). It was observed that our algorithm would select different conformations of 
residue sidechains when it detected energetically favorable interactions that were not 
detected by SCWRL. The RMSD profiles of SCWRL and HINTaSCWRL predicted 
structures were similar to each other. In two of the three cases, both algorithms 
predicted very similar positions for all sidechains. However, there was one case in 
which the predictions were notably different. On the other hand, it was clearly shown 
that the all the residues which were predicted differently by the two algorithms existed 
on the surface of the proteins. Thus, this was not a concern because the higher steric 
freedom afforded to the surface residues allows movement and thus deviation is 
expected. 
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Figure 4.7 Positions of Sidechain Showing Highest Deviation. (A) Asn13 of 2VC8 in 
the SCWRL structure shows an extra H-bond while the same in the HINTaSCWRL 
structure shows none. (B) Lys171 of the HINTaSCWRL structure shows an additional 
H-bond compared with the same in the SCWRL predicted structure. 
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With these facts in mind, we may again ask ourselves: Are we able to emulate 
SCWRL and its ability to optimize sidechains? Since the structures predicted by both 
algorithms are very close to each other, with the major deviations isolated on the 
surface of the protein, we can assuredly say yes! We cannot, however, make a claim 
about improving sidechain prediction capabilities of SCWRL, at least with regard to 
emulating crystal structures.  
However, the major aim of this project was not to emulate or improve sidechain 
optimization already provided by SCWRL, but to ascertain the ability to use HINT in 
conjunction with backbone-dependent rotamer libraries. Since the output structures 
obtained from our algorithm were extremely close to those produced by SCWRL and 
the differences were ascertained in the sample test cases to be caused by improved 
interactions, we have successfully fulfilled this aim. 
At the same time, this project is still in its infancy. Therefore, we must stress the 
possibility that further experimentation with the sidechain placement algorithm and 
scoring function could possibly provide us with much improved sidechain placement. 
4.10 FUTURE DIRECTIONS 
With the implementation of the HINTaSCWRL algorithm, the compatibility 
between HINT and sidechain rotamer libraries has been established. The next stage of 
this project will be to create an algorithm that optimizes residue sidechains in the 
immediate vicinity of docked ligands. This new algorithm will be somewhat different from 
the current state of HINTaSCWRL because at present the latter only considers 
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interactions within the protein; the sidechain positioning in the next stage will have to 
balance intra-protein interactions with protein-ligand interactions. Moreover, the role of 
backbone-dependent vs. backbone-independent rotamer libraries in such an algorithm 
will have to be investigated. 
Simultaneously, modifications in the sidechain placement strategy and scoring 
function must be explored in order to attempt improvement of the algorithm itself. The 
scaling of steric and hydropathic components of the HINT score is one possible avenue 
for exploration. This will be an interesting avenue to explore because packing methods 
have traditionally been adequate to place sidechains in algorithms such as SCWRL. 
Packing methods (i.e., using steric potentials such as the Lennard-Jones potential 
function and its variants) have proven to be especially useful due to the ease of 
implementation and enhanced speed of execution, thereby providing reasonable results 
within shorter runtimes. In contrast, a scoring function such as HINT takes longer to 
execute. However, it can account for several other kinds of interactions other than (and 
including) sterics. This should, at least in theory, allow better sidechain placement 
compared to algorithms that employ simple Lennard-Jones potentials. 
Furthermore, weighting the probability factor could possibly enhance the quality 
of sidechain optimization. However, it is unlikely that simple modulation of the HINT 
score and probability factors alone will allow better emulation of crystal structures 
(compared to SCWRL), especially if the sidechain positions are being provided by a 
rotamer library. Unless such rotamer libraries are exhaustive, it might be difficult to 
cover sufficient conformational space to achieve highly accurate predictions. Thus, 
  
164 
 
sidechains might have to be rotated, in which case a strategy will have to be devised to 
overcome the combinatorial explosion which is imminent. This strategy can perhaps 
also be implemented during resolution of sidechain clashes. 
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CHAPTER 5 
CONCLUSIONS 
Hydrophobicity impacts every aspect of drug design and even delivery, as has 
been repeatedly pointed out over the past century and within this dissertation.  Studies 
of this phenomenon have resulted in multiple theories, algorithms and tools for applying 
the concept.  A large amount of effort has been put forth into studying the partition 
coefficient both experimentally, especially in terms of its prediction because of its 
importance in ―druggability‖ of compounds.  Many theoretical methods are robust in 
estimating LogP for molecules similar to their training set, but large errors are fairly 
common for compounds with large chemical and structural differences from that set.   
Since Hansch and Fujita introduced the QSAR method, drug design projects 
have repeatedly found use for hydrophobic parameters.  This dependence of drug 
design on lipophilicity is intuitive, arising from drugs and proteins coming together, or 
proteins folding, in order to reduce the surface area in contact with polar water 
molecules.  Quantification of this phenomenon has taken many forms, such as 
calculating of hydrophobic surface contact area to represent hydrophobic interactions, 
supplementing 3D QSAR with hydrophobic fields (HINT and MLP) [1-3] and direct 
quantification of intermolecular interactions with HINT [4-8].  While there are numerous 
force fields available, most are Newtonian in origin and concentrate on H-bonding, 
Coulombic interactions, van der Waal‘s interactions and London forces for estimating 
the strength of molecular interactions, all of which are mostly if not entirely enthalpic.  
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HINT is different in that it accounts for both hydrophobic and hydrophilic interactions 
and is therefore representative of enthalpic, as well as that of entropic contributions 
towards biological interactions, being derived from a free energy experiment.  The 
availability of the HINT toolkit [9] makes it possible to develop application programs for 
computer-aided drug discovery and design. 
In this work, we presented current state of the projects aimed at exploring our 
hypothesis that most biological phenomena can be explained by addressing 
hydrophobic and hydrophilic interactions. The efflux pump project best epitomized the 
validity of this hypothesis. While the HINT force field has been successfully 
implemented in characterizing binding of small molecules to macromolecular targets 
and also intermacromolecular interactions in the past [4-8], these multidrug transporters 
posed a significantly different and complex challenge. The very fact that these huge 
proteins do not just bind small molecules, but transport them, was the root of this 
challenge. In theory, any such transport mechanism should be addressable by treating it 
as a series of consecutive and independent binding events. In accordance with this, we 
devised a method where HINT scores (representing these consecutive binding events) 
were used to successfully predict MIC ratios of multiple antibiotics of various classes, in 
conjunction with certain properties of the antibiotics themselves. It was found that LogP 
was a major contributor in the statistical models generated therein. However, the same 
descriptor alone was insufficient to achieve the same degree of predictability. More 
importantly, LogP itself is a measure of the efflux substrates hydrophobic nature and its 
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contribution towards the final model represents another way in which hydrophobic 
interactions might affect biomolecular phenomena and thereby supports our hypothesis. 
The third chapter described our attempts at discovery of antiviral agents, which 
resulted in identification of several interesting compounds, of which 34% were found to 
inhibit hemagglutinin-neuraminidase. This project produced only moderate success 
rates, partly due to some problems with the tools employed therein – particularly the 
inability of docking methods to effectively address induced-fit during binding of small 
molecules. We chose to design new in-house tools in order to address these problems 
in the long run and have presented our preliminary investigation towards establishing 
feasibility of the project herein. Our studies showed that even at the simplest level of 
implementation, the HINT scoring function successfully placed sidechains for residues, 
given the backbone coordinates, which is another example where our hypothesis 
appears to be true. It must be admitted though, that work on this project has only just 
begun and a lot more needs to be done before we can claim that our hypothesis is true 
beyond doubt in the context of this project. With the results of this project in mind, we 
have chosen rotamer libraries and the HINT scoring function as our basis for design of 
new tools to simulate target flexibility. Further attempts at optimizing the sidechain 
optimization algorithm will also continue. It is generally accepted that proteins fold in 
such a way that hydrophobic groups are largely shielded from water by hydrophilic 
groups. While evaluating the factors that affect prediction of protein folds, Park et al. 
noted that hydrophobicity of residues is the largest force defining protein structure, but 
that other factors were involved as well [10].  Accurate hydrophobicity measurements 
  
170 
 
and estimation of hydrophobic interactions could therefore have a tremendous impact 
on the modeling of not only protein folding, but also side chain orientation.  Better 
modeling and representation of both protein folding as well as side chain positioning, 
will also contribute to the understanding of biological processes which are significantly 
altered by macromolecular flexibility. 
Overall, good progress was made towards the implementation of our hydropathic 
force field in predictive model building and the design of new tools. There is no doubt in 
our mind that application of this methodology in computational life sciences and 
computer-aided drug design will lead to accurate theoretical prediction of biological 
phenomena. The complex phenomena of hydrophobicity and hydrophobic interactions 
are still only poorly understood and remain quite difficult to simulate. However, 
understanding and exploiting the hydrophobic effect in drug design, e.g., docking, target 
structure prediction, etc., will undoubtedly be increasingly important in the future. 
Hydrophobicity may not be the ―Holy Grail‖ of biomolecular phenomena, but it is 
definitely the one of the ―Commandments‖. 
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APPENDICES 
Appendix A 
List of Hits from Virtual Screening for Hemagglutinin-Neuraminidase Inhibitors 
ZINC ID HINT Score Database 
ZINC04552407 6783.014 Sigma Aldrich 
ZINC04533949 6772.188 Sigma Aldrich 
ZINC01530138 6701.919 Sigma Aldrich 
ZINC04825403 6504.188 Sigma Aldrich 
ZINC01737956 6410.739 Sigma Aldrich 
ZINC02384787 6387.623 Sigma Aldrich 
ZINC03873854 6317.374 Sigma Aldrich 
ZINC03873852 6260.759 Sigma Aldrich 
ZINC03873853 6125.606 Sigma Aldrich 
ZINC03873185 6120.066 Sigma Aldrich 
ZINC03873855 5931.146 Sigma Aldrich 
ZINC04544949 5902.57 Sigma Aldrich 
ZINC04545884 5895.988 Sigma Aldrich 
ZINC02390911 5886.638 Sigma Aldrich 
ZINC03871260 5865.923 Sigma Aldrich 
ZINC03830892 5855 Sigma Aldrich 
ZINC04899504 5842.17 Sigma Aldrich 
ZINC01529261 5760.611 Sigma Aldrich 
ZINC03873184 5660.111 Sigma Aldrich 
ZINC05274030 5658.885 Sigma Aldrich 
ZINC04544668 5558.37 Sigma Aldrich 
ZINC04556739 5543.093 Sigma Aldrich 
ZINC05295094 5479.984 Sigma Aldrich 
ZINC03873183 5478.967 Sigma Aldrich 
ZINC04556499 5465.758 Sigma Aldrich 
ZINC03014483 5445.177 Sigma Aldrich 
ZINC04899413 5437.815 Sigma Aldrich 
ZINC02508221 5420.523 Sigma Aldrich 
ZINC05274031 5374.107 Sigma Aldrich 
ZINC03870127 5365.563 Sigma Aldrich 
ZINC04533780 5351.754 Sigma Aldrich 
ZINC05274029 5350.48 Sigma Aldrich 
ZINC04533783 5330.799 Sigma Aldrich 
ZINC04214182 5325.671 Sigma Aldrich 
ZINC03873186 5316.4 Sigma Aldrich 
ZINC03830893 5265.247 Sigma Aldrich 
ZINC04556495 5250.292 Sigma Aldrich 
ZINC04533725 5241.01 Sigma Aldrich 
ZINC02390912 5217.136 Sigma Aldrich 
ZINC03871275 5209.737 Sigma Aldrich 
ZINC03873187 5182.773 Sigma Aldrich 
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ZINC05273655 5153.94 Sigma Aldrich 
ZINC04533726 5144.388 Sigma Aldrich 
ZINC03830452 5120.193 Sigma Aldrich 
ZINC01569744 5117.354 Sigma Aldrich 
ZINC03873182 5082.202 Sigma Aldrich 
ZINC03871276 4990.011 Sigma Aldrich 
ZINC03873188 4983.702 Sigma Aldrich 
ZINC01575534 4962.166 Sigma Aldrich 
ZINC02384673 4912.327 Sigma Aldrich 
ZINC00236772 4869.534 Vitas 
ZINC04556815 4853.672 Sigma Aldrich 
ZINC04533731 4853.62 Sigma Aldrich 
ZINC04552406 4840.231 Sigma Aldrich 
ZINC02707649 4832.24 LifeChemicals 
ZINC05274037 4823.205 Sigma Aldrich 
ZINC03869424 4815.127 Sigma Aldrich 
ZINC03014482 4809.821 Sigma Aldrich 
ZINC04531662 4791.451 Sigma Aldrich 
ZINC05257890 4786.626 LifeChemicals 
ZINC04820544 4744.787 Sigma Aldrich 
ZINC04106683 4699.967 Keyorganics 
ZINC05274006 4696.594 Sigma Aldrich 
ZINC01607828 4689.038 Sigma Aldrich 
ZINC05257957 4688.907 LifeChemicals 
ZINC05257889 4684.735 LifeChemicals 
ZINC04556493 4681.904 Sigma Aldrich 
ZINC04533734 4643.627 Sigma Aldrich 
ZINC03872461 4643.069 Sigma Aldrich 
ZINC04533843 4641.547 Sigma Aldrich 
ZINC03873181 4634.583 Sigma Aldrich 
ZINC01210754 4615.563 Vitas 
ZINC05273546 4585.158 Sigma Aldrich 
ZINC03871263 4572.668 Sigma Aldrich 
ZINC02575474 4554.932 Sigma Aldrich 
ZINC04533732 4552.692 Sigma Aldrich 
ZINC04939701 4546.525 LifeChemicals 
ZINC04533735 4496.596 Sigma Aldrich 
ZINC03870005 4465.234 Sigma Aldrich 
ZINC05274008 4386.57 Sigma Aldrich 
ZINC03872463 4378.871 Sigma Aldrich 
ZINC04760528 4363.481 Sigma Aldrich 
ZINC04544665 4358.829 Sigma Aldrich 
ZINC04511392 4318.523 Asinex 
ZINC04514036 4302.86 Sigma Aldrich 
ZINC04513860 4294.716 Sigma Aldrich 
ZINC04556886 4291.104 Sigma Aldrich 
ZINC04543872 4283.146 Sigma Aldrich 
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ZINC05273678 4276.885 Sigma Aldrich 
ZINC04566466 4269.913 Sigma Aldrich 
ZINC06142968 4261.341 Otava 
ZINC01893413 4243.928 Otava 
ZINC04739725 4236.693 Vitas 
ZINC04566465 4205.4 Sigma Aldrich 
ZINC05273548 4201.266 Sigma Aldrich 
ZINC05511105 4191.064 Otava 
ZINC01638013 4186.778 Sigma Aldrich 
ZINC04533969 4184.555 Sigma Aldrich 
ZINC04024388 4177.399 Keyorganics 
ZINC04291876 4159.401 LifeChemicals 
ZINC04291877 4154.487 LifeChemicals 
ZINC03872462 4152.638 Sigma Aldrich 
ZINC04099087 4145.463 Sigma Aldrich 
ZINC03999322 4136.824 Sigma Aldrich 
ZINC01607692 4134.645 Sigma Aldrich 
ZINC05260452 4134.227 Sigma Aldrich 
ZINC04557073 4121.642 Sigma Aldrich 
ZINC03869383 4119.558 Sigma Aldrich 
ZINC02575489 4091.542 Sigma Aldrich 
ZINC04514038 4079.696 Sigma Aldrich 
ZINC04556887 4048.887 Sigma Aldrich 
ZINC04545848 4048.283 Sigma Aldrich 
ZINC04544666 4045.601 Sigma Aldrich 
ZINC02685419 4044.966 LifeChemicals 
ZINC04159200 4032.111 LifeChemicals 
ZINC04533971 4030.039 Sigma Aldrich 
ZINC05511098 4024.855 Otava 
ZINC02685397 4023.99 LifeChemicals 
ZINC02685329 4003.465 LifeChemicals 
ZINC02685344 3997.909 LifeChemicals 
ZINC04535978 3996.699 Sigma Aldrich 
ZINC03871262 3987.519 Sigma Aldrich 
ZINC02685352 3980.843 LifeChemicals 
ZINC05545049 3971.142 Otava 
ZINC05273579 3967.291 Sigma Aldrich 
ZINC04514042 3961.863 Sigma Aldrich 
ZINC01893410 3958.873 Otava 
ZINC00236768 3958.214 Vitas 
ZINC01805621 3951.552 LifeChemicals 
ZINC02685380 3927.787 LifeChemicals 
ZINC00574780 3927.28 Vitas 
ZINC04040894 3923.655 Keyorganics 
ZINC05511073 3918.173 Otava 
ZINC05260460 3916.985 Sigma Aldrich 
ZINC04660887 3913.51 Otava 
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ZINC05273547 3908.913 Sigma Aldrich 
ZINC01893416 3874.391 Otava 
ZINC00816404 3862.188 Otava 
ZINC01576098 3857.324 Sigma Aldrich 
ZINC02685391 3856.261 LifeChemicals 
ZINC04507507 3842.097 Sigma Aldrich 
ZINC05274009 3832.105 Sigma Aldrich 
ZINC03394329 3823.13 Enamine 
ZINC04556744 3821.942 Sigma Aldrich 
ZINC04513863 3818.507 Sigma Aldrich 
ZINC04533809 3811.679 Sigma Aldrich 
ZINC04521828 3811.322 Sigma Aldrich 
ZINC06143684 3808.482 Otava 
ZINC01120022 3806.062 Otava 
ZINC02043137 3802.661 Sigma Aldrich 
ZINC04552284 3801.73 Sigma Aldrich 
ZINC01805618 3798.232 Otava 
ZINC02685333 3785.887 LifeChemicals 
ZINC05260454 3780.27 Sigma Aldrich 
ZINC04545932 3778.958 Sigma Aldrich 
ZINC05511099 3776.205 Otava 
ZINC05235949 3771.423 Otava 
ZINC02685401 3754.075 LifeChemicals 
ZINC03870800 3743.268 Sigma Aldrich 
ZINC02685375 3740.393 LifeChemicals 
ZINC04556500 3733.955 Sigma Aldrich 
ZINC05258510 3732.108 LifeChemicals 
ZINC02685370 3731.883 LifeChemicals 
ZINC02252499 3729.479 Vitas 
ZINC04552272 3716.438 Sigma Aldrich 
ZINC03871402 3712.854 Sigma Aldrich 
ZINC03870109 3712.259 Sigma Aldrich 
ZINC04735783 3706.273 Otava 
ZINC04523248 3701.213 Sigma Aldrich 
ZINC04533781 3700.264 Sigma Aldrich 
ZINC04534321 3685.927 Sigma Aldrich 
ZINC04543589 3664.898 Sigma Aldrich 
ZINC04660890 3648.144 Otava 
ZINC04552275 3638.23 Sigma Aldrich 
ZINC05511076 3623.76 Otava 
ZINC05545035 3621.934 Otava 
ZINC02522613 3618.054 Sigma Aldrich 
ZINC04735797 3616.808 Otava 
ZINC04534319 3616.223 Sigma Aldrich 
ZINC04672996 3613.007 Vitas 
ZINC04523366 3605.412 Sigma Aldrich 
ZINC04065004 3598.52 Vitas 
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ZINC05885060 3586.05 Enamine 
ZINC05260451 3577.245 Sigma Aldrich 
ZINC05273572 3568.69 Sigma Aldrich 
ZINC04735821 3558.965 Otava 
ZINC01893395 3554.209 Otava 
ZINC06590276 3528.214 Enamine 
ZINC02047153 3528.206 Sigma Aldrich 
ZINC04514046 3514.745 Sigma Aldrich 
ZINC04677137 3492.472 Vitas 
ZINC04083848 3490.832 Vitas 
ZINC04187766 3476.841 Vitas 
ZINC05511070 3470.568 Otava 
ZINC05511066 3463.047 Otava 
ZINC05511089 3443.054 Otava 
ZINC04735769 3406.209 Otava 
ZINC03268222 3401.479 Enamine 
ZINC04304712 3385.03 Otava 
ZINC04739051 3373.027 Vitas 
ZINC01122862 3367.326 Vitas 
ZINC04167058 3300.651 LifeChemicals 
ZINC00969636 3290.01 LifeChemicals 
ZINC05511112 3261.722 Otava 
ZINC01206008 3237.435 Otava 
ZINC00038207 3231.201 TimTec 
ZINC05235951 3228.151 Otava 
ZINC04939716 3220.544 LifeChemicals 
ZINC00653397 3201.981 TimTec 
ZINC03305588 3164.451 Enamine 
ZINC02700719 3131.295 LifeChemicals 
ZINC04373351 3124.746 Asinex 
ZINC00556918 3109.576 Otava 
ZINC02699820 3093.368 LifeChemicals 
ZINC05516169 3086.172 Otava 
ZINC00783224 3050.043 Asinex 
ZINC03274602 3048.249 Enamine 
ZINC03218782 3035.004 Enamine 
ZINC03248836 2934.242 Enamine 
ZINC01782161 2869.992 Otava 
ZINC02710650 2829.9 LifeChemicals 
ZINC04106684 2818.322 Keyorganics 
ZINC03217938 2801.973 Enamine 
ZINC04513866 2798.426 TimTec 
ZINC00839413 2732.374 TimTec 
ZINC04373354 2729.865 Asinex 
ZINC06590275 2702.556 Enamine 
ZINC00783223 2678.131 Asinex 
ZINC03358847 2656.639 Enamine 
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ZINC00074476 2629.257 Asinex 
ZINC04482492 2608.585 Enamine 
ZINC02685062 2599.128 Otava 
ZINC05827290 2584.551 Enamine 
ZINC07157728 2554.532 Enamine 
ZINC04993151 2544.796 Asinex 
ZINC03269810 2523.898 Enamine 
ZINC04660889 2522.86 Otava 
ZINC04037814 2517.244 Asinex 
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APPENDIX B 
Descriptor Values for All Antibiotics  
Antibiotic Efflux LogP MolWidth HINTnB HINTZ3 HINTcE HINTAcrBHole 
1 2 0.22 8.824 1421.4049 349.9535 269.3283 -358.842 
2 1.322 0.63 7.8673 -48.9615 208.3675 803.6375 -192.874 
3 1 1.67 8.4704 359.8735 -19.4607 759.0005 -563.7534 
4 0 0.78 8.5204 895.124 609.4122 1161 -141.4805 
5 0 -2.18 8.1583 1180.493 -407.6976 1681.1809 -511.7244 
6 1.585 0.14 7.6195 684.2153 654.4504 676.4913 365.8505 
7 0 -1.54 8.7335 -234.6077 1042.9979 823.7745 265.72 
8 0.585 1.57 8.9935 219.3652 892.0615 1536.8369 152.3447 
9 0.585 -0.01 8.6566 727.4464 694.5172 395.6584 -171.2888 
10 3.585 -0.24 8.8245 1036.7676 281.1794 -310.9403 -83.5398 
11 2.415 -0.05 8.2824 1369.0051 626.1984 624.5814 -1084.8589 
12 1 -0.11 11.03 531 840.4 460.5 -476.7 
13 0.415 -0.38 8.4421 11.3957 320.7032 -437.5324 -1774.9761 
14 0 -0.4 8.3236 1086.635 -342.8607 1831.3839 -471.9541 
15 0 0.6 9.5402 420.3004 701.2516 798.1672 -1500.9824 
16 4.087 1.92 6.9961 -169.3248 -33.8065 -321.4585 -398.8438 
17 0 -1.43 7.8187 266.208 -427.9128 1417.8339 264.2717 
18 1.322 1.13 7.0743 673.8554 -441.0727 154.8593 -135.5974 
19 1.415 0.88 7.066 883 1188.2214 2641.8313 1230.6249 
20 0 0.75 7.7892 1033 724.1004 2229.8894 1100.3538 
21 8.585 2.05 8.7708 897.123 -1201.1604 -372.9877 -116.3972 
22 1.322 0.37 7.3337 1031.1724 -749.2806 653.3875 -2067.1899 
23 5.170 0.21 10.16 576.3 354.8 234.4 -604 
24 7 3.21 8.8458 302.0901 -645.2233 12.4986 -891.8931 
25 7.415 2.61 8.5613 876.5013 -1601.5297 -667.899 -30.9436 
26 2.585 0.2 9.9196 183.9795 -330.1823 355.9706 -324.9861 
27 4 0.67 10.9224 49.3987 147.8679 -35.149 -172.376 
28 0 0.06 7.87 891.5 265.4 1209.4 -321.2 
29 1 1.41 6.9541 1038.7643 -668.0494 -547.1687 -517.5837 
30 2 0.24 6.9829 351.8297 -862.1061 -127.8168 -968.7239 
31 0 -0.19 7.3593 1248.1177 1084.7677 2562.1274 -356.574 
32 0 0.22 8.4364 914.1481 -276.4886 604.3444 -809.584 
33 2.585 0.11 7.2725 520.443 1222.7812 1487.6881 -311.5596 
34 3 0.98 8.4555 -744.2012 -80.3125 164.3973 42.7482 
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35 3 -0.91 9.4782 -278.7676 -67.7812 -786.8657 -1105.425 
36 7 2.56 9.3903 419.9081 248.6562 172.3196 -25.4482 
37 3 2.1 5.9864 436.4709 339.5 259.7588 231.7992 
38 3 -0.56 8.881 -879.8488 -272.5312 -110.5498 -358.8451 
39 0 0.15 6.2727 440.6515 259.0312 314.0884 -305.9413 
40 5.736 3.07 8.6761 -394.235 -420.5938 982.9062 -493.9512 
41 1 0.95 9.6246 360.6436 321.3438 -264.627 -638.6501 
42 8 4.33 9.0142 318.0577 110.0312 921.7446 -49.2852 
43 2 -0.57 9.0729 62.2588 587.7812 -621.0016 -471.9078 
44 0 -0.47 9.4612 -44.4861 440.125 -599.4806 -651.1274 
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